data_2kl7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.813 0.339 . . . . 62.130000000000003 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 64.349999999999994 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.030000000000001 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.409999999999997 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.119999999999997 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.239999999999995 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.4 ' HE2' ' HG3' ' A' ' 56' ' ' PRO . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.040000000000006 111.285 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.450000000000003 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.439999999999998 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 72.129999999999995 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.239999999999995 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.349999999999994 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.150000000000006 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.319999999999993 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.030000000000001 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 72.540000000000006 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.439999999999998 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.019999999999996 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 71.400000000000006 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.319999999999993 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.219999999999999 110.364 174.367 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 109.89 -0.411 . . . . 75.120000000000005 109.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.129999999999995 114.409 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.149999999999999 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.4 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.120000000000005 111.501 172.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 74.430000000000007 113.779 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.400000000000006 113.259 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.009999999999998 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.200000000000003 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.310000000000002 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.219999999999999 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 43.119999999999997 110.738 -176.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.121 0.415 . . . . 64.230000000000004 112.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.549999999999997 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.310000000000002 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 75.219999999999999 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.239999999999995 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.010000000000005 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.230000000000004 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.239999999999995 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.420000000000002 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.340000000000003 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 72.5 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.520000000000003 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 75.409999999999997 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.409 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 74.430000000000007 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.240000000000002 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 75.230000000000004 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.239999999999995 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 73.129999999999995 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 75.540000000000006 110.96 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.011 -0.366 . . . . 74.400000000000006 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 74.340000000000003 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.400000000000006 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.340000000000003 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.010000000000005 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.420000000000002 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 72.209999999999994 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 71.239999999999995 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.9 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 64.310000000000002 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.229999999999997 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.540000000000006 110.57 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HB2' ' HZ1' ' A' ' 18' ' ' LYS . 47.8 mt-10 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.140000000000001 112.124 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 75.099999999999994 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.510000000000005 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.120000000000005 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 71.540000000000006 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HZ1' ' HB2' ' A' ' 11' ' ' GLU . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.540000000000006 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD13 ' HE2' ' A' ' 18' ' ' LYS . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.420000000000002 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 75.099999999999994 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.129999999999995 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 53.149999999999999 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.219999999999999 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 75.200000000000003 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.140000000000001 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.403 HD13 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.540000000000006 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.5 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 64.409999999999997 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.403 ' HB2' ' HE3' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 74.140000000000001 111.105 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 110.197 -0.298 . . . . 73.439999999999998 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.019999999999996 115.387 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.9 m120 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 65.049999999999997 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 75.010000000000005 112.28 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 71.25 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.099999999999994 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.239999999999995 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.049999999999997 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.420000000000002 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 71.340000000000003 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.409999999999997 111.045 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.593 0.235 . . . . 64.319999999999993 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.099999999999994 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.299999999999997 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.329999999999998 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.230000000000004 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.403 ' HE2' ' HG3' ' A' ' 56' ' ' PRO . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.209999999999994 111.945 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 75.109999999999999 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.109999999999999 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 74.420000000000002 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 74.230000000000004 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.329999999999998 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.040000000000006 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.507 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 61.0 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 74.230000000000004 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.219999999999999 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 75.109999999999999 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.129999999999995 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.099999999999994 110.138 171.328 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.519 0.2 . . . . 73.5 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.129999999999995 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 73.239999999999995 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.109999999999999 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 52.340000000000003 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.329999999999998 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 71.219999999999999 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.009999999999998 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.239999999999995 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.230000000000004 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.109999999999999 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 75.140000000000001 111.623 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 75.010000000000005 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.319999999999993 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.329999999999998 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.299999999999997 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.010000000000005 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.010000000000005 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.230000000000004 112.048 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.230000000000004 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.140000000000001 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.129999999999995 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 75.019999999999996 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.120000000000005 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 62.25 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.540000000000006 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 75.329999999999998 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.350000000000001 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.450000000000003 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.450000000000003 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.451 172.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.737 0.303 . . . . 74.239999999999995 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.565 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 75.430000000000007 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.230000000000004 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 72.530000000000001 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.210000000000001 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.219999999999999 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.140000000000001 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.049999999999997 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.099999999999994 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.240000000000002 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.219999999999999 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.033 -178.723 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.858 0.361 . . . . 74.510000000000005 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.519999999999996 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.439999999999998 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.530000000000001 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.120000000000005 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 74.209999999999994 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 72.120000000000005 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.140000000000001 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 63.340000000000003 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.540000000000006 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.239999999999995 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 75.219999999999999 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 74.239999999999995 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 63.200000000000003 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.340000000000003 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 65.200000000000003 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.329999999999998 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.400000000000006 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 72.420000000000002 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 112.291 -179.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.716 0.293 . . . . 73.230000000000004 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.040000000000006 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 74.329999999999998 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.239999999999995 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.049999999999997 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 72.340000000000003 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 71.319999999999993 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.109999999999999 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.329999999999998 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.120000000000005 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.399999999999999 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 74.430000000000007 110.241 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.866 0.321 . . . . 72.319999999999993 111.866 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.150000000000006 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.409999999999997 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 72.150000000000006 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.129999999999995 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD12 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.209999999999994 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.120000000000005 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 75.239999999999995 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.140000000000001 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.299999999999997 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.540000000000006 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.456 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.219999999999999 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 72.540000000000006 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.150000000000006 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 75.349999999999994 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 70.340000000000003 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 73.439999999999998 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 74.540000000000006 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.112 173.205 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 110.012 -0.366 . . . . 72.510000000000005 110.012 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 74.239999999999995 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 74.019999999999996 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.340000000000003 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.539999999999999 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 75.200000000000003 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.340000000000003 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.430000000000007 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.530000000000001 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.299999999999997 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.230000000000004 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.239999999999995 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 64.430000000000007 111.435 -176.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.030000000000001 113.169 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.120000000000005 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.340000000000003 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.510000000000005 114.075 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.299999999999997 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.439999999999998 112.721 -169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 75.209999999999994 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.229999999999997 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.530000000000001 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.099999999999994 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 65.209999999999994 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 74.519999999999996 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.420000000000002 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.539999999999999 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 73.530000000000001 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.430000000000007 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 74.099999999999994 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.299999999999997 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 71.239999999999995 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.109999999999999 111.768 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 53.340000000000003 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 62.140000000000001 110.79 174.195 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.297 -0.26 . . . . 72.430000000000007 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.109999999999999 112.874 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.340000000000003 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.340000000000003 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.540000000000006 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.349999999999994 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 71.430000000000007 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.239999999999995 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.319999999999993 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.400000000000006 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.540000000000006 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.150000000000006 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.439999999999998 111.673 177.058 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.129999999999995 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.604 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 74.030000000000001 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 72.030000000000001 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.349999999999994 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.509999999999998 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 62.310000000000002 111.889 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.349999999999994 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.140000000000001 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 73.219999999999999 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.109999999999999 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.219999999999999 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 64.430000000000007 113.026 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 75.140000000000001 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.549999999999997 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 62.409999999999997 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.040000000000006 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 64.340000000000003 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 73.340000000000003 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 74.540000000000006 110.739 175.629 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 120.806 0.336 . . . . 74.099999999999994 111.132 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.711 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.420000000000002 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.129999999999995 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.711 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.430000000000007 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.656 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.230000000000004 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.010000000000005 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.099999999999994 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.497 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.140000000000001 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 63.32 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 61.43 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.010000000000005 111.252 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.705 0.288 . . . . 63.509999999999998 111.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.010000000000005 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 71.129999999999995 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.430000000000007 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.409999999999997 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.109999999999999 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.230000000000004 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.140000000000001 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 61.240000000000002 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.430000000000007 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.120000000000005 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.229999999999997 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 75.540000000000006 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.435 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.430000000000007 111.246 173.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.507 HD13 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 74.099999999999994 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.200000000000003 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.519999999999996 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.409999999999997 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.439999999999998 112.093 -177.676 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.518 0.199 . . . . 75.230000000000004 110.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.310000000000002 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 74.099999999999994 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.239999999999995 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 72.310000000000002 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.209999999999994 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 73.019999999999996 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.420000000000002 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.450000000000003 109.814 173.085 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 65.510000000000005 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 71.540000000000006 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.120000000000005 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 112.063 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.439999999999998 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.439999999999998 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.310000000000002 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.109999999999999 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 64.239999999999995 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 62.439999999999998 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.329999999999998 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 74.340000000000003 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.400000000000006 111.138 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 75.129999999999995 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 74.319999999999993 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 75.040000000000006 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.140000000000001 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 74.299999999999997 110.328 173.132 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 110.476 -0.194 . . . . 75.200000000000003 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.47 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.400000000000006 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.120000000000005 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 64.519999999999996 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.319999999999993 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.430000000000007 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 53.039999999999999 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.510000000000005 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 70.150000000000006 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.150000000000006 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.230000000000004 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.519999999999996 110.858 178.432 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.901 0.381 . . . . 75.230000000000004 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 63.340000000000003 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 61.399999999999999 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 65.310000000000002 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 71.019999999999996 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.530000000000001 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 73.349999999999994 112.153 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.340000000000003 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.120000000000005 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.200000000000003 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 73.150000000000006 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 73.230000000000004 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 71.219999999999999 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 73.409999999999997 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 75.439999999999998 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.319999999999993 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.200000000000003 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.109999999999999 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.420000000000002 111.594 178.581 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.619 0.247 . . . . 71.310000000000002 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.439999999999998 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.439999999999998 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.648 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 72.310000000000002 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 63.0 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.209999999999994 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.109999999999999 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 71.109999999999999 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 74.409999999999997 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 73.129999999999995 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.319999999999993 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.420000000000002 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.519999999999996 109.975 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.781 0.324 . . . . 75.239999999999995 110.723 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.239999999999995 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 60.340000000000003 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.240000000000002 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.040000000000006 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.209999999999994 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.530000000000001 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 63.539999999999999 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.510000000000005 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.140000000000001 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.129999999999995 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.200000000000003 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 54.340000000000003 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 74.439999999999998 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.019999999999996 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.030000000000001 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.140000000000001 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 62.240000000000002 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.420000000000002 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 109.93 170.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 110.241 -0.281 . . . . 72.200000000000003 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.450000000000003 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.010000000000005 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.507 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 73.349999999999994 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.349999999999994 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.120000000000005 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.049999999999997 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.230000000000004 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.239999999999995 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 61.25 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.566 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.340000000000003 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 51.039999999999999 110.929 177.215 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.985 0.365 . . . . 72.310000000000002 111.985 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.120000000000005 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.340000000000003 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.010000000000005 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.510000000000005 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.499 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.726 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.519999999999996 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.549999999999997 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 75.540000000000006 111.645 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 53.43 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.120000000000005 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 74.430000000000007 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.240000000000002 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.519999999999996 113.244 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.329999999999998 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 75.430000000000007 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 74.430000000000007 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 62.329999999999998 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.130000000000003 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.200000000000003 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.319999999999993 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.209999999999994 111.44 178.009 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 80.2 m80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 110.004 -0.369 . . . . 74.420000000000002 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 75.299999999999997 112.974 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.439 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 74.299999999999997 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.409999999999997 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.420000000000002 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.409999999999997 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.549999999999997 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 74.299999999999997 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.120000000000005 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.439999999999998 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.140000000000001 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.37 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.530000000000001 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 75.239999999999995 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.430000000000007 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.099999999999994 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.420000000000002 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.53 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.450000000000003 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 74.120000000000005 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 73.140000000000001 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 74.019999999999996 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.150000000000006 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.340000000000003 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.340000000000003 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.120000000000005 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.150000000000006 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 63.140000000000001 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 75.349999999999994 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.140000000000001 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.219999999999999 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 72.019999999999996 111.547 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.998 0.427 . . . . 75.549999999999997 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.310000000000002 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.439999999999998 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.119999999999997 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.119999999999997 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 72.409999999999997 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.329999999999998 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 37.950000000000003 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 72.099999999999994 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.420000000000002 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.129999999999995 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.030000000000001 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.420000000000002 110.259 177.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.450000000000003 111.837 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 72.340000000000003 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 71.510000000000005 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 71.519999999999996 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.319999999999993 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.439999999999998 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' HD11 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.150000000000006 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.420000000000002 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.120000000000005 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.340000000000003 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.299999999999997 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.509999999999998 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.329999999999998 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.120000000000005 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 75.340000000000003 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.442 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.530000000000001 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.200000000000003 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.109999999999999 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.140000000000001 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 74.209999999999994 111.073 177.461 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 120.811 0.338 . . . . 70.439999999999998 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.310000000000002 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 73.549999999999997 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 72.040000000000006 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 72.420000000000002 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 36.909999999999997 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 63.43 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.230000000000004 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 63.030000000000001 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.150000000000006 111.11 178.468 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.1 0.407 . . . . 60.119999999999997 112.1 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 73.430000000000007 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.019999999999996 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.329999999999998 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.510000000000005 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 74.129999999999995 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.430000000000007 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.030000000000001 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.540000000000006 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 65.310000000000002 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 42.329999999999998 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.531 ' HA ' HG21 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.239999999999995 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.420000000000002 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 74.140000000000001 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.230000000000004 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 75.010000000000005 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 75.150000000000006 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 74.530000000000001 111.66 178.716 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 110.227 -0.286 . . . . 74.530000000000001 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 74.299999999999997 113.121 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.319999999999993 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HB2' ' HE3' ' A' ' 17' ' ' MET . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 74.219999999999999 112.267 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 75.109999999999999 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 44.399999999999999 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.140000000000001 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.040000000000006 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.150000000000006 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 62.100000000000001 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 71.0 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 60.130000000000003 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.409999999999997 110.15 176.617 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.688 0.255 . . . . 72.310000000000002 111.688 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.540000000000006 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 74.0 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.439999999999998 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.219999999999999 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.129999999999995 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.299999999999997 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.239999999999995 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.52 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.140000000000001 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.040000000000006 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.230000000000004 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 71.120000000000005 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.420000000000002 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HA ' HG21 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 72.099999999999994 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.430000000000007 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 75.400000000000006 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 73.209999999999994 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 75.409999999999997 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.140000000000001 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.329999999999998 111.964 -177.852 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.805 0.336 . . . . 74.349999999999994 111.463 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 71.019999999999996 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.049999999999997 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.683 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.200000000000003 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.450000000000003 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.310000000000002 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.409999999999997 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 71.230000000000004 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.129999999999995 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 73.239999999999995 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 71.030000000000001 111.984 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 110.807 179.698 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.162 0.43 . . . . 65.120000000000005 112.162 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.310000000000002 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.030000000000001 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.439999999999998 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 72.150000000000006 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.239999999999995 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 75.219999999999999 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD12 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.340000000000003 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 74.530000000000001 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.109999999999999 112.377 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.510000000000005 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.150000000000006 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.510000000000005 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.039999999999999 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.329999999999998 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.229999999999997 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.430000000000007 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 75.040000000000006 109.668 170.306 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.77 0.319 . . . . 52.210000000000001 111.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 63.409999999999997 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 74.140000000000001 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 61.549999999999997 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 71.239999999999995 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 73.140000000000001 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 54.43 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 73.040000000000006 111.019 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 74.439999999999998 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.420000000000002 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.209999999999994 110.958 -175.622 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.020000000000003 112.558 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.519999999999996 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.009999999999998 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.319999999999993 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.319999999999993 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 74.129999999999995 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.329999999999998 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.420000000000002 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 74.239999999999995 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.349999999999994 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.299999999999997 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.329999999999998 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.219999999999999 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 73.230000000000004 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 65.319999999999993 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.120000000000005 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.409999999999997 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 74.299999999999997 112.38 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.605 0.24 . . . . 73.530000000000001 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.310000000000002 112.664 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 71.439999999999998 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HA ' HD12 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.549999999999997 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 63.32 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.140000000000001 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.329999999999998 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 74.109999999999999 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 71.219999999999999 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 63.310000000000002 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.200000000000003 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.340000000000003 110.96 177.28 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 4' ' ' ASN . 49.3 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.619 0.247 . . . . 55.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -95.4 -53.69 3.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.868 0.366 . . . . 72.049999999999997 111.818 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 p -98.34 -7.25 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.529 0.68 . . . . 73.099999999999994 110.498 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.657 ' HB2' ' HB3' ' A' ' 1' ' ' SER . 4.4 m120 -78.86 142.01 37.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.684 -0.689 . . . . 63.350000000000001 111.735 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -100.88 -174.04 2.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.407 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.3 m -75.55 25.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.634 0.605 . . . . 75.099999999999994 112.634 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pp -98.2 2.44 48.39 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.186 0.439 . . . . 70.450000000000003 112.186 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -62.04 155.99 22.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.218 0.533 . . . . 64.409999999999997 112.361 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.69 136.83 24.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 111.008 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.2 43.91 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.718 2.279 . . . . 71.219999999999999 114.173 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.59 6.47 8.64 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.907 -0.495 . . . . 62.130000000000003 111.69 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 64.349999999999994 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.030000000000001 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.409999999999997 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.119999999999997 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.239999999999995 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.4 ' HE2' ' HG3' ' A' ' 56' ' ' PRO . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.040000000000006 111.285 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.450000000000003 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.439999999999998 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 72.129999999999995 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.239999999999995 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.349999999999994 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.150000000000006 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.319999999999993 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.030000000000001 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 72.540000000000006 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.439999999999998 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.019999999999996 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 71.400000000000006 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.319999999999993 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.96 113.43 23.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.219999999999999 110.364 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.47 137.0 32.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.176 0.512 . . . . 51.140000000000001 112.221 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.08 82.49 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.542 0.687 . . . . 75.540000000000006 111.529 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.0 pp -121.39 -166.93 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.944 -0.571 . . . . 65.310000000000002 112.45 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 164.08 2.06 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.864 0.69 . . . . 71.519999999999996 112.864 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.84 139.13 56.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.426 0.632 . . . . 65.219999999999999 112.115 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.78 51.11 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.805 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -64.09 -12.19 36.86 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 112.144 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.07 29.77 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.339 -0.458 . . . . 74.519999999999996 112.304 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.56 -179.22 3.96 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.077 0.465 . . . . 74.430000000000007 111.88 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.74 -115.77 5.73 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 116.111 -0.495 . . . . 64.409999999999997 113.975 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -88.07 126.34 2.02 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 114.475 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.67 140.08 18.46 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.831 2.354 . . . . 65.239999999999995 111.702 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.04 150.78 61.0 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.625 2.217 . . . . 74.109999999999999 113.396 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.27 -40.68 73.75 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.632 2.222 . . . . 73.5 112.253 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.71 102.13 52.76 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.255 -0.43 . . . . 73.519999999999996 110.466 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.44 127.5 14.13 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.542 2.162 . . . . 74.340000000000003 113.333 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.19 -4.45 14.34 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.695 2.263 . . . . 74.439999999999998 112.869 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -151.13 105.04 3.18 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.396 -0.366 . . . . 63.030000000000001 111.351 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -73.16 -27.91 61.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.451 0.643 . . . . 71.109999999999999 110.171 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -126.71 126.26 24.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.324 -0.853 . . . . 75.120000000000005 109.89 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.129999999999995 114.409 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.149999999999999 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.120000000000005 111.501 172.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 74.430000000000007 113.779 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.400000000000006 113.259 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.009999999999998 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.200000000000003 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.310000000000002 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.219999999999999 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -80.52 110.83 16.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 43.119999999999997 110.738 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.1 99.12 11.16 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.497 -0.774 . . . . 73.319999999999993 111.761 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -113.97 108.88 17.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.79 -0.641 . . . . 74.150000000000006 110.81 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -118.55 145.68 45.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.323 0.583 . . . . 72.219999999999999 111.793 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.2 p -98.67 -3.18 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.761 -0.654 . . . . 75.209999999999994 112.014 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.93 159.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.029 0.381 . . . . 75.299999999999997 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.843 -0.599 . . . . 71.150000000000006 111.253 175.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 112.402 0.519 . . . . 73.209999999999994 112.402 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.56 -76.24 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.838 0.681 . . . . 61.229999999999997 112.838 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -82.79 -28.48 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.581 0.585 . . . . 74.420000000000002 112.581 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.78 171.01 9.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 110.94 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' HB2' HD23 ' A' ' 7' ' ' LEU . 27.7 mt-10 -96.44 -170.48 2.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.365 0.505 . . . . 70.549999999999997 112.365 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.51 16.08 5.91 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.033 0.383 . . . . 44.509999999999998 112.033 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 5' ' ' GLU . 2.5 pt? -69.3 -6.17 27.84 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.895 0.378 . . . . 74.510000000000005 111.496 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -77.41 -174.6 3.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.934 0.397 . . . . 73.129999999999995 111.298 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.93 126.47 89.39 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.182 -0.303 . . . . 71.409999999999997 110.182 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -37.8 103.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.55 2.834 . . . . 64.319999999999993 114.08 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.48 5.84 43.56 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.795 -0.639 . . . . 64.230000000000004 112.121 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.549999999999997 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.310000000000002 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 75.219999999999999 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.239999999999995 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.010000000000005 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.230000000000004 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.239999999999995 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.420000000000002 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.340000000000003 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 72.5 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.520000000000003 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 75.409999999999997 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.409 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 74.430000000000007 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.240000000000002 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 75.230000000000004 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.239999999999995 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 73.129999999999995 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.07 154.11 22.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 75.540000000000006 110.96 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.15 124.57 31.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.086 0.47 . . . . 62.240000000000002 111.873 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 35' ' ' VAL . 21.1 m -90.17 95.02 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 64.010000000000005 111.827 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -125.6 -151.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.593 -0.73 . . . . 74.430000000000007 110.012 176.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.43 -160.8 0.8 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.094 -0.379 . . . . 74.439999999999998 110.966 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -64.44 -32.69 74.41 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.05 0.389 . . . . 73.040000000000006 112.05 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.16 112.02 8.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.986 0.422 . . . . 75.329999999999998 110.599 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -79.22 18.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.014 0.746 . . . . 71.5 113.014 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.61 22.49 64.33 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 114.528 0.571 . . . . 73.439999999999998 114.528 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.037 0.446 . . . . 61.509999999999998 111.358 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.11 -60.44 0.58 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.984 -0.627 . . . . 74.340000000000003 113.275 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.56 133.81 31.08 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.543 2.162 . . . . 74.209999999999994 112.826 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.9 151.87 14.47 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.641 2.228 . . . . 74.030000000000001 112.381 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.39 127.0 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.114 1.876 . . . . 71.430000000000007 111.98 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.73 -48.56 18.78 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.772 2.315 . . . . 73.150000000000006 112.19 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.39 99.65 42.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.981 -0.554 . . . . 71.140000000000001 110.288 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.41 119.08 6.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.627 2.218 . . . . 74.340000000000003 112.505 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.38 -29.96 72.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.186 1.924 . . . . 75.200000000000003 111.679 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.59 170.37 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.24 -0.891 . . . . 60.240000000000002 109.769 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.07 12.18 4.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 111.553 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -104.25 157.56 33.78 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.707 -0.679 . . . . 74.400000000000006 110.011 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 74.340000000000003 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.400000000000006 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.340000000000003 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.010000000000005 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.420000000000002 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 72.209999999999994 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 71.239999999999995 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.9 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 64.310000000000002 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.229999999999997 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.15 107.63 15.85 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.540000000000006 110.57 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -117.91 102.05 8.77 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.954 0.407 . . . . 74.340000000000003 110.944 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -66.77 -18.88 65.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.89 0.376 . . . . 71.010000000000005 111.27 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.7 m -62.65 -29.88 70.96 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.708 0.632 . . . . 74.329999999999998 112.708 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.76 152.41 51.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.267 0.469 . . . . 72.450000000000003 112.267 -174.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.33 174.24 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 111.627 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 119.021 -0.514 . . . . 74.420000000000002 111.704 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.604 0.24 . . . . 75.040000000000006 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.73 125.22 23.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.765 0.317 . . . . 74.010000000000005 111.828 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -76.87 146.62 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.519 0.676 . . . . 74.319999999999993 112.695 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.17 142.79 47.08 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.793 -0.64 . . . . 73.519999999999996 110.357 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB2' HD23 ' A' ' 7' ' ' LEU . 36.4 mt-10 -73.37 -178.93 3.18 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.152 0.501 . . . . 72.420000000000002 111.724 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.1 m -65.16 4.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.987 1.106 . . . . 61.219999999999999 113.987 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 5' ' ' GLU . 2.6 pt? -84.43 -14.11 50.22 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.062 -0.399 . . . . 74.530000000000001 111.282 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 5' ' ' GLU . 9.8 t -65.96 139.65 58.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.809 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.98 126.66 79.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 116.326 -0.397 . . . . 72.340000000000003 111.123 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.63 94.91 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.46 2.107 . . . . 75.230000000000004 112.363 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HB2' ' HZ1' ' A' ' 18' ' ' LYS . 47.8 mt-10 -84.09 -6.76 59.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.140000000000001 112.124 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 75.099999999999994 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.510000000000005 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.120000000000005 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 71.540000000000006 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HZ1' ' HB2' ' A' ' 11' ' ' GLU . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.540000000000006 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD13 ' HE2' ' A' ' 18' ' ' LYS . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.420000000000002 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 75.099999999999994 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.129999999999995 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 53.149999999999999 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.219999999999999 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 75.200000000000003 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.140000000000001 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.403 HD13 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.540000000000006 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.5 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 64.409999999999997 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.403 ' HB2' ' HE3' ' A' ' 17' ' ' MET . . . -86.88 154.24 21.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 74.140000000000001 111.105 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.94 36.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.879 0.696 . . . . 61.340000000000003 112.879 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -98.83 -2.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 111.676 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 37' ' ' ASN . 2.1 pp -77.85 -161.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 112.453 0.538 . . . . 70.400000000000006 112.453 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' H ' ' HB ' ' A' ' 36' ' ' ILE . 5.5 t30 -41.17 136.03 1.7 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.823 0.675 . . . . 73.349999999999994 112.823 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.93 112.94 0.74 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.02 -0.536 . . . . 75.109999999999999 111.789 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.74 63.0 5.82 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.449 0.537 . . . . 74.219999999999999 112.449 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -173.73 117.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.07 0.462 . . . . 75.540000000000006 111.369 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.58 74.47 0.44 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.392 -0.432 . . . . 75.150000000000006 112.352 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -71.61 114.12 9.36 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 73.420000000000002 111.914 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.28 -141.13 20.41 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.07 -0.586 . . . . 74.329999999999998 114.079 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.04 164.57 17.55 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.193 2.595 . . . . 71.430000000000007 113.352 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.95 118.28 5.57 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 122.321 2.014 . . . . 74.099999999999994 112.323 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.17 136.44 51.87 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.756 2.304 . . . . 73.140000000000001 113.186 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.74 -45.24 34.49 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.699 2.266 . . . . 65.030000000000001 112.377 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.7 p -135.08 98.43 12.88 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 121.526 0.679 . . . . 75.129999999999995 110.137 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.37 152.66 6.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.868 2.379 . . . . 71.120000000000005 114.003 -174.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.92 -0.03 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.628 2.219 . . . . 64.120000000000005 111.998 170.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.72 37.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.72 -0.673 . . . . 75.140000000000001 111.92 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 174.08 -20.55 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.814 -0.63 . . . . 72.239999999999995 110.487 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -149.0 118.79 4.02 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.801 -0.636 . . . . 73.439999999999998 110.197 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.019999999999996 115.387 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.9 m120 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 65.049999999999997 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 75.010000000000005 112.28 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 71.25 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.099999999999994 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.239999999999995 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.049999999999997 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.420000000000002 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 71.340000000000003 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.8 111.23 17.84 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.409999999999997 111.045 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -93.78 100.23 12.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.497 0.665 . . . . 74.329999999999998 112.066 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -87.39 -63.78 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.604 -0.517 . . . . 74.129999999999995 109.604 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.5 m 58.9 103.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.542 -0.753 . . . . 73.340000000000003 112.206 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.16 105.01 0.29 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.732 0.301 . . . . 72.129999999999995 110.563 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t 74.64 90.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.022 0.929 . . . . 53.329999999999998 111.354 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.417 -0.81 . . . . 63.409999999999997 110.407 179.379 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.814 0.34 . . . . 72.230000000000004 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -115.49 -79.96 0.59 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.182 0.438 . . . . 73.030000000000001 112.182 -172.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -121.88 113.15 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.549 0.69 . . . . 75.010000000000005 111.697 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.88 110.03 22.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.445 0.64 . . . . 73.310000000000002 111.782 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 7' ' ' LEU . 41.6 mt-10 -99.23 71.0 1.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.715 -0.675 . . . . 63.350000000000001 111.467 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.0 m 69.61 -37.61 0.38 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.163 0.431 . . . . 53.350000000000001 112.163 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 5' ' ' GLU . 1.8 pt? -76.24 35.65 0.14 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.352 0.596 . . . . 73.340000000000003 111.559 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -58.05 144.32 40.34 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.939 0.718 . . . . 74.349999999999994 112.939 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.0 mm -74.66 139.43 74.2 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.905 -0.589 . . . . 74.420000000000002 110.43 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 65.56 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.811 2.341 . . . . 75.310000000000002 113.382 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -94.44 4.85 53.32 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.144 -0.48 . . . . 64.319999999999993 111.192 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.099999999999994 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.299999999999997 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.329999999999998 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.230000000000004 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.403 ' HE2' ' HG3' ' A' ' 56' ' ' PRO . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.209999999999994 111.945 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 75.109999999999999 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.109999999999999 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 74.420000000000002 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 74.230000000000004 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.329999999999998 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.040000000000006 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.507 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 61.0 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 74.230000000000004 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.219999999999999 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 75.109999999999999 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.129999999999995 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.15 133.21 35.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.099999999999994 110.138 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB3' HG13 ' A' ' 36' ' ' ILE . . . -87.58 146.78 25.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.639 0.607 . . . . 72.430000000000007 112.639 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.31 -9.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.143 -0.48 . . . . 72.030000000000001 111.635 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 34' ' ' ALA . 2.7 pp -78.26 173.96 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.154 0.502 . . . . 72.120000000000005 112.317 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -101.92 106.25 17.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.602 0.593 . . . . 74.150000000000006 112.602 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -107.63 23.88 13.76 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.235 -0.438 . . . . 50.520000000000003 111.308 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.63 85.29 0.63 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.35 0.595 . . . . 72.239999999999995 110.38 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -111.08 -14.53 13.88 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.734 -0.666 . . . . 75.219999999999999 111.654 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.2 -139.02 41.72 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.226 -0.511 . . . . 61.329999999999998 113.492 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.82 -1.86 54.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.86 0.362 . . . . 73.150000000000006 111.641 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 169.88 -93.35 0.1 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.215 -0.516 . . . . 52.43 112.77 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 1.1 Cg_endo -82.69 111.58 2.02 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.926 2.417 . . . . 73.510000000000005 112.266 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.38 154.66 71.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.289 1.993 . . . . 64.25 112.625 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.83 150.18 79.05 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.766 2.311 . . . . 74.140000000000001 112.822 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.32 -8.24 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.82 2.347 . . . . 61.130000000000003 113.181 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.58 105.39 14.37 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.363 0.265 . . . . 64.340000000000003 111.15 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -97.1 92.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 123.201 2.6 . . . . 64.450000000000003 112.845 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.23 -16.79 19.51 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.483 2.122 . . . . 74.040000000000006 113.31 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.4 -45.83 10.81 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.887 0.329 . . . . 45.229999999999997 111.887 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 6.4 tp60 56.72 20.13 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.59 0.709 . . . . 74.439999999999998 111.341 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.85 148.5 30.39 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.966 -0.561 . . . . 73.5 110.726 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.129999999999995 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 73.239999999999995 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.109999999999999 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 52.340000000000003 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.329999999999998 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 71.219999999999999 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.009999999999998 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.239999999999995 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.230000000000004 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.109999999999999 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -94.76 110.39 22.25 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 75.140000000000001 111.623 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.86 144.15 44.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 72.5 110.711 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.01 104.04 14.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.299999999999997 110.795 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -79.32 -22.86 43.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.112 -0.495 . . . . 52.32 111.221 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m 60.72 21.03 11.05 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.142 0.423 . . . . 54.329999999999998 112.142 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.8 t -111.75 128.98 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.339 -0.391 . . . . 71.030000000000001 110.727 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.968 -0.539 . . . . 64.420000000000002 111.78 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.049 0.389 . . . . 73.420000000000002 112.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -65.89 -67.37 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.363 0.505 . . . . 71.219999999999999 112.363 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.23 152.87 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.109 0.48 . . . . 73.030000000000001 112.112 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -134.98 160.61 37.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 75.340000000000003 110.647 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.16 -171.0 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.068 0.461 . . . . 70.150000000000006 112.226 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.84 -17.17 34.31 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.374 0.879 . . . . 71.030000000000001 113.374 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -82.02 6.33 16.5 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.074 -0.391 . . . . 73.409999999999997 111.677 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -69.12 157.61 36.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.201 0.524 . . . . 74.340000000000003 112.31 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.6 134.65 57.49 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.05 -0.523 . . . . 74.409999999999997 111.062 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.52 79.77 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.82 2.347 . . . . 71.310000000000002 113.821 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -92.26 5.9 48.76 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 75.010000000000005 111.254 173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.319999999999993 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.329999999999998 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.299999999999997 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.010000000000005 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.010000000000005 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.607 ' SD ' HG11 ' A' ' 35' ' ' VAL . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.230000000000004 112.048 -172.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.230000000000004 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.140000000000001 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.129999999999995 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 75.019999999999996 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.120000000000005 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 62.25 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.540000000000006 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 75.329999999999998 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.350000000000001 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.450000000000003 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.450000000000003 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.76 154.39 22.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.451 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.46 141.22 50.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.115 0.483 . . . . 74.129999999999995 112.124 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG11 ' SD ' ' A' ' 17' ' ' MET . 23.1 m -80.57 45.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.154 0.502 . . . . 72.099999999999994 111.858 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -68.74 -166.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 112.517 0.562 . . . . 71.420000000000002 112.517 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -75.27 -83.24 0.06 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.358 0.503 . . . . 74.150000000000006 112.358 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -165.93 114.85 0.97 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.071 0.462 . . . . 72.409999999999997 111.614 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -110.61 61.25 0.61 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.148 0.499 . . . . 74.109999999999999 110.465 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -78.25 78.66 4.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.433 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 57.9 5.02 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.131 -0.556 . . . . 65.510000000000005 112.042 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -144.99 97.08 2.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.945 0.402 . . . . 73.430000000000007 110.715 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.22 -160.66 12.46 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.023 -0.535 . . . . 73.299999999999997 113.995 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.17 115.69 3.54 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.632 2.221 . . . . 74.329999999999998 112.637 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.14 138.36 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.794 2.329 . . . . 74.019999999999996 112.885 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.44 160.08 25.07 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.639 2.226 . . . . 64.239999999999995 112.853 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.02 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.3 2.0 . . . . 74.219999999999999 112.555 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.89 141.75 43.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.219 -0.446 . . . . 74.049999999999997 111.221 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.67 141.3 54.34 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.33 2.02 . . . . 75.040000000000006 112.685 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.08 -20.66 68.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.869 2.379 . . . . 72.299999999999997 113.317 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.92 85.87 0.98 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.052 0.453 . . . . 53.119999999999997 110.482 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.483 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 51.6 tt0 -151.16 174.08 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.255 -0.429 . . . . 60.420000000000002 111.282 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.483 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.2 m80 -125.07 150.2 65.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.609 0.363 . . . . 74.239999999999995 110.958 174.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.565 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 75.430000000000007 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.230000000000004 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 72.530000000000001 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.210000000000001 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.219999999999999 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.140000000000001 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.049999999999997 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.099999999999994 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.240000000000002 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.219999999999999 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -81.47 110.51 16.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.033 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -93.42 99.46 11.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.664 -0.698 . . . . 75.319999999999993 111.83 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.43 63.68 1.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.367 0.603 . . . . 71.530000000000001 110.586 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 m -72.8 83.85 1.2 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 111.073 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -76.41 -20.48 57.08 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.377 -0.374 . . . . 75.010000000000005 111.399 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.5 t -94.27 131.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.829 0.347 . . . . 75.310000000000002 111.196 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.933 -0.556 . . . . 72.420000000000002 111.431 177.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.849 0.356 . . . . 55.229999999999997 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.48 18.42 8.22 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.543 0.571 . . . . 73.450000000000003 112.543 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.98 150.98 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.66 0.384 . . . . 74.409999999999997 110.328 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -138.94 172.47 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.096 0.474 . . . . 75.329999999999998 111.344 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.11 -174.74 3.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.24 -0.437 . . . . 74.209999999999994 111.442 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 69' ' ' CYS . 55.0 m -70.43 5.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.602 0.964 . . . . 74.310000000000002 113.602 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -97.76 13.61 29.81 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.115 0.483 . . . . 75.340000000000003 110.753 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.5 t -71.33 178.1 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.66 0.615 . . . . 64.430000000000007 112.66 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.1 mm -86.2 141.73 35.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.625 -0.716 . . . . 75.129999999999995 110.552 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.61 82.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.562 2.175 . . . . 75.140000000000001 113.396 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 67.1 mt-10 -75.32 -35.79 61.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.082 -0.508 . . . . 74.510000000000005 111.038 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.519999999999996 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.439999999999998 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.530000000000001 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.120000000000005 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 74.209999999999994 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 72.120000000000005 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.140000000000001 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 63.340000000000003 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.540000000000006 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.239999999999995 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 75.219999999999999 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 74.239999999999995 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 63.200000000000003 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.340000000000003 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 65.200000000000003 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.329999999999998 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.400000000000006 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 72.420000000000002 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.94 154.43 20.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 112.291 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -112.78 154.01 26.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.265 -0.425 . . . . 72.329999999999998 110.881 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.35 14.56 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 113.088 0.773 . . . . 72.120000000000005 113.088 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.421 HD12 ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -75.03 161.28 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.065 0.459 . . . . 74.239999999999995 111.735 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -91.52 126.31 36.56 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.034 0.445 . . . . 71.040000000000006 112.108 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t70 60.6 115.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.973 0.909 . . . . 74.140000000000001 112.816 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.627 HD13 ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -138.49 30.3 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.233 -0.894 . . . . 73.25 110.713 178.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -57.51 112.84 1.55 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.051 -0.522 . . . . 71.549999999999997 111.667 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.1 -1.85 64.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.149 -0.548 . . . . 63.520000000000003 113.255 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.77 -57.62 4.18 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.673 -0.31 . . . . 72.239999999999995 111.464 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.18 -138.82 2.87 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.762 -0.733 . . . . 64.530000000000001 113.62 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.56 129.96 25.19 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.073 2.515 . . . . 73.040000000000006 113.658 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.89 134.53 50.54 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.038 2.492 . . . . 73.209999999999994 113.487 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.56 155.22 37.71 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.016 2.477 . . . . 74.329999999999998 113.183 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.63 -14.09 19.93 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.684 2.256 . . . . 75.439999999999998 113.785 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.34 100.58 7.67 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 121.435 0.636 . . . . 75.219999999999999 112.57 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.3 147.83 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.178 2.585 . . . . 72.109999999999999 112.283 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.44 -20.33 69.73 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.385 2.057 . . . . 75.140000000000001 113.049 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.2 171.7 4.02 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.595 0.358 . . . . 65.409999999999997 111.03 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.06 31.15 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.015 0.436 . . . . 62.439999999999998 111.932 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -123.06 148.03 53.24 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 122.114 -0.366 . . . . 73.230000000000004 111.632 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.627 ' HB3' HD13 ' A' ' 39' ' ' LEU . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.040000000000006 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 74.329999999999998 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.239999999999995 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.049999999999997 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 72.340000000000003 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 71.319999999999993 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.109999999999999 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.329999999999998 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.120000000000005 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.399999999999999 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.22 107.36 17.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 74.430000000000007 110.241 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.59 127.02 53.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.926 0.393 . . . . 74.239999999999995 110.64 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.82 104.04 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.132 -0.485 . . . . 73.239999999999995 111.893 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -78.43 83.5 4.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.28 -0.418 . . . . 73.530000000000001 111.218 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 80.6 m -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.295 -0.411 . . . . 55.310000000000002 112.098 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -129.81 136.85 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 111.296 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.924 -0.56 . . . . 62.130000000000003 111.759 178.646 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.831 0.348 . . . . 63.350000000000001 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -135.04 151.02 50.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.289 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -88.45 146.83 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.87 0.366 . . . . 73.420000000000002 111.482 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 3.3 p-10 -143.14 143.12 31.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.173 0.434 . . . . 73.099999999999994 112.173 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 7' ' ' LEU . 29.9 mt-10 -92.04 -158.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.904 -0.406 . . . . 72.420000000000002 109.904 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.73 -21.97 60.04 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 111.959 0.355 . . . . 62.350000000000001 111.959 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.8 pt? -71.14 -0.94 10.8 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.157 0.429 . . . . 74.329999999999998 112.157 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 4' ' ' ASN . 12.8 t -58.98 177.37 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.706 0.632 . . . . 74.430000000000007 112.706 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -73.74 133.92 79.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.154 -0.475 . . . . 64.099999999999994 111.092 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.29 72.14 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.754 2.302 . . . . 73.409999999999997 113.402 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -86.32 2.5 47.14 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 111.866 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.150000000000006 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.409999999999997 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 72.150000000000006 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.129999999999995 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD12 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.209999999999994 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.120000000000005 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 75.239999999999995 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.140000000000001 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.299999999999997 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.540000000000006 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.219999999999999 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 72.540000000000006 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.150000000000006 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 75.349999999999994 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 70.340000000000003 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 73.439999999999998 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 74.540000000000006 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -121.87 109.51 14.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.112 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.4 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.199 -0.455 . . . . 73.040000000000006 110.94 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 18.3 m 42.67 25.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.765 1.024 . . . . 71.400000000000006 113.765 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 33' ' ' ALA . 2.2 pp -93.99 2.71 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 112.499 0.555 . . . . 73.099999999999994 112.499 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' ND2' HD22 ' A' ' 39' ' ' LEU . 14.5 p-10 -145.37 132.89 20.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.211 0.529 . . . . 72.040000000000006 112.296 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.73 115.44 29.56 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.866 -0.606 . . . . 72.109999999999999 109.88 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 HD22 ' ND2' ' A' ' 37' ' ' ASN . 3.1 mm? -99.45 168.84 9.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.346 0.498 . . . . 74.439999999999998 112.346 -173.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 67.79 -6.18 0.73 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.284 0.846 . . . . 71.439999999999998 113.284 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.18 66.3 2.91 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.765 -0.731 . . . . 61.149999999999999 112.785 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -125.06 104.89 8.79 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.864 0.364 . . . . 72.200000000000003 111.634 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.22 -122.09 5.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.304 -0.474 . . . . 75.510000000000005 113.043 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.83 111.44 3.29 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.847 2.365 . . . . 70.209999999999994 113.304 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -92.66 159.86 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.032 2.488 . . . . 64.340000000000003 112.95 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.62 144.72 79.6 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.191 1.927 . . . . 73.25 112.532 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.19 -26.14 77.49 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.542 2.162 . . . . 61.119999999999997 112.987 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.95 105.78 48.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.469 -0.332 . . . . 72.439999999999998 111.211 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.8 105.64 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.804 2.336 . . . . 73.299999999999997 111.951 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.64 -51.09 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.422 2.082 . . . . 74.5 113.3 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -178.13 115.57 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.746 0.418 . . . . 53.009999999999998 110.618 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.54 83.04 0.41 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 112.114 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -107.45 146.48 33.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.401 -0.818 . . . . 72.510000000000005 110.012 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 74.239999999999995 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 74.019999999999996 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.340000000000003 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.539999999999999 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 75.200000000000003 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.340000000000003 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.430000000000007 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.530000000000001 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.299999999999997 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.230000000000004 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.239999999999995 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.55 126.07 31.86 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 64.430000000000007 111.435 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -93.45 137.19 32.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.804 -0.634 . . . . 75.430000000000007 111.617 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -103.16 34.1 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.399 0.618 . . . . 74.109999999999999 110.958 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.7 m -61.81 96.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.822 -0.627 . . . . 72.430000000000007 111.148 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.68 -32.7 70.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.376 -0.374 . . . . 74.519999999999996 111.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.3 152.28 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.957 0.408 . . . . 73.310000000000002 111.888 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.852 -0.594 . . . . 74.129999999999995 111.25 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.626 0.25 . . . . 63.350000000000001 111.246 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -84.82 -33.25 22.95 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.715 0.635 . . . . 74.209999999999994 112.715 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 71' ' ' ASP . 12.5 p -144.88 145.2 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 73.340000000000003 111.661 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.1 177.59 4.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.054 0.454 . . . . 75.150000000000006 111.989 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.538 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.4 mt-10 -122.76 168.75 11.84 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.064 0.459 . . . . 54.229999999999997 111.461 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -83.03 31.38 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.013 0.435 . . . . 75.200000000000003 111.67 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.7 pt? -86.79 -3.54 59.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.382 -0.372 . . . . 65.310000000000002 111.467 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 t -79.55 173.27 12.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.349 0.595 . . . . 74.5 112.43 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.4 135.93 22.19 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.917 -0.583 . . . . 73.409999999999997 111.339 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.61 77.08 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.375 2.05 . . . . 65.129999999999995 112.004 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.78 -29.74 62.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.030000000000001 113.169 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.120000000000005 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.340000000000003 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.510000000000005 114.075 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.299999999999997 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.439999999999998 112.721 -169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 75.209999999999994 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.229999999999997 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.530000000000001 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.099999999999994 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 65.209999999999994 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 74.519999999999996 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.420000000000002 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.539999999999999 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 73.530000000000001 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.430000000000007 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 74.099999999999994 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.299999999999997 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 71.239999999999995 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.109999999999999 111.768 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 53.340000000000003 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.69 141.62 28.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 62.140000000000001 110.79 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.93 144.99 26.71 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.255 0.465 . . . . 73.109999999999999 112.255 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.5 m -101.54 4.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.256 0.465 . . . . 73.200000000000003 112.256 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -69.69 165.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.168 0.432 . . . . 74.219999999999999 112.168 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.048 0.452 . . . . 64.420000000000002 111.665 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -129.04 158.67 38.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.318 -0.401 . . . . 72.530000000000001 110.235 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 39' ' ' LEU . 2.5 mm? -88.95 136.75 32.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.943 0.402 . . . . 72.200000000000003 111.263 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -66.15 -47.55 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.915 0.339 . . . . 60.210000000000001 111.915 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.68 95.66 1.02 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.822 -0.704 . . . . 53.32 112.88 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.85 5.09 49.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.047 0.388 . . . . 74.129999999999995 112.047 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.17 -69.63 0.49 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.611 -0.328 . . . . 63.509999999999998 112.537 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.94 172.09 5.27 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.917 2.411 . . . . 71.439999999999998 112.686 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.05 115.0 2.22 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.238 1.959 . . . . 64.219999999999999 112.06 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.15 121.16 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.743 2.962 . . . . 62.0 115.173 -172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.42 158.78 50.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.803 2.335 . . . . 74.230000000000004 112.547 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.61 108.84 58.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 112.599 0.592 . . . . 75.200000000000003 112.599 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.14 167.29 4.53 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.112 2.542 . . . . 75.319999999999993 112.661 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.73 -18.33 58.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.462 2.108 . . . . 74.409999999999997 113.151 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.22 145.76 7.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.05 0.54 . . . . 72.230000000000004 110.104 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -166.91 154.39 9.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.619 0.723 . . . . 72.310000000000002 112.62 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -103.59 146.06 31.79 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.767 -0.651 . . . . 72.430000000000007 110.297 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.109999999999999 112.874 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.340000000000003 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.340000000000003 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.540000000000006 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.349999999999994 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 71.430000000000007 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.239999999999995 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.319999999999993 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.400000000000006 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.540000000000006 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.150000000000006 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -104.2 107.41 18.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.439999999999998 111.673 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.75 106.53 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.093 0.473 . . . . 74.430000000000007 110.247 165.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.95 -64.6 0.82 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.698 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.4 p -159.66 -172.95 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.984 0.421 . . . . 73.0 111.248 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.93 -30.08 70.66 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.05 0.759 . . . . 72.450000000000003 113.05 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.84 156.68 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.746 0.647 . . . . 74.5 112.746 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.495 ' HB2' HG21 ' A' ' 3' ' ' VAL . 4.7 m-20 . . . . . 0 C--O 1.256 1.447 0 CA-C-N 115.623 -0.717 . . . . 62.240000000000002 111.526 175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.578 0.228 . . . . 73.150000000000006 111.229 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -64.01 0.96 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.911 0.337 . . . . 74.420000000000002 111.911 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.44 113.05 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 111.372 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -132.66 157.15 45.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.457 . . . . 74.109999999999999 110.788 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HB2' HD23 ' A' ' 7' ' ' LEU . 31.4 mt-10 -130.5 -171.92 2.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.054 0.454 . . . . 74.109999999999999 111.458 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -81.85 23.81 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.349 0.5 . . . . 74.510000000000005 112.349 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -93.71 -15.57 25.11 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 111.915 0.339 . . . . 75.120000000000005 111.915 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -79.59 176.8 9.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.637 0.606 . . . . 75.409999999999997 112.637 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.67 132.7 39.76 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 111.153 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.66 78.6 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.367 2.045 . . . . 73.530000000000001 113.403 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.5 7.0 31.36 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.129999999999995 111.175 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.604 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 74.030000000000001 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 72.030000000000001 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.349999999999994 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.509999999999998 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.779 ' SD ' HG13 ' A' ' 35' ' ' VAL . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 62.310000000000002 111.889 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.349999999999994 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.140000000000001 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 73.219999999999999 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.109999999999999 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.219999999999999 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 64.430000000000007 113.026 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 75.140000000000001 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.549999999999997 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 62.409999999999997 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.040000000000006 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 64.340000000000003 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 73.340000000000003 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.59 155.67 21.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 74.540000000000006 110.739 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -83.89 120.6 26.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.057 0.456 . . . . 73.439999999999998 111.88 -174.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.779 HG13 ' SD ' ' A' ' 17' ' ' MET . 17.4 m -81.58 -15.71 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.001 -0.545 . . . . 74.510000000000005 112.018 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.5 pp -86.43 167.26 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.026 0.75 . . . . 73.040000000000006 113.026 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.52 119.56 5.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.625 -0.716 . . . . 52.329999999999998 112.123 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 32.3 t70 -148.99 145.65 27.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.147 0.499 . . . . 63.43 111.682 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.31 160.9 41.99 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.044 -0.525 . . . . 71.010000000000005 110.914 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -139.02 -177.39 4.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.408 0.623 . . . . 63.350000000000001 112.113 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 141.93 -156.76 26.11 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.467 -0.788 . . . . 73.510000000000005 111.447 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -152.0 127.8 10.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.46 0.63 . . . . 73.409999999999997 111.297 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.58 -134.93 13.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.159 -0.544 . . . . 64.450000000000003 112.466 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.24 118.09 2.57 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.709 2.273 . . . . 64.329999999999998 113.544 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.49 168.45 22.72 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.112 2.542 . . . . 73.530000000000001 112.15 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.77 151.05 86.91 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.38 2.053 . . . . 74.0 112.898 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.91 17.4 1.71 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.805 2.337 . . . . 72.230000000000004 113.208 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.26 123.46 16.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.849 0.357 . . . . 73.319999999999993 111.665 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 124.43 6.12 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.178 1.919 . . . . 71.120000000000005 112.386 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.25 -37.4 18.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.19 1.927 . . . . 73.319999999999993 112.376 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.14 168.87 16.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 64.319999999999993 110.869 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -82.11 -10.08 59.31 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.087 0.47 . . . . 75.420000000000002 110.837 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 -105.85 154.07 39.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 111.132 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.711 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.420000000000002 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.129999999999995 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.711 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.430000000000007 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.656 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.230000000000004 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.010000000000005 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.099999999999994 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.497 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.140000000000001 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 63.32 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 61.43 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -90.42 112.79 24.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.010000000000005 111.252 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -104.57 101.55 11.2 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.673 -0.694 . . . . 64.519999999999996 112.227 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.14 102.69 15.23 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.352 -0.385 . . . . 74.040000000000006 110.904 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.1 p -126.44 112.61 15.81 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.063 0.459 . . . . 70.239999999999995 111.638 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.36 -19.66 63.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.261 -0.427 . . . . 75.420000000000002 111.656 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -103.41 144.22 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.917 0.389 . . . . 73.030000000000001 111.76 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 111.226 -178.529 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.775 0.322 . . . . 61.119999999999997 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.25 161.75 30.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.12 0.486 . . . . 61.240000000000002 112.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.19 123.07 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.261 -0.427 . . . . 64.439999999999998 111.0 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -160.92 165.56 29.83 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.631 0.253 . . . . 63.020000000000003 110.836 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB2' HD23 ' A' ' 7' ' ' LEU . 30.7 mt-10 -70.97 169.1 15.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.083 0.468 . . . . 64.329999999999998 111.027 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.5 p -81.56 25.67 0.51 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.281 0.475 . . . . 70.120000000000005 112.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -82.77 -0.37 47.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.499 . . . . 71.049999999999997 110.829 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -60.64 156.48 16.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.336 0.589 . . . . 65.200000000000003 112.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 138.62 74.74 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.003 -0.544 . . . . 75.329999999999998 110.567 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HG3' HG11 ' A' ' 70' ' ' VAL . 50.2 Cg_exo -57.04 77.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.509 2.139 . . . . 75.219999999999999 112.984 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.51 -0.37 37.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.118 -0.492 . . . . 63.509999999999998 111.592 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.010000000000005 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 71.129999999999995 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.430000000000007 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.409999999999997 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.109999999999999 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.230000000000004 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.140000000000001 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 61.240000000000002 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.430000000000007 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.120000000000005 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.229999999999997 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 75.540000000000006 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.435 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.430000000000007 111.246 173.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.507 HD13 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 74.099999999999994 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.200000000000003 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.519999999999996 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.409999999999997 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.33 143.06 46.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.439999999999998 112.093 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.99 154.4 22.23 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.261 -0.427 . . . . 75.409999999999997 111.408 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 15.5 m -90.85 85.52 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.516 0.674 . . . . 74.549999999999997 112.326 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -133.69 177.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 116.086 -0.506 . . . . 75.430000000000007 111.429 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.05 157.23 13.3 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.973 0.416 . . . . 71.219999999999999 112.002 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.78 116.49 2.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 111.924 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.8 mm? -73.37 -23.65 60.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.386 0.612 . . . . 75.340000000000003 110.763 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -87.74 144.81 26.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.846 -0.615 . . . . 74.409999999999997 111.368 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.98 133.27 1.45 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.789 -0.719 . . . . 50.240000000000002 113.805 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.96 161.36 13.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.88 0.372 . . . . 73.030000000000001 111.568 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.83 -142.9 47.13 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 116.123 -0.49 . . . . 62.100000000000001 113.596 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.66 168.94 5.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.099 2.533 . . . . 73.340000000000003 112.881 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.48 120.03 7.38 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.325 2.016 . . . . 72.120000000000005 112.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.36 162.54 33.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.528 2.152 . . . . 61.109999999999999 112.971 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.93 79.27 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 71.120000000000005 112.774 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -114.36 147.29 37.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 74.140000000000001 111.6 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.27 151.92 60.85 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.626 2.217 . . . . 72.129999999999995 113.162 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -16.46 55.36 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.629 2.219 . . . . 45.140000000000001 112.969 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.93 34.89 0.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.125 0.488 . . . . 75.400000000000006 111.378 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.47 156.68 10.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.479 0.657 . . . . 74.420000000000002 112.731 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.37 133.68 8.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.714 -0.675 . . . . 75.230000000000004 110.597 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.310000000000002 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 74.099999999999994 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.239999999999995 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 72.310000000000002 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.209999999999994 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 73.019999999999996 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.420000000000002 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -82.75 107.35 15.31 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.450000000000003 109.814 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.17 150.88 38.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.739 0.304 . . . . 65.099999999999994 111.753 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.04 89.14 0.6 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.029 0.442 . . . . 73.25 110.255 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 p -78.55 77.55 5.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.235 0.541 . . . . 73.439999999999998 112.292 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.3 m -82.84 -9.72 59.19 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.904 0.383 . . . . 71.310000000000002 111.404 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 10' ' ' PRO . 5.3 p -104.4 104.11 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.518 0.675 . . . . 64.310000000000002 111.878 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 118.634 -0.698 . . . . 72.329999999999998 111.79 178.067 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.923 0.392 . . . . 70.109999999999999 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.39 -64.16 1.21 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.03 0.443 . . . . 72.310000000000002 111.167 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.7 146.73 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.37 -0.377 . . . . 71.430000000000007 111.332 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -88.78 112.73 23.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.009 0.433 . . . . 73.549999999999997 110.73 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.6 47.81 0.51 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 112.163 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 m 66.04 -3.32 0.79 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.641 0.978 . . . . 62.43 113.641 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt? -73.05 60.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.521 1.153 . . . . 71.209999999999994 108.633 166.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 t -57.6 117.44 4.19 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.725 -1.125 . . . . 72.219999999999999 113.89 -165.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.96 120.74 83.1 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.476 -0.783 . . . . 73.150000000000006 108.991 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.38 90.84 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.284 1.989 . . . . 73.540000000000006 113.55 -172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -67.65 -31.95 72.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.266 -0.424 . . . . 75.430000000000007 110.66 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 65.510000000000005 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 71.540000000000006 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.120000000000005 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.66 ' SD ' HG12 ' A' ' 35' ' ' VAL . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 112.063 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.439999999999998 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.439999999999998 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.310000000000002 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.109999999999999 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 64.239999999999995 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 62.439999999999998 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.329999999999998 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 74.340000000000003 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.400000000000006 111.138 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 75.129999999999995 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 74.319999999999993 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 75.040000000000006 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.140000000000001 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.62 113.14 25.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 74.299999999999997 110.328 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.95 153.75 20.37 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.496 0.554 . . . . 63.5 112.496 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.66 HG12 ' SD ' ' A' ' 17' ' ' MET . 26.6 m -83.39 32.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.187 -0.461 . . . . 72.329999999999998 112.149 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 pp -69.46 174.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.493 0.553 . . . . 72.120000000000005 112.493 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.86 86.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.601 . . . . 72.129999999999995 112.236 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.77 134.69 12.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.709 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -150.72 148.18 28.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.638 0.256 . . . . 75.239999999999995 110.641 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -138.33 -70.05 0.43 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.876 0.37 . . . . 75.230000000000004 111.87 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.31 -95.93 0.32 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.82 -0.705 . . . . 64.319999999999993 112.382 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -171.14 119.81 0.5 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.971 0.415 . . . . 71.329999999999998 111.72 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.53 -110.7 1.96 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 114.692 0.637 . . . . 72.329999999999998 114.692 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.38 129.89 2.33 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.12 2.546 . . . . 74.5 113.848 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.47 154.13 31.27 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.393 2.062 . . . . 63.32 112.394 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.03 152.31 80.14 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.573 2.182 . . . . 73.120000000000005 112.831 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.07 -37.55 93.9 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.538 2.159 . . . . 73.439999999999998 112.216 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.11 99.6 43.79 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.042 -0.526 . . . . 72.420000000000002 110.206 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -98.57 98.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.201 2.601 . . . . 75.510000000000005 113.498 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.47 -3.88 12.73 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.389 2.059 . . . . 72.310000000000002 112.667 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.26 104.85 14.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.037 -0.529 . . . . 73.120000000000005 112.197 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -104.27 2.59 31.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.126 0.489 . . . . 74.209999999999994 110.662 170.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.42 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 69.8 m80 -94.54 147.67 33.63 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.911 -0.586 . . . . 75.200000000000003 110.476 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.400000000000006 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.120000000000005 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 64.519999999999996 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.319999999999993 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.430000000000007 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 53.039999999999999 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.510000000000005 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 70.150000000000006 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.150000000000006 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.230000000000004 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -109.49 105.8 15.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.519999999999996 110.858 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -119.24 119.41 34.0 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.732 0.301 . . . . 74.099999999999994 110.901 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.92 -56.13 2.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.373 0.509 . . . . 71.310000000000002 112.373 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.0 m -112.29 -66.26 1.1 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.562 0.579 . . . . 73.230000000000004 112.562 -173.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.6 m -124.79 151.45 45.14 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.694 0.283 . . . . 62.119999999999997 111.265 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.54 145.86 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.055 0.455 . . . . 65.540000000000006 111.376 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.256 1.423 0 CA-C-O 118.856 -0.592 . . . . 62.229999999999997 111.317 -175.159 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.141 0.496 . . . . 52.020000000000003 111.469 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.86 -175.52 4.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.156 0.503 . . . . 71.120000000000005 111.875 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.83 113.97 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.491 0.662 . . . . 62.310000000000002 112.137 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -100.7 116.67 33.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.454 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 164.77 25.1 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.045 -0.525 . . . . 63.020000000000003 111.994 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.9 t -80.98 38.87 0.48 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.344 0.592 . . . . 72.540000000000006 111.638 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.76 23.7 1.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.23 0.538 . . . . 71.150000000000006 111.936 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -73.52 130.67 40.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.961 0.726 . . . . 73.510000000000005 112.961 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 11' ' ' GLU . 48.6 mm -74.66 146.08 82.81 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.549 -0.75 . . . . 73.209999999999994 109.133 169.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HD2' HG22 ' A' ' 9' ' ' ILE . 85.2 Cg_exo -50.4 72.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 123.054 2.503 . . . . 65.219999999999999 114.609 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' ILE . 43.7 mt-10 -95.25 6.4 49.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.06 0.544 . . . . 75.230000000000004 110.929 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 63.340000000000003 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 61.399999999999999 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 65.310000000000002 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 71.019999999999996 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.530000000000001 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 73.349999999999994 112.153 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.340000000000003 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.120000000000005 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.200000000000003 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 73.150000000000006 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 73.230000000000004 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 71.219999999999999 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 73.409999999999997 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 75.439999999999998 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.319999999999993 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.200000000000003 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.109999999999999 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.19 154.55 20.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.420000000000002 111.594 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -93.62 126.13 38.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.753 0.311 . . . . 72.120000000000005 111.399 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -85.46 9.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.837 0.68 . . . . 74.140000000000001 112.837 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.4 pp -83.55 -172.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.63 0.604 . . . . 64.439999999999998 112.63 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -47.14 133.17 11.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.071 0.767 . . . . 74.450000000000003 113.071 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 25.2 t0 -66.67 144.79 56.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.125 0.488 . . . . 75.109999999999999 111.519 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 39' ' ' LEU . 3.1 mm? -78.46 170.71 16.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.299 0.481 . . . . 74.439999999999998 112.299 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.0 m170 66.02 18.05 10.94 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.875 0.694 . . . . 74.340000000000003 112.875 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.0 83.7 0.71 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.993 -0.622 . . . . 74.319999999999993 111.77 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.33 -175.81 2.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.182 0.808 . . . . 73.409999999999997 113.182 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.05 -175.97 48.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.822 -0.627 . . . . 65.219999999999999 112.974 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.81 158.25 57.52 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.335 2.023 . . . . 71.109999999999999 112.103 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.04 114.9 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.913 2.409 . . . . 70.010000000000005 113.116 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.09 123.33 12.96 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.762 2.308 . . . . 74.120000000000005 112.829 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.66 -42.47 53.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.672 2.248 . . . . 74.299999999999997 112.83 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.673 HG11 ' HD3' ' A' ' 50' ' ' PRO . 17.7 t -122.29 97.69 44.96 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-O 120.775 0.321 . . . . 75.329999999999998 111.205 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -112.8 63.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.282 3.322 . . . . 71.420000000000002 113.799 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HD3' HG11 ' A' ' 48' ' ' VAL . 95.6 Cg_endo -84.37 -49.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.07 1.847 . . . . 61.329999999999998 115.07 -171.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.53 -0.54 37.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.506 0.928 . . . . 74.329999999999998 113.506 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -60.02 111.19 1.4 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.998 0.74 . . . . 74.340000000000003 112.998 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -117.99 154.38 51.43 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 110.721 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.439999999999998 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.439999999999998 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.648 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 72.310000000000002 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 63.0 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.209999999999994 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.109999999999999 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 71.109999999999999 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 74.409999999999997 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 73.129999999999995 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.319999999999993 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.420000000000002 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.93 104.91 13.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.519999999999996 109.975 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.17 141.36 48.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.086 0.47 . . . . 73.430000000000007 111.757 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -92.97 97.23 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.114 0.483 . . . . 65.129999999999995 111.614 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -82.23 134.42 35.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.867 0.365 . . . . 73.209999999999994 111.145 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 p -93.81 -21.19 19.44 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.981 0.363 . . . . 74.540000000000006 111.981 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.14 171.55 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 111.985 0.365 . . . . 75.209999999999994 111.985 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 119.123 -0.465 . . . . 74.409999999999997 111.444 176.668 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.743 0.306 . . . . 74.140000000000001 111.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.87 -28.76 19.03 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.777 0.288 . . . . 70.329999999999998 111.777 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 p -64.9 85.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 121.825 0.821 . . . . 73.349999999999994 112.243 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.54 108.64 14.31 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.784 -0.644 . . . . 65.030000000000001 110.048 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HB2' HD22 ' A' ' 7' ' ' LEU . 37.3 mt-10 -77.49 -172.32 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.243 0.544 . . . . 72.310000000000002 111.713 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.0 t -77.84 24.81 0.22 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.761 0.652 . . . . 72.019999999999996 112.761 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -113.59 9.78 17.96 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 122.082 -0.386 . . . . 73.420000000000002 111.96 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -69.17 169.17 12.54 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.651 0.611 . . . . 65.420000000000002 112.651 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -83.76 131.1 53.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.999 -0.546 . . . . 62.509999999999998 110.479 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.18 90.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.784 2.323 . . . . 73.140000000000001 113.498 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HB2' HE22 ' A' ' 66' ' ' GLN . 40.5 mt-10 -81.12 -11.27 59.51 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.104 -0.498 . . . . 75.239999999999995 110.723 174.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.239999999999995 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 60.340000000000003 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.240000000000002 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.040000000000006 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.209999999999994 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.530000000000001 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 63.539999999999999 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.510000000000005 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.140000000000001 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.129999999999995 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.200000000000003 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 54.340000000000003 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 74.439999999999998 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.019999999999996 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.030000000000001 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.657 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.140000000000001 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 62.240000000000002 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.420000000000002 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.21 126.02 35.32 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 109.93 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.86 21.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.634 0.605 . . . . 62.439999999999998 112.634 -173.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.3 6.99 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.874 -0.603 . . . . 75.540000000000006 111.958 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.512 ' O ' HD11 ' A' ' 36' ' ' ILE . 2.4 pp -58.37 148.01 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 112.38 0.511 . . . . 74.510000000000005 112.38 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.14 36.65 1.04 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.21 0.528 . . . . 64.530000000000001 111.203 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.458 ' HB2' HD13 ' A' ' 36' ' ' ILE . 28.8 m-20 -87.32 93.03 9.28 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.709 0.766 . . . . 74.349999999999994 111.604 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -105.71 161.03 14.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.316 -0.857 . . . . 71.420000000000002 110.611 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -106.97 112.27 25.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.174 0.512 . . . . 73.530000000000001 112.107 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.04 148.58 17.3 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.972 -0.558 . . . . 73.25 111.71 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.66 85.58 1.62 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.187 -0.596 . . . . 61.520000000000003 111.491 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.36 -111.26 3.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.637 -0.71 . . . . 64.409999999999997 114.275 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.04 139.69 70.65 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.065 2.51 . . . . 74.109999999999999 113.47 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.83 134.07 61.03 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.745 2.297 . . . . 74.230000000000004 112.914 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.0 149.84 59.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.282 1.988 . . . . 72.340000000000003 112.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.19 -48.72 18.7 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.567 2.178 . . . . 73.099999999999994 112.907 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.624 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 47.0 t -114.86 130.12 24.44 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 71.120000000000005 110.683 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.14 100.93 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.801 2.334 . . . . 72.340000000000003 113.204 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 48' ' ' VAL . 56.6 Cg_endo -93.33 -27.68 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.798 2.332 . . . . 63.32 113.486 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.74 77.51 6.37 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.134 0.493 . . . . 72.040000000000006 111.646 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.16 6.35 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.849 -0.614 . . . . 64.219999999999999 111.267 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -144.5 153.15 54.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 110.241 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.450000000000003 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.010000000000005 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.507 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 73.349999999999994 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.349999999999994 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.120000000000005 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.049999999999997 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.230000000000004 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.239999999999995 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 61.25 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.566 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.340000000000003 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -108.09 106.48 16.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 51.039999999999999 110.929 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 11' ' ' GLU . 4.0 pt20 -119.14 153.58 34.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.345 -0.389 . . . . 74.340000000000003 111.022 171.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 64.61 38.88 6.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.9 0.381 . . . . 63.100000000000001 111.721 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.0 t -72.07 70.98 0.81 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.373 0.606 . . . . 75.420000000000002 111.642 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 m -103.45 26.24 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.049 -0.523 . . . . 74.510000000000005 110.506 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.2 93.18 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.602 0.715 . . . . 73.340000000000003 112.004 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.11 -0.948 . . . . 74.329999999999998 110.618 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.893 0.378 . . . . 71.340000000000003 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.07 -168.51 2.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.431 -0.35 . . . . 73.549999999999997 110.541 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.53 116.98 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.403 0.621 . . . . 71.439999999999998 111.908 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 62.8 t30 -147.46 175.61 10.69 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.07 -0.513 . . . . 72.109999999999999 110.668 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.85 158.09 16.99 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.906 -0.496 . . . . 70.299999999999997 111.24 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 69' ' ' CYS . 9.0 t -82.27 63.54 6.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.629 0.728 . . . . 53.049999999999997 111.171 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 23.89 5.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.59 -0.732 . . . . 63.450000000000003 110.488 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -79.96 -179.94 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.59 -0.732 . . . . 73.430000000000007 112.215 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.95 130.38 81.1 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.003 -0.544 . . . . 73.129999999999995 110.99 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.36 85.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.334 2.023 . . . . 71.340000000000003 112.77 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.38 -36.45 17.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 111.985 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.120000000000005 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.340000000000003 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.010000000000005 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.510000000000005 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.499 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.726 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.519999999999996 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.549999999999997 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 75.540000000000006 111.645 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 53.43 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.120000000000005 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 74.430000000000007 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.240000000000002 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.519999999999996 113.244 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.329999999999998 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 75.430000000000007 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 74.430000000000007 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 62.329999999999998 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.130000000000003 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.200000000000003 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.319999999999993 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.79 142.56 28.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.209999999999994 111.44 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.02 116.93 33.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.938 0.399 . . . . 55.420000000000002 111.208 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 19.5 m -78.23 62.02 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 112.418 0.525 . . . . 75.140000000000001 112.418 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.83 8.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.634 0.975 . . . . 74.420000000000002 113.634 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -122.71 151.55 41.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.283 0.845 . . . . 74.400000000000006 113.283 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.93 120.02 38.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.659 -0.701 . . . . 75.109999999999999 110.569 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.54 139.88 42.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.435 0.636 . . . . 73.409999999999997 112.032 176.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.38 -171.77 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.553 . . . . 74.200000000000003 110.758 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.35 -122.7 0.37 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.566 0.586 . . . . 55.0 114.566 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -103.63 165.13 11.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.353 0.501 . . . . 74.219999999999999 112.353 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.81 -155.09 53.2 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.094 -0.503 . . . . 72.430000000000007 113.87 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.45 154.36 71.98 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.86 2.373 . . . . 73.019999999999996 112.696 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.22 124.14 15.47 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.559 2.173 . . . . 63.109999999999999 112.655 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.54 155.92 39.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.554 2.169 . . . . 71.209999999999994 112.842 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.17 67.05 1.41 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.966 2.444 . . . . 64.030000000000001 113.421 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.06 134.39 21.44 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.091 -0.504 . . . . 74.230000000000004 110.154 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.89 142.56 99.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.636 2.224 . . . . 62.420000000000002 113.15 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.78 -27.78 54.2 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.067 2.511 . . . . 73.140000000000001 113.311 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.17 70.58 1.12 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.344 0.592 . . . . 65.5 110.333 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 16.1 tt0 -118.72 160.74 21.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.719 -0.673 . . . . 75.329999999999998 111.627 -171.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.491 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 80.2 m80 -107.12 144.77 29.81 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 110.004 171.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.543 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 75.299999999999997 112.974 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.439 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 74.299999999999997 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.409999999999997 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.420000000000002 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.409999999999997 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.549999999999997 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 74.299999999999997 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.120000000000005 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.439999999999998 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.140000000000001 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -84.77 111.13 19.33 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.37 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -110.56 99.44 8.42 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.616 0.722 . . . . 72.349999999999994 110.699 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.21 -50.2 7.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.69 -0.686 . . . . 70.219999999999999 112.54 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 70.9 m -73.41 74.0 1.38 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.302 0.482 . . . . 75.109999999999999 112.302 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 1.6 m -176.32 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.032 -0.531 . . . . 64.439999999999998 111.498 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.87 150.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.286 -0.416 . . . . 62.509999999999998 111.573 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.098 -0.477 . . . . 73.209999999999994 110.805 178.257 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 111.666 0.247 . . . . 65.540000000000006 111.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.77 -32.77 72.75 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.085 -0.385 . . . . 54.130000000000003 110.905 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.91 115.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.203 0.525 . . . . 74.019999999999996 111.407 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.421 ' OD1' ' HB ' ' A' ' 8' ' ' THR . 28.5 t-20 -146.51 124.82 12.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.33 -0.396 . . . . 75.549999999999997 111.028 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' HB2' HD23 ' A' ' 7' ' ' LEU . 34.5 mt-10 -103.08 -176.82 3.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.391 -0.368 . . . . 75.120000000000005 111.546 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 69' ' ' CYS . 44.6 t -59.82 -11.88 6.26 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.439 0.903 . . . . 71.239999999999995 113.439 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 5' ' ' GLU . 1.9 pt? -76.23 18.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.912 -0.492 . . . . 73.530000000000001 112.018 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.421 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 14.5 t -84.24 175.24 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.022 0.749 . . . . 64.200000000000003 113.022 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.94 135.53 28.6 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.736 -0.665 . . . . 72.430000000000007 110.735 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.71 80.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.321 2.014 . . . . 74.299999999999997 113.28 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.42 7.31 45.01 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.530000000000001 111.338 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 75.239999999999995 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.430000000000007 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.099999999999994 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.420000000000002 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.53 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.450000000000003 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 74.120000000000005 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 73.140000000000001 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 74.019999999999996 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.150000000000006 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.340000000000003 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.340000000000003 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.120000000000005 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.150000000000006 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 63.140000000000001 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 75.349999999999994 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.140000000000001 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.219999999999999 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.65 155.58 23.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 72.019999999999996 111.547 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.62 144.28 28.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.158 0.504 . . . . 61.039999999999999 112.226 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.76 11.86 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.211 0.819 . . . . 75.209999999999994 113.211 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.577 HG12 ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -68.89 -59.94 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 113.073 0.768 . . . . 74.340000000000003 113.073 -175.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.577 ' N ' HG12 ' A' ' 36' ' ' ILE . 7.2 t30 175.31 171.74 0.29 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.95 0.5 . . . . 73.510000000000005 109.653 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.01 151.81 46.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.816 0.341 . . . . 73.049999999999997 110.766 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.3 mm? -108.98 17.1 22.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.683 0.278 . . . . 74.319999999999993 111.436 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -94.53 -6.52 43.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.713 0.292 . . . . 74.299999999999997 111.781 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.4 150.55 51.93 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.145 -0.55 . . . . 54.450000000000003 113.834 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.591 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 30.6 tt0 -109.09 -178.47 3.58 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 110.041 -0.355 . . . . 63.130000000000003 110.041 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.591 ' H ' ' HG2' ' A' ' 42' ' ' GLU . . . -44.19 -61.57 3.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.592 -0.337 . . . . 62.0 113.616 176.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -99.39 88.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.348 2.699 . . . . 63.200000000000003 113.13 171.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 39.2 Cg_endo -99.33 162.79 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.363 2.708 . . . . 74.349999999999994 113.582 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.62 116.75 4.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.475 2.116 . . . . 74.129999999999995 112.253 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.48 20.34 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.725 2.283 . . . . 75.310000000000002 114.292 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.74 99.81 16.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 121.485 0.66 . . . . 74.129999999999995 112.115 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -93.1 161.84 2.58 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.022 2.481 . . . . 70.409999999999997 112.774 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.48 -25.45 79.71 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.258 1.972 . . . . 74.25 111.665 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.3 9.97 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.202 -0.908 . . . . 74.129999999999995 109.562 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.58 64.68 1.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.391 0.615 . . . . 64.140000000000001 110.586 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -151.17 150.32 26.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.209 -0.451 . . . . 75.549999999999997 111.15 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.310000000000002 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.439999999999998 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.119999999999997 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.119999999999997 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 72.409999999999997 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.329999999999998 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 37.950000000000003 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 72.099999999999994 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.420000000000002 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.129999999999995 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.030000000000001 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.8 110.96 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.420000000000002 110.259 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 3.7 pt20 -100.87 99.07 9.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.734 0.778 . . . . 65.239999999999995 111.354 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.31 -2.62 56.3 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.7 -0.682 . . . . 72.409999999999997 110.682 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -48.29 -56.52 7.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.42 -0.809 . . . . 65.150000000000006 112.52 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 12.8 t -136.01 103.5 5.38 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.105 -0.372 . . . . 74.120000000000005 111.739 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.2 175.5 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 111.289 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.802 -0.618 . . . . 73.239999999999995 111.719 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.695 0.283 . . . . 75.150000000000006 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.73 157.48 34.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 65.129999999999995 111.496 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.73 131.34 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.803 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -123.78 138.91 54.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.421 -0.354 . . . . 75.329999999999998 111.5 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB2' HD21 ' A' ' 7' ' ' LEU . 41.8 mt-10 -81.69 -170.89 3.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.321 0.582 . . . . 73.209999999999994 111.633 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.5 m -73.22 1.58 9.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.438 0.903 . . . . 50.140000000000001 113.438 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 5' ' ' GLU . 2.3 pt? -83.89 8.56 14.58 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.135 0.493 . . . . 71.409999999999997 110.988 174.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -68.66 165.71 18.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.162 0.506 . . . . 71.0 112.058 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 47.8 mm -80.95 127.39 74.79 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 111.394 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 8.2 Cg_exo -73.15 66.74 4.25 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.893 2.395 . . . . 74.0 113.031 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -76.84 -3.44 38.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.450000000000003 111.837 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 72.340000000000003 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 71.510000000000005 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 71.519999999999996 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.319999999999993 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.439999999999998 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' HD11 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.150000000000006 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.420000000000002 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.120000000000005 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.340000000000003 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.299999999999997 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.509999999999998 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.329999999999998 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.120000000000005 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 75.340000000000003 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.442 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.530000000000001 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.200000000000003 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.109999999999999 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.140000000000001 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.18 156.18 20.43 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 74.209999999999994 111.073 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.58 115.11 22.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 64.140000000000001 111.109 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.15 -10.18 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 112.009 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -64.28 167.73 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 116.224 -0.444 . . . . 74.049999999999997 112.101 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.64 54.82 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.167 0.803 . . . . 73.340000000000003 113.167 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.27 102.67 10.09 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.034 0.445 . . . . 74.349999999999994 110.633 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.74 145.42 40.56 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.192 0.52 . . . . 74.319999999999993 111.228 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -81.78 64.14 6.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.317 0.58 . . . . 62.439999999999998 110.406 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.47 149.06 38.08 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.562 -0.745 . . . . 55.140000000000001 113.9 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -112.12 144.68 41.1 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.848 0.356 . . . . 63.43 111.265 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.06 -153.44 35.98 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.336 -0.459 . . . . 55.329999999999998 113.637 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.41 168.3 13.12 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.031 2.487 . . . . 64.540000000000006 112.791 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -85.69 108.78 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.348 2.032 . . . . 70.310000000000002 113.118 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 171.7 13.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.711 2.274 . . . . 72.329999999999998 112.048 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.62 76.85 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.873 1.715 . . . . 72.209999999999994 112.715 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.17 150.25 59.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.879 -0.6 . . . . 71.450000000000003 111.048 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 52.8 Cg_exo -53.64 130.19 37.66 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.709 2.273 . . . . 75.049999999999997 113.699 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.29 -4.28 13.39 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.229 1.953 . . . . 63.409999999999997 112.488 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.47 -4.26 58.66 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.136 0.421 . . . . 64.219999999999999 112.136 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 49' ' ' PRO . 15.8 mm100 -51.62 138.02 23.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.327 0.584 . . . . 74.5 112.119 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -90.03 160.31 40.77 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.887 -0.597 . . . . 70.439999999999998 111.309 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.310000000000002 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 73.549999999999997 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 72.040000000000006 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 72.420000000000002 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 36.909999999999997 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 63.43 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.230000000000004 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 63.030000000000001 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.07 112.0 19.39 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.150000000000006 111.11 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -110.25 116.37 31.36 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.154 0.502 . . . . 70.040000000000006 111.467 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.44 64.61 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.208 0.528 . . . . 73.019999999999996 111.066 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -69.93 103.18 2.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.421 0.526 . . . . 74.019999999999996 112.421 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.39 -39.32 82.96 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.926 0.394 . . . . 60.140000000000001 111.403 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.34 103.75 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.582 0.706 . . . . 74.140000000000001 111.142 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.774 -0.648 . . . . 73.010000000000005 111.548 -178.587 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.817 0.341 . . . . 63.240000000000002 111.219 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -81.24 48.15 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.907 0.384 . . . . 73.099999999999994 111.529 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.4 t 58.0 74.63 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.46 0.647 . . . . 71.430000000000007 110.951 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.45 138.25 0.69 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.635 -0.711 . . . . 74.200000000000003 110.682 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HB2' HD23 ' A' ' 7' ' ' LEU . 55.7 mt-10 -95.06 -169.59 2.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.332 0.586 . . . . 64.099999999999994 111.669 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.7 m -81.83 5.79 17.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.909 0.707 . . . . 74.439999999999998 112.909 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 5' ' ' GLU . 2.2 pt? -73.03 -4.41 32.23 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 111.638 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -70.71 -176.63 1.35 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.135 0.493 . . . . 65.209999999999994 112.245 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.7 mm -96.1 136.43 22.1 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.415 -0.357 . . . . 73.019999999999996 111.135 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.91 78.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.323 2.015 . . . . 75.409999999999997 112.366 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 51.0 mt-10 -80.68 -12.63 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.23 -0.441 . . . . 60.119999999999997 112.1 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 73.430000000000007 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.019999999999996 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.329999999999998 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.510000000000005 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 74.129999999999995 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.430000000000007 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.030000000000001 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.540000000000006 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 65.310000000000002 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 42.329999999999998 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.531 ' HA ' HG21 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.239999999999995 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.420000000000002 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 74.140000000000001 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.230000000000004 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 75.010000000000005 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 75.150000000000006 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.94 137.9 31.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 74.530000000000001 111.66 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.15 153.03 22.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.022 0.439 . . . . 74.129999999999995 112.015 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 31.6 m -78.34 46.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.443 0.535 . . . . 71.030000000000001 112.443 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HB ' HD11 ' A' ' 39' ' ' LEU . 2.3 pp -102.55 155.56 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.176 0.435 . . . . 75.519999999999996 112.176 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -79.55 55.73 2.03 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.624 0.601 . . . . 74.230000000000004 112.624 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.37 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.149 0.796 . . . . 73.409999999999997 113.149 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.71 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -146.85 175.7 10.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.01 -0.541 . . . . 74.099999999999994 111.222 171.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -121.01 157.35 30.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.841 0.353 . . . . 72.439999999999998 111.378 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.03 -43.65 98.87 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.821 -0.704 . . . . 51.439999999999998 112.287 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.01 105.86 18.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.81 0.338 . . . . 72.310000000000002 110.991 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -179.39 18.54 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.039 -0.601 . . . . 70.540000000000006 113.534 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.2 167.11 3.6 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.135 2.557 . . . . 71.140000000000001 113.116 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.94 125.46 13.15 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.036 1.824 . . . . 74.340000000000003 111.846 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.58 118.33 2.91 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.859 2.372 . . . . 74.109999999999999 113.147 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.07 -52.43 4.8 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.072 2.515 . . . . 74.319999999999993 113.139 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.38 100.22 18.52 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.401 -0.363 . . . . 75.329999999999998 110.296 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.28 128.15 28.79 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.797 2.331 . . . . 71.329999999999998 113.297 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.96 -27.58 85.23 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.609 2.206 . . . . 74.150000000000006 113.147 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.37 154.53 35.81 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.681 0.277 . . . . 73.25 111.305 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.55 16.99 9.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 111.309 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -133.68 137.05 27.88 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.829 -0.623 . . . . 74.530000000000001 110.227 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 36' ' ' ILE . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 74.299999999999997 113.121 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.319999999999993 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HB2' ' HE3' ' A' ' 17' ' ' MET . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 74.219999999999999 112.267 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 75.109999999999999 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 44.399999999999999 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.140000000000001 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.040000000000006 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.150000000000006 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 62.100000000000001 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 71.0 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 60.130000000000003 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -82.49 110.86 17.97 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.409999999999997 110.15 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -95.68 135.01 37.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.647 0.61 . . . . 74.5 112.647 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 67.2 109.41 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.495 -0.775 . . . . 71.200000000000003 112.056 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 6.55 38.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.021 0.438 . . . . 74.319999999999993 111.509 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.8 m -101.63 1.12 37.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.15 -0.344 . . . . 75.25 111.81 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.35 143.32 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 120.651 0.262 . . . . 73.019999999999996 110.848 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.607 -0.711 . . . . 64.109999999999999 112.082 -178.471 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.822 0.344 . . . . 64.049999999999997 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.56 158.01 15.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.849 0.357 . . . . 75.049999999999997 110.736 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.27 131.5 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.479 0.548 . . . . 61.509999999999998 112.479 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.82 132.17 45.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.366 -0.208 . . . . 65.140000000000001 110.6 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 33.4 mt-10 -69.8 177.68 2.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.031 0.443 . . . . 73.319999999999993 111.976 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 69' ' ' CYS . 84.1 m -75.48 -6.2 48.94 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.334 0.865 . . . . 63.450000000000003 113.334 -170.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 1.6 pt? -81.79 24.29 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.278 0.561 . . . . 73.040000000000006 111.342 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -83.22 176.89 8.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.052 -0.522 . . . . 75.439999999999998 111.996 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.81 127.64 81.51 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.437 -0.347 . . . . 74.420000000000002 111.71 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.42 87.62 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.316 2.011 . . . . 72.239999999999995 113.185 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.85 6.65 38.1 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.981 -0.554 . . . . 72.310000000000002 111.688 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.540000000000006 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 74.0 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.439999999999998 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.219999999999999 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.129999999999995 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.299999999999997 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.239999999999995 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.52 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.140000000000001 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.040000000000006 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.230000000000004 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 71.120000000000005 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.420000000000002 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HA ' HG21 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 72.099999999999994 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.430000000000007 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 75.400000000000006 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 73.209999999999994 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 75.409999999999997 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.140000000000001 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.2 154.25 19.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.329999999999998 111.964 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.99 154.18 44.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.043 0.449 . . . . 73.140000000000001 111.657 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.2 92.67 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.434 0.635 . . . . 72.030000000000001 111.971 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.643 ' H ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.59 139.72 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.91 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.5 11.98 1.42 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.089 0.403 . . . . 75.129999999999995 112.089 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' HIS . 7.3 m-20 -93.38 -14.15 27.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.648 0.24 . . . . 74.409999999999997 111.648 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.582 HD11 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 29.15 -70.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.984 1.476 . . . . 65.319999999999993 114.984 -173.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.2 m-70 -63.44 -41.7 98.66 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.981 -0.449 . . . . 71.109999999999999 111.328 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.43 -64.07 3.58 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.316 -0.468 . . . . 61.210000000000001 113.756 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.64 124.77 22.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.73 0.3 . . . . 74.310000000000002 110.884 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.67 -154.0 32.07 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.214 -0.517 . . . . 75.150000000000006 112.499 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.806 2.337 . . . . 75.120000000000005 112.598 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.15 153.04 31.67 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.029 1.819 . . . . 53.439999999999998 112.127 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.85 154.84 53.07 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.276 1.984 . . . . 64.230000000000004 112.272 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 86.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.328 2.018 . . . . 71.120000000000005 112.471 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.01 154.03 81.19 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.948 -0.569 . . . . 75.439999999999998 111.197 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.17 151.95 39.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.318 2.012 . . . . 75.519999999999996 112.053 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.11 -16.41 33.15 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.535 2.157 . . . . 65.510000000000005 113.497 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 -12.2 60.02 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.458 0.54 . . . . 71.409999999999997 112.458 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -62.92 138.22 58.49 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.139 0.495 . . . . 75.109999999999999 111.521 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -106.8 139.2 20.14 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.359 -0.382 . . . . 74.349999999999994 111.463 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 71.019999999999996 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.049999999999997 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.683 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.200000000000003 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.450000000000003 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.310000000000002 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.409999999999997 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 71.230000000000004 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.129999999999995 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 73.239999999999995 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 71.030000000000001 111.984 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.71 111.48 18.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 110.807 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.25 107.76 17.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 75.319999999999993 112.071 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.33 -164.43 1.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.412 -0.813 . . . . 73.310000000000002 109.359 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.9 p -173.84 155.16 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.939 0.876 . . . . 74.349999999999994 113.068 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 28.6 p -155.23 168.08 28.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.861 -1.063 . . . . 63.450000000000003 109.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.66 94.63 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.929 0.395 . . . . 75.400000000000006 112.063 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.618 -0.706 . . . . 73.239999999999995 111.256 173.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.527 0.203 . . . . 63.350000000000001 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.66 -62.3 1.42 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.132 0.492 . . . . 70.340000000000003 110.647 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.78 90.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.616 0.722 . . . . 73.099999999999994 111.617 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -114.55 130.2 56.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 65.129999999999995 110.822 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.38 175.81 3.77 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.326 0.584 . . . . 72.120000000000005 111.828 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.666 ' N ' ' SG ' ' A' ' 69' ' ' CYS . 79.6 m -68.25 9.7 0.3 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.507 0.558 . . . . 73.219999999999999 112.507 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pp -70.91 -14.07 62.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.963 0.411 . . . . 75.349999999999994 111.788 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -73.76 174.81 7.89 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.117 0.485 . . . . 73.150000000000006 111.848 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 50.7 mm -90.63 130.65 40.38 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.366 -0.379 . . . . 64.129999999999995 111.369 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 17.9 Cg_exo -66.92 70.42 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.626 2.217 . . . . 75.420000000000002 112.745 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.88 6.0 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.048 -0.523 . . . . 65.120000000000005 112.162 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.310000000000002 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.030000000000001 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.439999999999998 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 72.150000000000006 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.239999999999995 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 75.219999999999999 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD12 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.340000000000003 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 74.530000000000001 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.109999999999999 112.377 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.510000000000005 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.150000000000006 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.510000000000005 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.039999999999999 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.329999999999998 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.229999999999997 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.430000000000007 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.3 128.16 41.92 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 75.040000000000006 109.668 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' HB1' HD12 ' A' ' 36' ' ' ILE . . . -107.34 151.52 25.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.304 0.574 . . . . 74.150000000000006 112.435 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.451 ' HB ' ' HD2' ' A' ' 53' ' ' HIS . 27.4 m -89.72 27.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.056 -0.52 . . . . 61.100000000000001 112.021 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.593 HD12 ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -70.25 173.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.434 0.531 . . . . 73.299999999999997 112.434 -178.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 90.34 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.196 -0.456 . . . . 74.049999999999997 111.773 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.5 112.1 5.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.053 0.454 . . . . 71.329999999999998 111.165 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.75 166.86 23.6 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.122 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -160.41 141.74 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.708 0.289 . . . . 74.400000000000006 111.592 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.66 -176.79 15.66 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.343 -0.456 . . . . 64.420000000000002 112.998 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.04 -41.08 91.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.104 0.478 . . . . 75.140000000000001 111.447 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.8 -69.75 0.03 OUTLIER Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.85 -0.613 . . . . 64.540000000000006 111.672 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 157.17 45.97 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.628 2.219 . . . . 73.319999999999993 111.717 170.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.33 117.87 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.447 2.098 . . . . 73.439999999999998 113.544 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.54 164.58 35.18 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.888 2.392 . . . . 75.219999999999999 112.407 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.75 106.74 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.551 2.167 . . . . 72.420000000000002 112.965 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.09 129.32 23.68 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.802 0.334 . . . . 75.349999999999994 111.811 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.8 162.02 10.56 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.845 2.364 . . . . 75.219999999999999 112.846 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.49 -42.85 64.3 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.486 2.124 . . . . 75.239999999999995 112.411 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.08 47.83 1.38 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.371 0.605 . . . . 71.310000000000002 110.849 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -66.43 140.85 58.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.308 0.575 . . . . 73.239999999999995 112.35 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.451 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 63.6 m80 -131.14 145.71 58.93 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.872 -0.604 . . . . 52.210000000000001 111.308 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 63.409999999999997 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 74.140000000000001 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 61.549999999999997 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 71.239999999999995 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 73.140000000000001 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 54.43 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 73.040000000000006 111.019 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 74.439999999999998 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.420000000000002 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -80.91 111.7 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.209999999999994 110.958 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.3 pt20 -85.06 95.79 9.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.976 0.732 . . . . 74.200000000000003 112.976 -172.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 7.8 t70 165.94 -74.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.103 0.961 . . . . 54.329999999999998 109.644 171.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.5 m 58.75 -72.61 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.159 1.17 . . . . 74.319999999999993 114.159 171.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 42.0 t -50.63 -50.96 53.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.833 0.679 . . . . 75.019999999999996 112.833 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.68 -170.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.525 -0.307 . . . . 74.209999999999994 111.226 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.647 -0.692 . . . . 60.439999999999998 110.727 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.834 0.35 . . . . 72.219999999999999 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -151.97 -164.29 1.94 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.859 0.362 . . . . 75.329999999999998 111.97 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.43 -19.66 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 112.4 0.519 . . . . 64.430000000000007 112.4 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -164.89 146.15 7.76 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.133 -0.354 . . . . 72.25 111.401 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB2' HD22 ' A' ' 7' ' ' LEU . 36.9 mt-10 -78.26 -169.66 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.552 0.692 . . . . 74.400000000000006 112.815 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 69' ' ' CYS . 21.9 m -58.69 -27.16 64.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.898 0.703 . . . . 61.450000000000003 112.898 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -61.53 -2.32 0.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.831 0.678 . . . . 75.019999999999996 112.831 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -72.7 179.03 3.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.394 0.616 . . . . 51.420000000000002 111.815 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.81 130.89 46.95 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 74.230000000000004 111.059 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.55 76.22 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.29 1.994 . . . . 74.230000000000004 112.123 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.95 2.89 24.86 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.020000000000003 112.558 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.519999999999996 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.009999999999998 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.319999999999993 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.319999999999993 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 74.129999999999995 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.329999999999998 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.420000000000002 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 74.239999999999995 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.349999999999994 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.299999999999997 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.329999999999998 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.219999999999999 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 73.230000000000004 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 65.319999999999993 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.120000000000005 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.409999999999997 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . -98.16 153.77 18.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 74.299999999999997 112.38 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 142.78 47.37 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.942 0.401 . . . . 71.010000000000005 111.813 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.43 -4.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.289 0.848 . . . . 72.340000000000003 113.289 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.54 -2.72 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 113.368 0.877 . . . . 74.219999999999999 113.368 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 25.5 t-20 62.13 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.793 0.437 . . . . 74.109999999999999 111.288 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 41.62 58.14 2.83 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.261 0.624 . . . . 64.019999999999996 112.24 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.31 5.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.086 -0.506 . . . . 73.030000000000001 111.698 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -73.02 129.79 38.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 74.219999999999999 110.96 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.34 19.28 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.072 -0.585 . . . . 41.5 113.595 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.68 21.77 1.77 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.31 0.576 . . . . 63.329999999999998 111.0 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.42 -133.16 4.76 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.8 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.75 114.84 3.73 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.171 1.914 . . . . 64.150000000000006 112.417 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.47 151.1 80.48 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.482 2.122 . . . . 72.109999999999999 113.154 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.98 157.28 4.01 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.017 2.478 . . . . 73.120000000000005 113.272 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.06 80.31 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.569 2.179 . . . . 74.129999999999995 113.503 -175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.95 137.86 23.1 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.363 -0.38 . . . . 75.150000000000006 111.456 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.5 143.56 47.62 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.706 2.271 . . . . 60.310000000000002 112.917 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.55 -8.94 23.73 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.579 2.186 . . . . 62.140000000000001 113.155 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.24 65.83 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.328 0.585 . . . . 52.450000000000003 111.497 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 17.2 tt0 -147.36 158.21 43.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.802 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.435 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.9 m80 -89.48 159.96 43.03 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.642 -0.254 . . . . 73.530000000000001 110.999 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.310000000000002 112.664 175.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 71.439999999999998 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HA ' HD12 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.549999999999997 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 63.32 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.140000000000001 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.329999999999998 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 74.109999999999999 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 71.219999999999999 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 63.310000000000002 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.200000000000003 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.67 109.19 20.93 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.340000000000003 110.96 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.81 122.87 44.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 72.420000000000002 110.745 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.09 98.06 7.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.126 0.488 . . . . 75.510000000000005 110.383 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.5 p -76.19 96.47 3.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.583 0.586 . . . . 74.519999999999996 112.583 -173.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 31.2 p -95.65 98.0 10.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.192 0.52 . . . . 73.540000000000006 110.59 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.67 156.6 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.533 0.568 . . . . 65.099999999999994 112.533 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 119.086 -0.483 . . . . 75.349999999999994 111.055 175.295 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.813 0.339 . . . . 62.13 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 41.42 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.03 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.41 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.12 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.24 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.04 111.285 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.45 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.44 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.45 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 70.34 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.24 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.35 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.15 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.32 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.518 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.03 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 53.31 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.44 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 72.21 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.02 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 61.13 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.32 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.22 110.364 174.367 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 109.89 -0.411 . . . . 71.01 109.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.13 114.409 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.15 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.12 111.501 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 62.13 113.779 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 58' ' ' PRO . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.4 113.259 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.01 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.01 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.2 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.23 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.22 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 42.53 110.738 -176.292 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.121 0.415 . . . . 64.23 112.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.55 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.31 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 73.13 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.24 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.01 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.23 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.24 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.31 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.34 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 65.43 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.52 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 44.43 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.24 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 63.22 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.24 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 72.25 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 71.14 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.04 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 64.4 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 74.43 110.96 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.011 -0.366 . . . . 72.22 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 53.51 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.4 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.34 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.01 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.42 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 50.44 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 65.22 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.12 110.9 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 53.23 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.23 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.54 110.57 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.14 112.124 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 51.35 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.13 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.51 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.12 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 54.13 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.54 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 43.15 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.42 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.22 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 62.52 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.13 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 50.43 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.22 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 74.04 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.14 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.422 HD12 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.54 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.34 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.35 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 61.13 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 71.44 111.105 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 110.197 -0.298 . . . . 55.41 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.02 115.387 -168.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 64.24 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 72.12 112.28 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 65.54 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.1 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.24 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.05 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.42 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.32 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 70.14 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.41 111.045 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.593 0.235 . . . . 64.32 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.1 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.3 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.11 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.33 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.23 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.21 111.945 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 74.35 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.555 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.11 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 73.45 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 73.14 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 54.43 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.33 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.04 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 52.01 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 73.3 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.22 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 70.43 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.13 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.1 110.138 171.328 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.519 0.2 . . . . 73.5 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.477 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.13 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 65.24 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.477 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.11 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 41.13 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.33 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 34.03 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.01 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.24 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.23 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.11 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.03 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 64.5 111.623 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 74.31 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.32 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.33 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.3 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.01 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.01 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.23 112.048 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.23 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.14 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.13 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 73.31 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.12 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 45.21 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.566 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.54 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 73.04 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.35 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.45 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.45 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.44 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.12 110.451 172.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.737 0.303 . . . . 74.21 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 51.52 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.23 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 61.15 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.21 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.22 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.33 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.14 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.05 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.1 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.24 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.22 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.31 111.033 -178.723 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.858 0.361 . . . . 74.51 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.52 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.52 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.44 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.53 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.22 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.12 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 71.32 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 71.21 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.14 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 54.42 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.54 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.24 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 62.43 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 73.2 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 54.4 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.34 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.43 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 64.45 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.33 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.4 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 41.14 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.32 112.291 -179.0 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.716 0.293 . . . . 71.42 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.04 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 72.12 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.24 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.05 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 54.12 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 62.31 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.11 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.33 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.12 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.4 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.44 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 61.32 110.241 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.866 0.321 . . . . 72.32 111.866 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.15 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.43 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.41 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 62.03 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.01 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.45 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.11 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.12 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.41 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 71.52 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.14 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.22 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.3 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.54 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.22 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 63.13 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.15 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 72.44 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 65.43 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 72.54 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 73.3 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.21 111.112 173.205 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 110.012 -0.366 . . . . 72.51 110.012 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 72.53 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 63.2 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.34 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.54 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 71.02 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.34 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.43 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.53 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.3 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.23 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.24 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 63.44 111.435 -176.141 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.03 113.169 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.12 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.41 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.34 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.51 114.075 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.3 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.44 112.721 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 71.02 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.23 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.53 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.1 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 64.13 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 73.14 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.42 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.54 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 72.41 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.43 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 73.42 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.3 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 62.52 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.11 111.768 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 45.34 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 52.23 110.79 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.297 -0.26 . . . . 72.43 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.11 112.874 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.34 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.34 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.54 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.35 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 64.13 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.24 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.32 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.4 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.54 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.15 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.44 111.673 177.058 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.13 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.03 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 42.25 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.35 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.51 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 43.15 111.889 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.35 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.14 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.595 HD13 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.45 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 64.23 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.21 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.11 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.22 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 50.33 113.026 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 72.11 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.55 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 54.54 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.04 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 63.05 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 64.3 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.1 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 64.44 110.739 175.629 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 120.806 0.336 . . . . 74.1 111.132 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.42 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.13 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.702 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.43 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.05 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.01 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.1 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.33 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.14 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 43.21 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 55.42 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.01 111.252 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.705 0.288 . . . . 63.51 111.592 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.01 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 62.52 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.43 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.41 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.11 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.23 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.14 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.12 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 51.34 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.03 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 74.01 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.12 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.23 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 74.3 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.4 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.43 111.246 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.532 HD12 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 72.02 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.2 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.23 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.41 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.44 112.093 -177.676 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.518 0.199 . . . . 75.23 110.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.31 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.14 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 63.53 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.24 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 63.44 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.21 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.42 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 71.34 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.42 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 60.33 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.45 109.814 173.085 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 120.963 0.411 . . . . 75.43 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 64.23 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 53.43 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.3 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.12 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.43 112.063 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.44 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.44 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.31 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.11 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.32 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 63.21 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 30.14 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.33 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 64.55 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.4 111.138 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 73.53 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 71.21 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 71.43 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.14 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 61.02 110.328 173.132 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 110.476 -0.194 . . . . 75.2 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.4 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.12 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 63.44 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.32 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.43 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 52.23 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.51 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 64.11 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.15 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.23 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.52 110.858 178.432 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.901 0.381 . . . . 75.23 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.11 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 51.02 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.31 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 54.0 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 63.11 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.44 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 63.22 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.53 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' A' ' 18' ' ' LYS . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 65.21 112.153 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.34 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.12 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.2 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 34.33 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 52.52 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 54.35 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 55.4 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.21 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 65.14 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.32 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.2 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.11 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.42 111.594 178.581 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.619 0.247 . . . . 71.31 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.44 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.35 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 64.31 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 61.31 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.21 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.11 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 32.25 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 70.52 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 71.35 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.32 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.42 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.52 109.975 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.781 0.324 . . . . 72.12 110.723 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.24 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 41.34 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.13 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.24 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.04 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.0 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.53 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 45.22 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.51 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.14 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.52 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.13 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.2 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 34.52 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 71.2 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.02 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.03 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.14 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 61.05 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.42 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.4 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.42 109.93 170.989 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 110.241 -0.281 . . . . 72.2 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.45 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.01 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 61.23 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.663 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.24 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.02 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.12 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.05 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.23 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.24 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 43.15 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.34 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 43.22 110.929 177.215 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.985 0.365 . . . . 63.23 111.985 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.12 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.34 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.01 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.51 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.41 111.726 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.52 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.55 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 74.41 111.645 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 52.13 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.12 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 72.55 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.24 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.52 113.244 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.33 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 71.33 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 71.15 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 60.22 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.12 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.2 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.32 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.21 111.44 178.009 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 80.2 m80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 110.004 -0.369 . . . . 74.42 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 65.34 112.974 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 63.12 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.41 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.42 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.41 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.55 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 73.11 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.12 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.44 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.14 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.22 111.37 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.53 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 72.53 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.43 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.14 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.1 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.42 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.45 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 62.02 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 63.53 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.15 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.34 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.34 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.12 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.15 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 72.44 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 62.14 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 65.41 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 73.12 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.21 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.14 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.22 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 71.31 111.547 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.998 0.427 . . . . 75.55 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.31 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.44 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.758 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.12 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.12 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 63.51 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.33 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 22.1 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 63.41 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.42 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.13 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.03 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.42 110.259 177.931 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.45 111.837 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 71.03 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.11 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 61.11 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 65.02 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.32 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.44 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD13 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.15 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.42 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.12 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.34 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.3 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 71.42 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.51 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.33 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 12' ' ' ALA . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.12 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 63.04 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.416 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.53 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 64.3 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.2 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.11 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.14 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 71.55 111.073 177.461 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 120.811 0.338 . . . . 70.44 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.31 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.46 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 71.34 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 61.33 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 70.01 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 23.55 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 53.42 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.23 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 53.13 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.15 111.11 178.468 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.1 0.407 . . . . 60.12 112.1 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.11 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 70.01 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.02 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.33 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.51 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 62.51 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.14 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.54 HG22 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.43 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.03 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.54 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 64.31 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 33.32 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.24 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.42 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 54.14 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.23 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 61.21 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 52.11 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 44.1 111.66 178.716 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 110.227 -0.286 . . . . 74.53 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 73.03 113.121 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.32 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 71.12 112.267 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 74.44 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 43.31 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.14 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.04 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.15 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 60.14 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 63.42 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 53.44 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.41 110.15 176.617 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.688 0.255 . . . . 72.31 111.688 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.54 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 55.42 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.44 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.22 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.13 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.11 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.3 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.24 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.14 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.4 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.04 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.23 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 54.31 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.42 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 65.14 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 72.03 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.43 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 71.03 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 72.5 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 72.32 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.14 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.33 111.964 -177.852 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.805 0.336 . . . . 74.35 111.463 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 64.25 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.05 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.2 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.45 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.31 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.41 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 13.12 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.13 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 51.24 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 51.43 111.984 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.23 110.807 179.698 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.162 0.43 . . . . 65.12 112.162 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.31 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.03 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.44 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 62.53 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.24 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 74.04 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HE2' HD13 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.34 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.43 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 71.52 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.11 112.377 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.51 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.12 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.0 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.04 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.33 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 64.12 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.04 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 72.12 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.43 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 62.11 109.668 170.306 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.77 0.319 . . . . 51.43 111.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 54.41 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 72.43 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 54.42 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 61.25 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 32.2 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 30.35 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 70.33 111.019 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 72.1 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.42 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.24 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.21 110.958 -175.622 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.02 112.558 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 43.22 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.52 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.52 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.01 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.32 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.32 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 72.05 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.33 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.42 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 71.21 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.35 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.3 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.33 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.22 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 62.03 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 63.34 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.32 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.12 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.54 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.41 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 45.43 112.38 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.605 0.24 . . . . 73.53 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.31 112.664 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.24 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 65.31 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.405 ' HA ' HD11 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.55 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 51.51 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.14 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.33 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 72.33 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 65.01 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 33.04 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.2 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.34 110.96 177.28 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 4' ' ' ASN . 49.3 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.619 0.247 . . . . 55.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -95.4 -53.69 3.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.868 0.366 . . . . 72.05 111.818 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 p -98.34 -7.25 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.529 0.68 . . . . 71.13 110.498 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' A' ' 1' ' ' SER . 4.4 m120 -78.86 142.01 37.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.684 -0.689 . . . . 52.23 111.735 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -100.88 -174.04 2.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.909 0.385 . . . . 74.03 111.407 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.3 m -75.55 25.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.634 0.605 . . . . 75.1 112.634 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pp -98.2 2.44 48.39 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.186 0.439 . . . . 70.45 112.186 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -62.04 155.99 22.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.218 0.533 . . . . 64.41 112.361 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 11' ' ' GLU . 48.4 mm -92.69 136.83 24.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.198 -0.455 . . . . 54.1 111.008 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 9' ' ' ILE . 58.6 Cg_endo -70.2 43.91 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.718 2.279 . . . . 70.12 114.173 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 9' ' ' ILE . 41.8 mt-10 -78.59 6.47 8.64 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.907 -0.495 . . . . 62.13 111.69 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 41.42 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.03 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.41 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.12 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.24 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.04 111.285 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.45 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.44 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.45 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 70.34 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.24 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.35 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.15 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.32 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.518 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.03 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 53.31 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.44 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 72.21 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.02 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 61.13 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.32 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.96 113.43 23.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.22 110.364 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.47 137.0 32.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.176 0.512 . . . . 51.14 112.221 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.08 82.49 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.542 0.687 . . . . 75.54 111.529 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.0 pp -121.39 -166.93 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.944 -0.571 . . . . 63.41 112.45 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.44 164.08 2.06 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.864 0.69 . . . . 62.21 112.864 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.84 139.13 56.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.426 0.632 . . . . 65.22 112.115 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.78 51.11 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.927 -0.579 . . . . 64.24 110.805 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -64.09 -12.19 36.86 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.197 -0.456 . . . . 73.52 112.144 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.07 29.77 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.339 -0.458 . . . . 74.52 112.304 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.56 -179.22 3.96 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.077 0.465 . . . . 73.25 111.88 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.74 -115.77 5.73 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 116.111 -0.495 . . . . 35.11 113.975 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 69.7 Cg_endo -88.07 126.34 2.02 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.885 2.39 . . . . 74.34 114.475 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 3.5 Cg_exo -77.67 140.08 18.46 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.831 2.354 . . . . 55.13 111.702 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.04 150.78 61.0 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.625 2.217 . . . . 74.11 113.396 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.27 -40.68 73.75 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.632 2.222 . . . . 73.5 112.253 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.71 102.13 52.76 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.255 -0.43 . . . . 73.52 110.466 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.44 127.5 14.13 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.542 2.162 . . . . 74.34 113.333 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.19 -4.45 14.34 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.695 2.263 . . . . 73.35 112.869 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -151.13 105.04 3.18 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.396 -0.366 . . . . 63.03 111.351 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -73.16 -27.91 61.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.451 0.643 . . . . 71.11 110.171 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -126.71 126.26 24.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.324 -0.853 . . . . 71.01 109.89 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.13 114.409 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.15 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.12 111.501 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 62.13 113.779 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 58' ' ' PRO . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.4 113.259 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.01 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.01 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.2 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.23 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.22 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -80.52 110.83 16.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 42.53 110.738 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.1 99.12 11.16 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.497 -0.774 . . . . 73.32 111.761 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -113.97 108.88 17.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.79 -0.641 . . . . 74.15 110.81 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -118.55 145.68 45.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.323 0.583 . . . . 72.22 111.793 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.2 p -98.67 -3.18 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.761 -0.654 . . . . 72.51 112.014 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.93 159.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.029 0.381 . . . . 75.3 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.843 -0.599 . . . . 71.15 111.253 175.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 112.402 0.519 . . . . 73.21 112.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.56 -76.24 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.838 0.681 . . . . 61.23 112.838 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -82.79 -28.48 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.581 0.585 . . . . 74.12 112.581 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.78 171.01 9.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.757 0.313 . . . . 72.42 110.94 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HB2' HD22 ' A' ' 7' ' ' LEU . 27.7 mt-10 -96.44 -170.48 2.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.365 0.505 . . . . 70.55 112.365 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.51 16.08 5.91 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.033 0.383 . . . . 44.51 112.033 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.5 pt? -69.3 -6.17 27.84 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.895 0.378 . . . . 63.1 111.496 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -77.41 -174.6 3.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.934 0.397 . . . . 71.12 111.298 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.93 126.47 89.39 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.182 -0.303 . . . . 71.11 110.182 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -37.8 103.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.55 2.834 . . . . 64.32 114.08 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.48 5.84 43.56 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.795 -0.639 . . . . 64.23 112.121 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.55 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.31 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 73.13 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.24 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.01 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.23 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.24 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.31 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.34 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 65.43 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.52 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 44.43 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.24 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 63.22 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.24 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 72.25 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 71.14 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.04 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 64.4 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.07 154.11 22.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 74.43 110.96 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.15 124.57 31.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.086 0.47 . . . . 44.35 111.873 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 35' ' ' VAL . 21.1 m -90.17 95.02 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 62.33 111.827 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -125.6 -151.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.593 -0.73 . . . . 72.03 110.012 176.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.43 -160.8 0.8 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.094 -0.379 . . . . 74.44 110.966 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -64.44 -32.69 74.41 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.05 0.389 . . . . 73.04 112.05 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.16 112.02 8.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.986 0.422 . . . . 71.13 110.599 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -79.22 18.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.014 0.746 . . . . 71.31 113.014 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.61 22.49 64.33 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 114.528 0.571 . . . . 73.44 114.528 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.037 0.446 . . . . 61.51 111.358 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.11 -60.44 0.58 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.984 -0.627 . . . . 64.52 113.275 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.56 133.81 31.08 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.543 2.162 . . . . 74.21 112.826 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.9 151.87 14.47 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.641 2.228 . . . . 34.24 112.381 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 44.7 Cg_endo -68.39 127.0 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.114 1.876 . . . . 71.43 111.98 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 46' ' ' PRO . 9.5 Cg_endo -49.73 -48.56 18.78 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.772 2.315 . . . . 73.15 112.19 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.39 99.65 42.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.981 -0.554 . . . . 65.21 110.288 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 16.6 Cg_exo -68.41 119.08 6.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.627 2.218 . . . . 74.34 112.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 49' ' ' PRO . 31.2 Cg_endo -63.38 -29.96 72.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.186 1.924 . . . . 75.2 111.679 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.59 170.37 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.24 -0.891 . . . . 42.24 109.769 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.07 12.18 4.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.323 0.582 . . . . 72.45 111.553 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -104.25 157.56 33.78 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.707 -0.679 . . . . 72.22 110.011 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 53.51 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.4 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.34 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.01 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.42 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 50.44 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 65.22 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.12 110.9 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 53.23 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.23 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.15 107.63 15.85 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.54 110.57 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -117.91 102.05 8.77 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.954 0.407 . . . . 74.34 110.944 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -66.77 -18.88 65.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.89 0.376 . . . . 51.15 111.27 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.7 m -62.65 -29.88 70.96 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.708 0.632 . . . . 74.33 112.708 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.76 152.41 51.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.267 0.469 . . . . 72.45 112.267 -174.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.33 174.24 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.15 -0.477 . . . . 74.35 111.627 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 119.021 -0.514 . . . . 74.42 111.704 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.604 0.24 . . . . 75.04 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.73 125.22 23.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.765 0.317 . . . . 74.01 111.828 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -76.87 146.62 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.519 0.676 . . . . 51.32 112.695 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.17 142.79 47.08 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.793 -0.64 . . . . 73.02 110.357 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HB2' HD22 ' A' ' 7' ' ' LEU . 36.4 mt-10 -73.37 -178.93 3.18 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.152 0.501 . . . . 72.42 111.724 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.1 m -65.16 4.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.987 1.106 . . . . 61.22 113.987 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.6 pt? -84.43 -14.11 50.22 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.062 -0.399 . . . . 74.53 111.282 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 5' ' ' GLU . 9.8 t -65.96 139.65 58.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.073 0.463 . . . . 75.33 111.809 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.98 126.66 79.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 116.326 -0.397 . . . . 72.22 111.123 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.63 94.91 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.46 2.107 . . . . 64.51 112.363 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.09 -6.76 59.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.14 112.124 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 51.35 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.13 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.51 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.12 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 54.13 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.54 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 43.15 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.42 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.22 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 62.52 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.13 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 50.43 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.22 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 74.04 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.14 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.422 HD12 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.54 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.34 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.35 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 61.13 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . -86.88 154.24 21.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 71.44 111.105 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.94 36.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.879 0.696 . . . . 61.34 112.879 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -98.83 -2.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.112 -0.495 . . . . 74.11 111.676 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 pp -77.85 -161.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 112.453 0.538 . . . . 70.4 112.453 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -41.17 136.03 1.7 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.823 0.675 . . . . 70.44 112.823 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.93 112.94 0.74 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.02 -0.536 . . . . 75.11 111.789 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.74 63.0 5.82 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.449 0.537 . . . . 74.22 112.449 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -173.73 117.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.07 0.462 . . . . 71.33 111.369 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.58 74.47 0.44 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.392 -0.432 . . . . 75.15 112.352 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -71.61 114.12 9.36 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 73.42 111.914 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.28 -141.13 20.41 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.07 -0.586 . . . . 74.33 114.079 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.04 164.57 17.55 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.193 2.595 . . . . 64.32 113.352 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 54.7 Cg_endo -68.95 118.28 5.57 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 122.321 2.014 . . . . 61.2 112.323 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 24.7 Cg_exo -64.17 136.44 51.87 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.756 2.304 . . . . 73.14 113.186 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.74 -45.24 34.49 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.699 2.266 . . . . 65.03 112.377 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 48' ' ' VAL . 4.7 p -135.08 98.43 12.88 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 121.526 0.679 . . . . 75.13 110.137 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.37 152.66 6.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.868 2.379 . . . . 61.31 114.003 -174.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.92 -0.03 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.628 2.219 . . . . 64.12 111.998 170.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.72 37.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.72 -0.673 . . . . 75.14 111.92 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 174.08 -20.55 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.814 -0.63 . . . . 72.24 110.487 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -149.0 118.79 4.02 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.801 -0.636 . . . . 55.41 110.197 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.02 115.387 -168.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 64.24 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 72.12 112.28 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 65.54 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.1 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.24 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.05 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.42 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.32 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 70.14 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.8 111.23 17.84 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.41 111.045 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -93.78 100.23 12.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.497 0.665 . . . . 74.33 112.066 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -87.39 -63.78 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.604 -0.517 . . . . 74.13 109.604 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.5 m 58.9 103.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.542 -0.753 . . . . 73.34 112.206 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.16 105.01 0.29 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.732 0.301 . . . . 72.13 110.563 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t 74.64 90.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.022 0.929 . . . . 53.33 111.354 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.417 -0.81 . . . . 63.41 110.407 179.379 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.814 0.34 . . . . 72.23 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -115.49 -79.96 0.59 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.182 0.438 . . . . 73.03 112.182 -172.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -121.88 113.15 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.549 0.69 . . . . 75.01 111.697 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.88 110.03 22.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.445 0.64 . . . . 70.4 111.782 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 7' ' ' LEU . 41.6 mt-10 -99.23 71.0 1.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.715 -0.675 . . . . 54.44 111.467 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.0 m 69.61 -37.61 0.38 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.163 0.431 . . . . 53.35 112.163 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 pt? -76.24 35.65 0.14 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.352 0.596 . . . . 73.25 111.559 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -58.05 144.32 40.34 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.939 0.718 . . . . 74.35 112.939 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.0 mm -74.66 139.43 74.2 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.43 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 65.56 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.811 2.341 . . . . 75.31 113.382 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -94.44 4.85 53.32 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.144 -0.48 . . . . 64.32 111.192 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.1 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.3 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.11 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.33 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.23 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.21 111.945 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 74.35 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.555 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.11 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 73.45 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 73.14 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 54.43 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.33 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.04 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 52.01 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 73.3 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.22 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 70.43 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.13 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.15 133.21 35.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.1 110.138 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB1' HG13 ' A' ' 36' ' ' ILE . . . -87.58 146.78 25.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.639 0.607 . . . . 72.43 112.639 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.31 -9.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.635 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.567 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.7 pp -78.26 173.96 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.154 0.502 . . . . 72.01 112.317 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -101.92 106.25 17.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.602 0.593 . . . . 74.15 112.602 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -107.63 23.88 13.76 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.235 -0.438 . . . . 50.52 111.308 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.429 HD22 ' H ' ' A' ' 39' ' ' LEU . 2.7 mm? -70.63 85.29 0.63 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.35 0.595 . . . . 62.25 110.38 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -111.08 -14.53 13.88 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.734 -0.666 . . . . 62.43 111.654 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.2 -139.02 41.72 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.226 -0.511 . . . . 61.33 113.492 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.82 -1.86 54.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.86 0.362 . . . . 73.15 111.641 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 169.88 -93.35 0.1 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.215 -0.516 . . . . 52.43 112.77 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 1.1 Cg_endo -82.69 111.58 2.02 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.926 2.417 . . . . 73.51 112.266 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.38 154.66 71.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.289 1.993 . . . . 64.25 112.625 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.83 150.18 79.05 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.766 2.311 . . . . 74.14 112.822 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.32 -8.24 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.82 2.347 . . . . 55.45 113.181 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.58 105.39 14.37 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.363 0.265 . . . . 64.34 111.15 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -97.1 92.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 123.201 2.6 . . . . 64.45 112.845 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.23 -16.79 19.51 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.483 2.122 . . . . 74.04 113.31 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.4 -45.83 10.81 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.887 0.329 . . . . 44.05 111.887 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 6.4 tp60 56.72 20.13 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.59 0.709 . . . . 74.44 111.341 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.85 148.5 30.39 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.966 -0.561 . . . . 73.5 110.726 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.477 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.13 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 65.24 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.477 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.11 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 41.13 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.33 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 34.03 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.01 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.24 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.23 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.11 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.03 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -94.76 110.39 22.25 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 64.5 111.623 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.86 144.15 44.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 72.5 110.711 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.01 104.04 14.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.3 110.795 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -79.32 -22.86 43.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.112 -0.495 . . . . 51.35 111.221 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m 60.72 21.03 11.05 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.142 0.423 . . . . 54.33 112.142 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.8 t -111.75 128.98 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.339 -0.391 . . . . 63.41 110.727 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.968 -0.539 . . . . 64.42 111.78 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.049 0.389 . . . . 73.42 112.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -65.89 -67.37 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.363 0.505 . . . . 62.43 112.363 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.23 152.87 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.109 0.48 . . . . 73.03 112.112 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -134.98 160.61 37.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.647 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.16 -171.0 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.068 0.461 . . . . 70.15 112.226 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.84 -17.17 34.31 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.374 0.879 . . . . 71.03 113.374 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.1 pt? -82.02 6.33 16.5 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.074 -0.391 . . . . 73.41 111.677 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -69.12 157.61 36.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.201 0.524 . . . . 74.34 112.31 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.6 134.65 57.49 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.05 -0.523 . . . . 64.3 111.062 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.52 79.77 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.82 2.347 . . . . 71.31 113.821 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -92.26 5.9 48.76 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 74.31 111.254 173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.32 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.33 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.3 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.01 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.01 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.62 ' SD ' HG13 ' A' ' 35' ' ' VAL . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.23 112.048 -172.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.23 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.14 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.13 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 73.31 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.12 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 45.21 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.566 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.54 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 73.04 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.35 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.45 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.45 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.44 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.76 154.39 22.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.12 110.451 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.46 141.22 50.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.115 0.483 . . . . 74.13 112.124 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.62 HG13 ' SD ' ' A' ' 17' ' ' MET . 23.1 m -80.57 45.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.154 0.502 . . . . 72.1 111.858 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.566 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -68.74 -166.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 112.517 0.562 . . . . 52.53 112.517 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -75.27 -83.24 0.06 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.358 0.503 . . . . 72.33 112.358 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -165.93 114.85 0.97 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.071 0.462 . . . . 72.41 111.614 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -110.61 61.25 0.61 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.148 0.499 . . . . 74.11 110.465 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -78.25 78.66 4.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.117 -0.492 . . . . 75.33 111.433 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 57.9 5.02 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.131 -0.556 . . . . 51.33 112.042 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -144.99 97.08 2.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.945 0.402 . . . . 73.43 110.715 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.22 -160.66 12.46 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.023 -0.535 . . . . 73.3 113.995 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.5 Cg_endo -79.17 115.69 3.54 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.632 2.221 . . . . 74.33 112.637 176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 15.1 Cg_exo -70.14 138.36 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.794 2.329 . . . . 74.02 112.885 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 31.4 Cg_exo -60.44 160.08 25.07 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.639 2.226 . . . . 64.24 112.853 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.02 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.3 2.0 . . . . 73.22 112.555 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.89 141.75 43.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.219 -0.446 . . . . 63.41 111.221 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.67 141.3 54.34 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.33 2.02 . . . . 75.04 112.685 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.08 -20.66 68.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.869 2.379 . . . . 72.3 113.317 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.92 85.87 0.98 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.052 0.453 . . . . 35.53 110.482 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 51.6 tt0 -151.16 174.08 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.255 -0.429 . . . . 60.42 111.282 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.495 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.2 m80 -125.07 150.2 65.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.609 0.363 . . . . 74.21 110.958 174.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 51.52 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.23 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 61.15 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.21 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.22 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.33 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.14 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.05 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.1 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.24 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.22 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -81.47 110.51 16.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.31 111.033 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -93.42 99.46 11.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.664 -0.698 . . . . 75.32 111.83 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.43 63.68 1.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.367 0.603 . . . . 71.53 110.586 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 m -72.8 83.85 1.2 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.22 -0.445 . . . . 52.03 111.073 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -76.41 -20.48 57.08 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.377 -0.374 . . . . 75.01 111.399 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.5 t -94.27 131.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.829 0.347 . . . . 75.31 111.196 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.933 -0.556 . . . . 63.23 111.431 177.753 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.849 0.356 . . . . 55.23 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.48 18.42 8.22 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.543 0.571 . . . . 73.45 112.543 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.98 150.98 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.66 0.384 . . . . 74.04 110.328 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -138.94 172.47 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.096 0.474 . . . . 75.33 111.344 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.11 -174.74 3.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.24 -0.437 . . . . 74.21 111.442 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 69' ' ' CYS . 55.0 m -70.43 5.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.602 0.964 . . . . 74.31 113.602 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.2 pt? -97.76 13.61 29.81 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.115 0.483 . . . . 73.4 110.753 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.5 t -71.33 178.1 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.66 0.615 . . . . 64.43 112.66 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.1 mm -86.2 141.73 35.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.625 -0.716 . . . . 75.13 110.552 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.61 82.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.562 2.175 . . . . 72.13 113.396 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 67.1 mt-10 -75.32 -35.79 61.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.082 -0.508 . . . . 74.51 111.038 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.52 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.52 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.44 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.53 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.22 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.12 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 71.32 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 71.21 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.14 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 54.42 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.54 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.24 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 62.43 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 73.2 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 54.4 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.34 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.43 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 64.45 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.33 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.4 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 41.14 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.94 154.43 20.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.32 112.291 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -112.78 154.01 26.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.265 -0.425 . . . . 72.33 110.881 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.35 14.56 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 113.088 0.773 . . . . 60.52 113.088 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -75.03 161.28 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.065 0.459 . . . . 72.11 111.735 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -91.52 126.31 36.56 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.034 0.445 . . . . 71.04 112.108 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t70 60.6 115.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.973 0.909 . . . . 74.14 112.816 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -138.49 30.3 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.233 -0.894 . . . . 73.23 110.713 178.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -57.51 112.84 1.55 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.051 -0.522 . . . . 71.32 111.667 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.1 -1.85 64.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.149 -0.548 . . . . 63.52 113.255 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.77 -57.62 4.18 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.673 -0.31 . . . . 72.24 111.464 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.18 -138.82 2.87 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.762 -0.733 . . . . 64.53 113.62 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 24.2 Cg_exo -64.56 129.96 25.19 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.073 2.515 . . . . 72.11 113.658 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 35.7 Cg_exo -61.89 134.53 50.54 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.038 2.492 . . . . 73.21 113.487 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.56 155.22 37.71 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.016 2.477 . . . . 74.33 113.183 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.63 -14.09 19.93 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.684 2.256 . . . . 75.15 113.785 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.34 100.58 7.67 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 121.435 0.636 . . . . 64.11 112.57 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.3 147.83 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.178 2.585 . . . . 72.11 112.283 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.44 -20.33 69.73 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.385 2.057 . . . . 75.14 113.049 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.2 171.7 4.02 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.595 0.358 . . . . 65.41 111.03 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.06 31.15 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.015 0.436 . . . . 62.44 111.932 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -123.06 148.03 53.24 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 122.114 -0.366 . . . . 71.42 111.632 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 39' ' ' LEU . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.04 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 72.12 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.24 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.05 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 54.12 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 62.31 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.11 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.33 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.12 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.4 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.44 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.22 107.36 17.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 61.32 110.241 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.59 127.02 53.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.926 0.393 . . . . 70.04 110.64 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.82 104.04 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.132 -0.485 . . . . 73.24 111.893 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -78.43 83.5 4.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.28 -0.418 . . . . 73.41 111.218 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 80.6 m -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.295 -0.411 . . . . 55.31 112.098 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -129.81 136.85 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.755 0.312 . . . . 60.14 111.296 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.924 -0.56 . . . . 41.5 111.759 178.646 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.831 0.348 . . . . 63.35 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -135.04 151.02 50.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.871 0.367 . . . . 62.1 111.289 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -88.45 146.83 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.87 0.366 . . . . 71.5 111.482 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 3.3 p-10 -143.14 143.12 31.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.173 0.434 . . . . 71.4 112.173 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.539 ' HB2' HD22 ' A' ' 7' ' ' LEU . 29.9 mt-10 -92.04 -158.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.904 -0.406 . . . . 64.33 109.904 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.73 -21.97 60.04 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 111.959 0.355 . . . . 62.35 111.959 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.8 pt? -71.14 -0.94 10.8 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.157 0.429 . . . . 74.33 112.157 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 4' ' ' ASN . 12.8 t -58.98 177.37 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.706 0.632 . . . . 41.5 112.706 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -73.74 133.92 79.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.154 -0.475 . . . . 64.1 111.092 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.29 72.14 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.754 2.302 . . . . 73.41 113.402 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -86.32 2.5 47.14 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.226 -0.443 . . . . 72.32 111.866 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.15 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.43 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.41 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 62.03 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.01 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.45 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.11 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.12 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.41 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 71.52 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.14 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.22 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.3 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.54 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.22 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 63.13 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.15 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 72.44 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 65.43 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 72.54 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 73.3 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' ILE . . . -121.87 109.51 14.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.21 111.112 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.4 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.199 -0.455 . . . . 64.11 110.94 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 18.3 m 42.67 25.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.765 1.024 . . . . 63.43 113.765 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 33' ' ' ALA . 2.2 pp -93.99 2.71 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 112.499 0.555 . . . . 61.42 112.499 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' ND2' HD21 ' A' ' 39' ' ' LEU . 14.5 p-10 -145.37 132.89 20.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.211 0.529 . . . . 72.04 112.296 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.73 115.44 29.56 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.866 -0.606 . . . . 72.11 109.88 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD21 ' ND2' ' A' ' 37' ' ' ASN . 3.1 mm? -99.45 168.84 9.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.346 0.498 . . . . 74.44 112.346 -173.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 67.79 -6.18 0.73 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.284 0.846 . . . . 71.33 113.284 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.18 66.3 2.91 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.765 -0.731 . . . . 61.15 112.785 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -125.06 104.89 8.79 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.864 0.364 . . . . 72.2 111.634 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.22 -122.09 5.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.304 -0.474 . . . . 75.51 113.043 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.83 111.44 3.29 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.847 2.365 . . . . 63.44 113.304 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -92.66 159.86 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.032 2.488 . . . . 64.34 112.95 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.62 144.72 79.6 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.191 1.927 . . . . 73.25 112.532 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.19 -26.14 77.49 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.542 2.162 . . . . 61.12 112.987 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.95 105.78 48.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.469 -0.332 . . . . 72.15 111.211 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 2.8 Cg_exo -76.8 105.64 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.804 2.336 . . . . 62.42 111.951 174.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 49' ' ' PRO . 32.1 Cg_endo -62.64 -51.09 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.422 2.082 . . . . 74.22 113.3 -173.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -178.13 115.57 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.746 0.418 . . . . 53.01 110.618 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.54 83.04 0.41 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.695 0.76 . . . . 74.21 112.114 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -107.45 146.48 33.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.401 -0.818 . . . . 72.51 110.012 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HG3' ' H ' ' A' ' 35' ' ' VAL . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 72.53 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 63.2 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.34 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.54 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 71.02 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.34 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.43 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.53 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.3 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.23 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.24 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.55 126.07 31.86 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 63.44 111.435 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -93.45 137.19 32.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.804 -0.634 . . . . 62.45 111.617 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -103.16 34.1 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.399 0.618 . . . . 63.32 110.958 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.7 m -61.81 96.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.822 -0.627 . . . . 72.43 111.148 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.68 -32.7 70.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.376 -0.374 . . . . 74.52 111.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.3 152.28 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.957 0.408 . . . . 61.53 111.888 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.852 -0.594 . . . . 74.13 111.25 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.626 0.25 . . . . 63.14 111.246 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -84.82 -33.25 22.95 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.715 0.635 . . . . 74.21 112.715 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 71' ' ' ASP . 12.5 p -144.88 145.2 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 51.13 111.661 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -106.1 177.59 4.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.054 0.454 . . . . 75.15 111.989 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.4 mt-10 -122.76 168.75 11.84 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.064 0.459 . . . . 54.23 111.461 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -83.03 31.38 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.013 0.435 . . . . 75.2 111.67 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.7 pt? -86.79 -3.54 59.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.382 -0.372 . . . . 53.5 111.467 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 t -79.55 173.27 12.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.349 0.595 . . . . 74.5 112.43 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.4 135.93 22.19 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.917 -0.583 . . . . 73.41 111.339 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.61 77.08 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.375 2.05 . . . . 65.13 112.004 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.78 -29.74 62.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.03 113.169 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.12 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.41 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.34 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.51 114.075 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.3 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.44 112.721 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 71.02 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.23 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.53 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.1 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 64.13 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 73.14 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.42 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.54 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 72.41 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.43 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 73.42 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.3 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 62.52 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.11 111.768 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 45.34 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . -88.69 141.62 28.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 52.23 110.79 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' HG13 ' A' ' 36' ' ' ILE . . . -86.93 144.99 26.71 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.255 0.465 . . . . 73.11 112.255 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.5 m -101.54 4.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.256 0.465 . . . . 73.2 112.256 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.3 pp -69.69 165.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.168 0.432 . . . . 71.52 112.168 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.048 0.452 . . . . 64.42 111.665 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -129.04 158.67 38.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.318 -0.401 . . . . 72.53 110.235 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.5 mm? -88.95 136.75 32.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.943 0.402 . . . . 72.2 111.263 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -66.15 -47.55 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.915 0.339 . . . . 43.34 111.915 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.68 95.66 1.02 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.822 -0.704 . . . . 53.12 112.88 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.85 5.09 49.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.047 0.388 . . . . 74.13 112.047 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.17 -69.63 0.49 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.611 -0.328 . . . . 63.51 112.537 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.94 172.09 5.27 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.917 2.411 . . . . 54.4 112.686 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.05 115.0 2.22 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.238 1.959 . . . . 64.22 112.06 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.15 121.16 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.743 2.962 . . . . 54.44 115.173 -172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.42 158.78 50.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.803 2.335 . . . . 72.44 112.547 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.61 108.84 58.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 112.599 0.592 . . . . 62.21 112.599 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 52' ' ' GLN . 62.3 Cg_endo -90.14 167.29 4.53 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.112 2.542 . . . . 75.32 112.661 171.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.73 -18.33 58.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.462 2.108 . . . . 74.33 113.151 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.22 145.76 7.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.05 0.54 . . . . 72.13 110.104 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 54.5 tp60 -166.91 154.39 9.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.619 0.723 . . . . 72.31 112.62 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -103.59 146.06 31.79 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.767 -0.651 . . . . 72.43 110.297 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.11 112.874 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.34 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.34 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.54 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.35 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 64.13 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.24 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.32 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.4 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.54 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.15 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -104.2 107.41 18.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.44 111.673 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.75 106.53 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.093 0.473 . . . . 74.34 110.247 165.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.95 -64.6 0.82 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.186 -0.461 . . . . 73.33 111.698 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.4 p -159.66 -172.95 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.984 0.421 . . . . 73.0 111.248 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.93 -30.08 70.66 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.05 0.759 . . . . 72.45 113.05 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.84 156.68 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.746 0.647 . . . . 74.5 112.746 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HB2' HG23 ' A' ' 3' ' ' VAL . 4.7 m-20 . . . . . 0 C--O 1.256 1.447 0 CA-C-N 115.623 -0.717 . . . . 62.24 111.526 175.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.578 0.228 . . . . 73.15 111.229 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -64.01 0.96 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.911 0.337 . . . . 74.42 111.911 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.44 113.05 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.089 0.471 . . . . 51.22 111.372 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -132.66 157.15 45.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.457 . . . . 74.11 110.788 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.4 mt-10 -130.5 -171.92 2.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.054 0.454 . . . . 74.11 111.458 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -81.85 23.81 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.349 0.5 . . . . 65.43 112.349 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -93.71 -15.57 25.11 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 111.915 0.339 . . . . 75.12 111.915 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -79.59 176.8 9.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.637 0.606 . . . . 75.41 112.637 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.67 132.7 39.76 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 73.11 111.153 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.66 78.6 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.367 2.045 . . . . 34.21 113.403 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.5 7.0 31.36 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.13 111.175 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.03 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 42.25 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.35 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.51 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.802 ' SD ' HG12 ' A' ' 35' ' ' VAL . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 43.15 111.889 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.35 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.14 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.595 HD13 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.45 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 64.23 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.21 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.11 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.22 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 50.33 113.026 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 72.11 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.55 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 54.54 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.04 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 63.05 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 64.3 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.1 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.59 155.67 21.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 64.44 110.739 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -83.89 120.6 26.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.057 0.456 . . . . 73.44 111.88 -174.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG12 ' SD ' ' A' ' 17' ' ' MET . 17.4 m -81.58 -15.71 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.001 -0.545 . . . . 70.41 112.018 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.5 pp -86.43 167.26 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.026 0.75 . . . . 70.55 113.026 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.52 119.56 5.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.625 -0.716 . . . . 52.33 112.123 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 32.3 t70 -148.99 145.65 27.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.147 0.499 . . . . 63.43 111.682 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.31 160.9 41.99 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.044 -0.525 . . . . 61.23 110.914 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -139.02 -177.39 4.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.408 0.623 . . . . 63.35 112.113 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 141.93 -156.76 26.11 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.467 -0.788 . . . . 73.51 111.447 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -152.0 127.8 10.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.46 0.63 . . . . 73.41 111.297 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.58 -134.93 13.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.159 -0.544 . . . . 64.45 112.466 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.24 118.09 2.57 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.709 2.273 . . . . 64.33 113.544 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.49 168.45 22.72 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.112 2.542 . . . . 72.51 112.15 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.77 151.05 86.91 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.38 2.053 . . . . 74.0 112.898 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.91 17.4 1.71 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.805 2.337 . . . . 71.12 113.208 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.26 123.46 16.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.849 0.357 . . . . 65.43 111.665 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 124.43 6.12 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.178 1.919 . . . . 61.43 112.386 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.25 -37.4 18.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.19 1.927 . . . . 73.32 112.376 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.14 168.87 16.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 64.32 110.869 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -82.11 -10.08 59.31 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.087 0.47 . . . . 75.42 110.837 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 -105.85 154.07 39.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.03 -0.532 . . . . 74.1 111.132 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.42 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.13 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.702 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.43 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.05 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.01 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.1 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.33 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.14 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 43.21 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 55.42 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -90.42 112.79 24.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.01 111.252 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -104.57 101.55 11.2 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.673 -0.694 . . . . 64.52 112.227 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.14 102.69 15.23 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.352 -0.385 . . . . 74.04 110.904 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.1 p -126.44 112.61 15.81 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.063 0.459 . . . . 70.24 111.638 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.36 -19.66 63.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.261 -0.427 . . . . 54.54 111.656 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -103.41 144.22 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.917 0.389 . . . . 73.03 111.76 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 116.224 -0.444 . . . . 73.3 111.226 -178.529 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.775 0.322 . . . . 61.12 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.25 161.75 30.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.12 0.486 . . . . 55.22 112.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.19 123.07 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.261 -0.427 . . . . 64.44 111.0 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -160.92 165.56 29.83 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.631 0.253 . . . . 63.02 110.836 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.675 ' HB2' HD22 ' A' ' 7' ' ' LEU . 30.7 mt-10 -70.97 169.1 15.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.083 0.468 . . . . 64.33 111.027 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 67' ' ' ASP . 26.5 p -81.56 25.67 0.51 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.281 0.475 . . . . 70.12 112.281 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.675 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -82.77 -0.37 47.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.499 . . . . 71.05 110.829 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -60.64 156.48 16.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.336 0.589 . . . . 55.23 112.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 138.62 74.74 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.003 -0.544 . . . . 75.33 110.567 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' HG11 ' A' ' 70' ' ' VAL . 50.2 Cg_exo -57.04 77.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.509 2.139 . . . . 75.22 112.984 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.51 -0.37 37.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.118 -0.492 . . . . 63.51 111.592 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.01 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 62.52 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.43 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.41 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.11 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.23 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.14 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.12 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 51.34 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.03 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 74.01 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.12 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.23 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 74.3 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.4 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.43 111.246 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD12 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 72.02 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.2 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.23 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.41 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.33 143.06 46.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.44 112.093 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.99 154.4 22.23 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.261 -0.427 . . . . 72.13 111.408 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.466 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 15.5 m -90.85 85.52 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.516 0.674 . . . . 61.1 112.326 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -133.69 177.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 116.086 -0.506 . . . . 75.03 111.429 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.05 157.23 13.3 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.973 0.416 . . . . 71.22 112.002 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.78 116.49 2.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.269 -0.423 . . . . 64.34 111.924 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.8 mm? -73.37 -23.65 60.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.386 0.612 . . . . 74.23 110.763 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -87.74 144.81 26.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.846 -0.615 . . . . 74.41 111.368 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.98 133.27 1.45 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.789 -0.719 . . . . 50.24 113.805 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.96 161.36 13.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.88 0.372 . . . . 73.03 111.568 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.83 -142.9 47.13 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 116.123 -0.49 . . . . 62.1 113.596 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.66 168.94 5.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.099 2.533 . . . . 62.15 112.881 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.48 120.03 7.38 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.325 2.016 . . . . 72.12 112.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.36 162.54 33.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.528 2.152 . . . . 61.11 112.971 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.93 79.27 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 71.12 112.774 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -114.36 147.29 37.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 71.5 111.6 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.27 151.92 60.85 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.626 2.217 . . . . 72.13 113.162 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -16.46 55.36 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.629 2.219 . . . . 45.14 112.969 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.93 34.89 0.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.125 0.488 . . . . 74.31 111.378 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.47 156.68 10.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.479 0.657 . . . . 73.55 112.731 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.37 133.68 8.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.714 -0.675 . . . . 75.23 110.597 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.31 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.14 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 63.53 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.24 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 63.44 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.21 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.42 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 71.34 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.42 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 60.33 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -82.75 107.35 15.31 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.45 109.814 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -118.17 150.88 38.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.739 0.304 . . . . 65.1 111.753 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 2.6 m-20 -70.04 89.14 0.6 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.029 0.442 . . . . 71.45 110.255 172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 p -78.55 77.55 5.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.235 0.541 . . . . 72.3 112.292 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.3 m -82.84 -9.72 59.19 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.904 0.383 . . . . 61.54 111.404 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 10' ' ' PRO . 5.3 p -104.4 104.11 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.518 0.675 . . . . 55.54 111.878 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 118.634 -0.698 . . . . 72.33 111.79 178.067 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.923 0.392 . . . . 70.11 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.39 -64.16 1.21 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.03 0.443 . . . . 72.31 111.167 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.7 146.73 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.37 -0.377 . . . . 71.43 111.332 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -88.78 112.73 23.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.009 0.433 . . . . 73.55 110.73 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.6 47.81 0.51 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.188 -0.46 . . . . 71.31 112.163 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 m 66.04 -3.32 0.79 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.641 0.978 . . . . 62.43 113.641 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt? -73.05 60.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.521 1.153 . . . . 64.53 108.633 166.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 t -57.6 117.44 4.19 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.725 -1.125 . . . . 63.13 113.89 -165.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.96 120.74 83.1 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.476 -0.783 . . . . 61.23 108.991 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.38 90.84 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.284 1.989 . . . . 73.54 113.55 -172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -67.65 -31.95 72.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.266 -0.424 . . . . 75.43 110.66 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 64.23 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 53.43 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.3 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.12 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.667 ' SD ' HG13 ' A' ' 35' ' ' VAL . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.43 112.063 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.44 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.44 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.31 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.11 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.32 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 63.21 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 30.14 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.33 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 64.55 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.4 111.138 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 73.53 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 71.21 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 71.43 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.14 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.62 113.14 25.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 61.02 110.328 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.95 153.75 20.37 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.496 0.554 . . . . 63.5 112.496 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.667 HG13 ' SD ' ' A' ' 17' ' ' MET . 26.6 m -83.39 32.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.187 -0.461 . . . . 72.33 112.149 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 pp -69.46 174.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.493 0.553 . . . . 72.12 112.493 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.86 86.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.601 . . . . 72.13 112.236 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.77 134.69 12.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.233 -0.439 . . . . 55.41 110.709 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -150.72 148.18 28.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.638 0.256 . . . . 74.42 110.641 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -138.33 -70.05 0.43 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.876 0.37 . . . . 75.23 111.87 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.31 -95.93 0.32 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.82 -0.705 . . . . 64.32 112.382 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -171.14 119.81 0.5 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.971 0.415 . . . . 71.33 111.72 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.53 -110.7 1.96 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 114.692 0.637 . . . . 72.33 114.692 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.38 129.89 2.33 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.12 2.546 . . . . 64.53 113.848 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 73.5 Cg_endo -77.47 154.13 31.27 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.393 2.062 . . . . 63.32 112.394 175.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 25.6 Cg_exo -63.03 152.31 80.14 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.573 2.182 . . . . 51.22 112.831 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.07 -37.55 93.9 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.538 2.159 . . . . 61.23 112.216 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.11 99.6 43.79 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.042 -0.526 . . . . 72.42 110.206 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -98.57 98.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.201 2.601 . . . . 75.51 113.498 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.47 -3.88 12.73 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.389 2.059 . . . . 72.31 112.667 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.26 104.85 14.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.037 -0.529 . . . . 73.12 112.197 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -104.27 2.59 31.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.126 0.489 . . . . 74.21 110.662 170.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -94.54 147.67 33.63 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.911 -0.586 . . . . 75.2 110.476 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.4 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.12 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 63.44 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.32 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.43 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 52.23 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.51 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 64.11 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.15 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.23 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -109.49 105.8 15.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.52 110.858 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -119.24 119.41 34.0 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.732 0.301 . . . . 74.1 110.901 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.92 -56.13 2.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.373 0.509 . . . . 63.31 112.373 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.0 m -112.29 -66.26 1.1 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.562 0.579 . . . . 73.23 112.562 -173.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.6 m -124.79 151.45 45.14 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.694 0.283 . . . . 62.12 111.265 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.54 145.86 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.055 0.455 . . . . 65.54 111.376 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.256 1.423 0 CA-C-O 118.856 -0.592 . . . . 62.23 111.317 -175.159 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.141 0.496 . . . . 52.02 111.469 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.86 -175.52 4.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.156 0.503 . . . . 71.12 111.875 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.83 113.97 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.491 0.662 . . . . 62.31 112.137 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -100.7 116.67 33.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.178 -0.465 . . . . 74.32 110.454 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 164.77 25.1 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.045 -0.525 . . . . 63.02 111.994 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.9 t -80.98 38.87 0.48 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.344 0.592 . . . . 44.01 111.638 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 7' ' ' LEU . 1.5 pp -87.76 23.7 1.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.23 0.538 . . . . 71.15 111.936 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -73.52 130.67 40.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.961 0.726 . . . . 51.43 112.961 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 11' ' ' GLU . 48.6 mm -74.66 146.08 82.81 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.549 -0.75 . . . . 73.21 109.133 169.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 9' ' ' ILE . 85.2 Cg_exo -50.4 72.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 123.054 2.503 . . . . 65.22 114.609 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' ILE . 43.7 mt-10 -95.25 6.4 49.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.06 0.544 . . . . 75.23 110.929 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.11 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 51.02 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.31 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 54.0 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 63.11 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.44 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 63.22 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.53 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' A' ' 18' ' ' LYS . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 65.21 112.153 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.34 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.12 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.2 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 34.33 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 52.52 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 54.35 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 55.4 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.21 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 65.14 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.32 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.2 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.11 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.19 154.55 20.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.42 111.594 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -93.62 126.13 38.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.753 0.311 . . . . 72.12 111.399 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -85.46 9.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.837 0.68 . . . . 73.41 112.837 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.4 pp -83.55 -172.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.63 0.604 . . . . 64.44 112.63 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -47.14 133.17 11.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.071 0.767 . . . . 60.31 113.071 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 25.2 t0 -66.67 144.79 56.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.125 0.488 . . . . 75.11 111.519 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' N ' HD22 ' A' ' 39' ' ' LEU . 3.1 mm? -78.46 170.71 16.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.299 0.481 . . . . 74.44 112.299 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.0 m170 66.02 18.05 10.94 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.875 0.694 . . . . 74.34 112.875 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.0 83.7 0.71 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.993 -0.622 . . . . 74.32 111.77 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.33 -175.81 2.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.182 0.808 . . . . 73.41 113.182 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.05 -175.97 48.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.822 -0.627 . . . . 65.22 112.974 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.81 158.25 57.52 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.335 2.023 . . . . 71.11 112.103 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.04 114.9 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.913 2.409 . . . . 61.13 113.116 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.09 123.33 12.96 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.762 2.308 . . . . 74.12 112.829 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.66 -42.47 53.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.672 2.248 . . . . 74.3 112.83 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 50' ' ' PRO . 17.7 t -122.29 97.69 44.96 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-O 120.775 0.321 . . . . 75.33 111.205 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -112.8 63.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.282 3.322 . . . . 44.55 113.799 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 48' ' ' VAL . 95.6 Cg_endo -84.37 -49.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.07 1.847 . . . . 61.33 115.07 -171.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.53 -0.54 37.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.506 0.928 . . . . 74.13 113.506 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -60.02 111.19 1.4 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.998 0.74 . . . . 65.13 112.998 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -117.99 154.38 51.43 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.807 -0.633 . . . . 71.31 110.721 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.44 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.35 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 64.31 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 61.31 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.21 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.11 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 32.25 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 70.52 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 71.35 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.32 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.42 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.93 104.91 13.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.52 109.975 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.17 141.36 48.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.086 0.47 . . . . 73.43 111.757 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -92.97 97.23 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.114 0.483 . . . . 65.13 111.614 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -82.23 134.42 35.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.867 0.365 . . . . 73.21 111.145 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 p -93.81 -21.19 19.44 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.981 0.363 . . . . 71.43 111.981 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.14 171.55 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 111.985 0.365 . . . . 71.33 111.985 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 119.123 -0.465 . . . . 74.41 111.444 176.668 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.743 0.306 . . . . 74.14 111.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.87 -28.76 19.03 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.777 0.288 . . . . 70.33 111.777 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 3' ' ' VAL . 6.8 p -64.9 85.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 121.825 0.821 . . . . 55.31 112.243 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -120.54 108.64 14.31 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.784 -0.644 . . . . 64.02 110.048 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HB2' HD22 ' A' ' 7' ' ' LEU . 37.3 mt-10 -77.49 -172.32 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.243 0.544 . . . . 72.31 111.713 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.0 t -77.84 24.81 0.22 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.761 0.652 . . . . 72.02 112.761 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -113.59 9.78 17.96 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 122.082 -0.386 . . . . 73.42 111.96 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -69.17 169.17 12.54 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.651 0.611 . . . . 65.42 112.651 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -83.76 131.1 53.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.999 -0.546 . . . . 55.44 110.479 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.18 90.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.784 2.323 . . . . 73.14 113.498 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB2' HE22 ' A' ' 66' ' ' GLN . 40.5 mt-10 -81.12 -11.27 59.51 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.104 -0.498 . . . . 72.12 110.723 174.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.24 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 41.34 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.13 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.24 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.04 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.0 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.53 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 45.22 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.51 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.14 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.52 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.13 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.2 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 34.52 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 71.2 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.02 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.03 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.14 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 61.05 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.42 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.4 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.21 126.02 35.32 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.42 109.93 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.86 21.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.634 0.605 . . . . 62.44 112.634 -173.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.3 6.99 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.874 -0.603 . . . . 75.54 111.958 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 36' ' ' ILE . 2.4 pp -58.37 148.01 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 112.38 0.511 . . . . 74.51 112.38 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.14 36.65 1.04 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.21 0.528 . . . . 64.53 111.203 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB2' HD13 ' A' ' 36' ' ' ILE . 28.8 m-20 -87.32 93.03 9.28 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.709 0.766 . . . . 74.35 111.604 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -105.71 161.03 14.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.316 -0.857 . . . . 61.45 110.611 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -106.97 112.27 25.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.174 0.512 . . . . 73.53 112.107 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.04 148.58 17.3 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.972 -0.558 . . . . 73.25 111.71 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.66 85.58 1.62 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.187 -0.596 . . . . 52.24 111.491 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.36 -111.26 3.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.637 -0.71 . . . . 64.41 114.275 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 53.4 Cg_exo -54.04 139.69 70.65 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.065 2.51 . . . . 74.11 113.47 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 50.5 Cg_exo -54.83 134.07 61.03 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.745 2.297 . . . . 73.14 112.914 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.0 149.84 59.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.282 1.988 . . . . 72.34 112.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.19 -48.72 18.7 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.567 2.178 . . . . 73.1 112.907 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.632 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 47.0 t -114.86 130.12 24.44 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 71.12 110.683 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.14 100.93 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.801 2.334 . . . . 72.34 113.204 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 48' ' ' VAL . 56.6 Cg_endo -93.33 -27.68 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.798 2.332 . . . . 63.32 113.486 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.74 77.51 6.37 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.134 0.493 . . . . 51.25 111.646 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.16 6.35 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.849 -0.614 . . . . 64.22 111.267 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -144.5 153.15 54.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.887 -0.597 . . . . 72.2 110.241 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.45 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.01 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 61.23 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.663 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.24 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.02 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.12 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.05 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.23 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.24 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 43.15 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.34 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -108.09 106.48 16.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 43.22 110.929 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.494 HE22 ' HB2' ' A' ' 11' ' ' GLU . 4.0 pt20 -119.14 153.58 34.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.345 -0.389 . . . . 74.34 111.022 171.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 64.61 38.88 6.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.9 0.381 . . . . 63.1 111.721 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.0 t -72.07 70.98 0.81 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.373 0.606 . . . . 73.51 111.642 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 m -103.45 26.24 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.049 -0.523 . . . . 74.51 110.506 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.2 93.18 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.602 0.715 . . . . 72.31 112.004 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.11 -0.948 . . . . 74.33 110.618 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.893 0.378 . . . . 71.11 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.07 -168.51 2.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.431 -0.35 . . . . 73.55 110.541 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.53 116.98 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.403 0.621 . . . . 71.44 111.908 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 68' ' ' SER . 62.8 t30 -147.46 175.61 10.69 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.07 -0.513 . . . . 72.11 110.668 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.85 158.09 16.99 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.906 -0.496 . . . . 70.3 111.24 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 69' ' ' CYS . 9.0 t -82.27 63.54 6.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.629 0.728 . . . . 53.05 111.171 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 23.89 5.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.59 -0.732 . . . . 61.13 110.488 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -79.96 -179.94 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.59 -0.732 . . . . 73.43 112.215 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.95 130.38 81.1 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.003 -0.544 . . . . 73.13 110.99 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.36 85.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.334 2.023 . . . . 71.34 112.77 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.38 -36.45 17.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.182 -0.463 . . . . 63.23 111.985 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.12 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.34 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.01 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.51 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.41 111.726 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.52 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.55 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 74.41 111.645 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 52.13 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.12 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 72.55 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.24 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.52 113.244 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.33 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 71.33 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 71.15 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 60.22 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.12 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.2 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.32 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.79 142.56 28.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.21 111.44 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.02 116.93 33.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.938 0.399 . . . . 45.21 111.208 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 19.5 m -78.23 62.02 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 112.418 0.525 . . . . 73.12 112.418 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.83 8.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.634 0.975 . . . . 71.32 113.634 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -122.71 151.55 41.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.283 0.845 . . . . 74.4 113.283 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.93 120.02 38.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.659 -0.701 . . . . 75.11 110.569 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.54 139.88 42.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.435 0.636 . . . . 73.41 112.032 176.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.38 -171.77 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.553 . . . . 72.12 110.758 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.35 -122.7 0.37 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.566 0.586 . . . . 42.35 114.566 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -103.63 165.13 11.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.353 0.501 . . . . 74.21 112.353 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.81 -155.09 53.2 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.094 -0.503 . . . . 45.11 113.87 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.45 154.36 71.98 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.86 2.373 . . . . 73.02 112.696 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.22 124.14 15.47 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.559 2.173 . . . . 55.53 112.655 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.54 155.92 39.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.554 2.169 . . . . 71.21 112.842 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.17 67.05 1.41 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.966 2.444 . . . . 64.03 113.421 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.06 134.39 21.44 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.091 -0.504 . . . . 74.23 110.154 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.89 142.56 99.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.636 2.224 . . . . 62.42 113.15 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.78 -27.78 54.2 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.067 2.511 . . . . 73.14 113.311 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.17 70.58 1.12 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.344 0.592 . . . . 65.5 110.333 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 16.1 tt0 -118.72 160.74 21.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.719 -0.673 . . . . 74.1 111.627 -171.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 80.2 m80 -107.12 144.77 29.81 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.262 -0.426 . . . . 74.42 110.004 171.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 65.34 112.974 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 63.12 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.41 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.42 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.41 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.55 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 73.11 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.12 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.44 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.14 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -84.77 111.13 19.33 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.22 111.37 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -110.56 99.44 8.42 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.616 0.722 . . . . 65.11 110.699 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.21 -50.2 7.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.69 -0.686 . . . . 70.22 112.54 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 70.9 m -73.41 74.0 1.38 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.302 0.482 . . . . 75.11 112.302 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 1.6 m -176.32 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.032 -0.531 . . . . 64.44 111.498 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.87 150.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.286 -0.416 . . . . 62.51 111.573 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.098 -0.477 . . . . 71.43 110.805 178.257 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 111.666 0.247 . . . . 65.54 111.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.77 -32.77 72.75 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.085 -0.385 . . . . 44.14 110.905 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.91 115.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.203 0.525 . . . . 55.35 111.407 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' OD1' ' HB ' ' A' ' 8' ' ' THR . 28.5 t-20 -146.51 124.82 12.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.33 -0.396 . . . . 75.55 111.028 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HB2' HD22 ' A' ' 7' ' ' LEU . 34.5 mt-10 -103.08 -176.82 3.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.391 -0.368 . . . . 75.12 111.546 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 69' ' ' CYS . 44.6 t -59.82 -11.88 6.26 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.439 0.903 . . . . 71.24 113.439 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.9 pt? -76.23 18.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.912 -0.492 . . . . 73.53 112.018 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.411 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 14.5 t -84.24 175.24 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.022 0.749 . . . . 64.2 113.022 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.94 135.53 28.6 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.736 -0.665 . . . . 72.43 110.735 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.71 80.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.321 2.014 . . . . 60.12 113.28 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.42 7.31 45.01 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.53 111.338 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 72.53 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.43 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.14 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.1 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.42 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.45 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 62.02 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 63.53 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.15 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.34 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.34 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.12 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.15 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 72.44 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 62.14 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 65.41 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 73.12 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.21 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.14 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.22 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.65 155.58 23.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 71.31 111.547 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.62 144.28 28.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.158 0.504 . . . . 60.43 112.226 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.76 11.86 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.211 0.819 . . . . 64.44 113.211 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.569 HG12 ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -68.89 -59.94 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 113.073 0.768 . . . . 74.34 113.073 -175.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' N ' HG12 ' A' ' 36' ' ' ILE . 7.2 t30 175.31 171.74 0.29 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.95 0.5 . . . . 73.51 109.653 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.01 151.81 46.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.816 0.341 . . . . 73.05 110.766 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.3 mm? -108.98 17.1 22.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.683 0.278 . . . . 53.31 111.436 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -94.53 -6.52 43.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.713 0.292 . . . . 74.3 111.781 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.4 150.55 51.93 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.145 -0.55 . . . . 54.45 113.834 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 30.6 tt0 -109.09 -178.47 3.58 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 110.041 -0.355 . . . . 53.13 110.041 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' H ' ' HG2' ' A' ' 42' ' ' GLU . . . -44.19 -61.57 3.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.592 -0.337 . . . . 62.0 113.616 176.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -99.39 88.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.348 2.699 . . . . 63.2 113.13 171.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 39.2 Cg_endo -99.33 162.79 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.363 2.708 . . . . 73.44 113.582 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.62 116.75 4.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.475 2.116 . . . . 74.13 112.253 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.48 20.34 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.725 2.283 . . . . 73.03 114.292 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 48' ' ' VAL . 15.4 m -131.74 99.81 16.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 121.485 0.66 . . . . 74.13 112.115 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -93.1 161.84 2.58 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.022 2.481 . . . . 70.41 112.774 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.48 -25.45 79.71 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.258 1.972 . . . . 52.31 111.665 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.3 9.97 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.202 -0.908 . . . . 74.13 109.562 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.58 64.68 1.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.391 0.615 . . . . 64.14 110.586 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -151.17 150.32 26.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.209 -0.451 . . . . 75.55 111.15 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.31 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.44 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.758 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.12 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.12 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 63.51 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.33 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 22.1 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 63.41 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.42 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.13 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.03 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.8 110.96 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.42 110.259 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 26.5 pt20 -100.87 99.07 9.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.734 0.778 . . . . 65.24 111.354 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.31 -2.62 56.3 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.7 -0.682 . . . . 72.41 110.682 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -48.29 -56.52 7.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.42 -0.809 . . . . 60.33 112.52 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 12.8 t -136.01 103.5 5.38 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.105 -0.372 . . . . 71.1 111.739 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.2 175.5 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.476 -0.329 . . . . 74.11 111.289 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.802 -0.618 . . . . 73.04 111.719 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.695 0.283 . . . . 62.15 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.73 157.48 34.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 65.13 111.496 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.73 131.34 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.032 0.444 . . . . 72.3 111.803 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -123.78 138.91 54.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.421 -0.354 . . . . 75.33 111.5 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 7' ' ' LEU . 41.8 mt-10 -81.69 -170.89 3.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.321 0.582 . . . . 73.21 111.633 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.5 m -73.22 1.58 9.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.438 0.903 . . . . 50.14 113.438 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.3 pt? -83.89 8.56 14.58 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.135 0.493 . . . . 71.41 110.988 174.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -68.66 165.71 18.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.162 0.506 . . . . 61.35 112.058 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 47.8 mm -80.95 127.39 74.79 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.229 -0.441 . . . . 55.24 111.394 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 8.2 Cg_exo -73.15 66.74 4.25 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.893 2.395 . . . . 74.0 113.031 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -76.84 -3.44 38.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.45 111.837 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 71.03 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.11 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 61.11 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 65.02 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.32 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.44 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD13 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.15 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.42 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.12 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.34 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.3 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 71.42 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.51 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.33 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 12' ' ' ALA . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.12 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 63.04 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.416 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.53 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 64.3 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.2 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.11 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.14 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.18 156.18 20.43 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 71.55 111.073 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.58 115.11 22.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 64.14 111.109 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.15 -10.18 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.185 -0.461 . . . . 73.21 112.009 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -64.28 167.73 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 116.224 -0.444 . . . . 74.05 112.101 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.64 54.82 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.167 0.803 . . . . 50.12 113.167 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.27 102.67 10.09 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.034 0.445 . . . . 74.35 110.633 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.74 145.42 40.56 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.192 0.52 . . . . 61.15 111.228 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -81.78 64.14 6.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.317 0.58 . . . . 62.44 110.406 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.47 149.06 38.08 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.562 -0.745 . . . . 35.22 113.9 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -112.12 144.68 41.1 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.848 0.356 . . . . 63.43 111.265 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.06 -153.44 35.98 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.336 -0.459 . . . . 55.33 113.637 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.41 168.3 13.12 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.031 2.487 . . . . 64.54 112.791 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -85.69 108.78 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.348 2.032 . . . . 70.31 113.118 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 171.7 13.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.711 2.274 . . . . 72.33 112.048 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.62 76.85 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.873 1.715 . . . . 54.02 112.715 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.17 150.25 59.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.879 -0.6 . . . . 71.23 111.048 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 52.8 Cg_exo -53.64 130.19 37.66 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.709 2.273 . . . . 75.05 113.699 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.29 -4.28 13.39 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.229 1.953 . . . . 63.41 112.488 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.47 -4.26 58.66 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.136 0.421 . . . . 60.24 112.136 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 49' ' ' PRO . 15.8 mm100 -51.62 138.02 23.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.327 0.584 . . . . 74.5 112.119 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -90.03 160.31 40.77 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.887 -0.597 . . . . 70.44 111.309 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.31 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.46 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 71.34 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 61.33 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 70.01 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 23.55 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 53.42 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.23 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 53.13 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.07 112.0 19.39 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.15 111.11 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -110.25 116.37 31.36 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.154 0.502 . . . . 70.04 111.467 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.44 64.61 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.208 0.528 . . . . 73.02 111.066 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -69.93 103.18 2.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.421 0.526 . . . . 74.02 112.421 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.39 -39.32 82.96 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.926 0.394 . . . . 60.14 111.403 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.34 103.75 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.582 0.706 . . . . 71.34 111.142 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.774 -0.648 . . . . 73.01 111.548 -178.587 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.817 0.341 . . . . 63.24 111.219 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -81.24 48.15 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.907 0.384 . . . . 73.1 111.529 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.4 t 58.0 74.63 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.46 0.647 . . . . 63.24 110.951 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.45 138.25 0.69 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.635 -0.711 . . . . 74.2 110.682 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' HB2' HD22 ' A' ' 7' ' ' LEU . 55.7 mt-10 -95.06 -169.59 2.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.332 0.586 . . . . 64.1 111.669 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.7 m -81.83 5.79 17.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.909 0.707 . . . . 74.44 112.909 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.2 pt? -73.03 -4.41 32.23 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.924 0.392 . . . . 72.12 111.638 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -70.71 -176.63 1.35 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.135 0.493 . . . . 65.21 112.245 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.7 mm -96.1 136.43 22.1 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.415 -0.357 . . . . 71.31 111.135 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.91 78.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.323 2.015 . . . . 74.03 112.366 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 51.0 mt-10 -80.68 -12.63 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.23 -0.441 . . . . 60.12 112.1 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.11 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 70.01 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.02 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.33 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.51 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 62.51 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.14 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.54 HG22 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.43 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.03 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.54 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 64.31 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 33.32 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.24 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.42 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 54.14 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.23 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 61.21 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 52.11 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.94 137.9 31.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 44.1 111.66 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.15 153.03 22.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.022 0.439 . . . . 64.43 112.015 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 31.6 m -78.34 46.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.443 0.535 . . . . 65.32 112.443 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.75 ' HB ' HD11 ' A' ' 39' ' ' LEU . 2.3 pp -102.55 155.56 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.176 0.435 . . . . 75.52 112.176 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -79.55 55.73 2.03 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.624 0.601 . . . . 74.23 112.624 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.37 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.149 0.796 . . . . 55.4 113.149 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -146.85 175.7 10.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.01 -0.541 . . . . 74.1 111.222 171.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -121.01 157.35 30.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.841 0.353 . . . . 64.21 111.378 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.03 -43.65 98.87 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.821 -0.704 . . . . 51.44 112.287 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.01 105.86 18.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.81 0.338 . . . . 72.31 110.991 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -179.39 18.54 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.039 -0.601 . . . . 64.22 113.534 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.2 167.11 3.6 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.135 2.557 . . . . 63.23 113.116 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.94 125.46 13.15 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.036 1.824 . . . . 74.34 111.846 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.58 118.33 2.91 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.859 2.372 . . . . 74.11 113.147 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.07 -52.43 4.8 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.072 2.515 . . . . 74.32 113.139 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.38 100.22 18.52 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.401 -0.363 . . . . 74.15 110.296 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.28 128.15 28.79 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.797 2.331 . . . . 71.33 113.297 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.96 -27.58 85.23 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.609 2.206 . . . . 52.44 113.147 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.37 154.53 35.81 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.681 0.277 . . . . 73.25 111.305 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.55 16.99 9.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.27 0.557 . . . . 75.24 111.309 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -133.68 137.05 27.88 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.829 -0.623 . . . . 74.53 110.227 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 73.03 113.121 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.32 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 71.12 112.267 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 74.44 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 43.31 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.14 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.04 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.15 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 60.14 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 63.42 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 53.44 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -82.49 110.86 17.97 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.41 110.15 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -95.68 135.01 37.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.647 0.61 . . . . 74.5 112.647 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 67.2 109.41 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.495 -0.775 . . . . 71.2 112.056 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 6.55 38.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.021 0.438 . . . . 73.34 111.509 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.8 m -101.63 1.12 37.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.15 -0.344 . . . . 75.25 111.81 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.35 143.32 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 120.651 0.262 . . . . 71.52 110.848 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.607 -0.711 . . . . 64.11 112.082 -178.471 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.822 0.344 . . . . 64.05 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.56 158.01 15.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.849 0.357 . . . . 75.05 110.736 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.27 131.5 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.479 0.548 . . . . 61.51 112.479 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.82 132.17 45.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.366 -0.208 . . . . 65.14 110.6 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 33.4 mt-10 -69.8 177.68 2.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.031 0.443 . . . . 73.32 111.976 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 69' ' ' CYS . 84.1 m -75.48 -6.2 48.94 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.334 0.865 . . . . 63.32 113.334 -170.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 1.6 pt? -81.79 24.29 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.278 0.561 . . . . 73.04 111.342 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -83.22 176.89 8.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.052 -0.522 . . . . 75.44 111.996 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.81 127.64 81.51 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.437 -0.347 . . . . 64.12 111.71 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.42 87.62 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.316 2.011 . . . . 72.24 113.185 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.85 6.65 38.1 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.981 -0.554 . . . . 72.31 111.688 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.54 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 55.42 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.44 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.22 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.13 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.11 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.3 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.24 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.14 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.4 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.04 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.23 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 54.31 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.42 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 65.14 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 72.03 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.43 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 71.03 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 72.5 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 72.32 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.14 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.2 154.25 19.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.33 111.964 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.99 154.18 44.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.043 0.449 . . . . 45.2 111.657 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.2 92.67 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.434 0.635 . . . . 72.03 111.971 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.59 139.72 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.037 0.446 . . . . 65.4 111.91 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.5 11.98 1.42 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.089 0.403 . . . . 75.13 112.089 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' HIS . 7.3 m-20 -93.38 -14.15 27.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.648 0.24 . . . . 74.41 111.648 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 29.15 -70.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.984 1.476 . . . . 64.02 114.984 -173.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.2 m-70 -63.44 -41.7 98.66 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.981 -0.449 . . . . 63.03 111.328 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.43 -64.07 3.58 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.316 -0.468 . . . . 61.21 113.756 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.64 124.77 22.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.73 0.3 . . . . 74.31 110.884 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.67 -154.0 32.07 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.214 -0.517 . . . . 75.15 112.499 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.806 2.337 . . . . 70.1 112.598 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.15 153.04 31.67 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.029 1.819 . . . . 44.14 112.127 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.85 154.84 53.07 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.276 1.984 . . . . 62.51 112.272 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 86.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.328 2.018 . . . . 71.12 112.471 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.01 154.03 81.19 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.948 -0.569 . . . . 72.32 111.197 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.17 151.95 39.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.318 2.012 . . . . 73.44 112.053 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.11 -16.41 33.15 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.535 2.157 . . . . 65.51 113.497 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 -12.2 60.02 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.458 0.54 . . . . 71.41 112.458 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -62.92 138.22 58.49 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.139 0.495 . . . . 75.11 111.521 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -106.8 139.2 20.14 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.359 -0.382 . . . . 74.35 111.463 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 64.25 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.05 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.2 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.45 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.31 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.41 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 13.12 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.13 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 51.24 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 51.43 111.984 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.71 111.48 18.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.23 110.807 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -111.25 107.76 17.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 75.32 112.071 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.33 -164.43 1.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.412 -0.813 . . . . 73.31 109.359 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.9 p -173.84 155.16 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.939 0.876 . . . . 74.35 113.068 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 28.6 p -155.23 168.08 28.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.861 -1.063 . . . . 44.13 109.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.66 94.63 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.929 0.395 . . . . 52.03 112.063 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.618 -0.706 . . . . 73.24 111.256 173.782 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.527 0.203 . . . . 63.35 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.66 -62.3 1.42 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.132 0.492 . . . . 70.34 110.647 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.78 90.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.616 0.722 . . . . 73.1 111.617 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -114.55 130.2 56.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 65.13 110.822 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.38 175.81 3.77 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.326 0.584 . . . . 44.43 111.828 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.666 ' N ' ' SG ' ' A' ' 69' ' ' CYS . 79.6 m -68.25 9.7 0.3 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.507 0.558 . . . . 73.22 112.507 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 8' ' ' THR . 2.5 pp -70.91 -14.07 62.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.963 0.411 . . . . 75.35 111.788 175.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.403 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.7 t -73.76 174.81 7.89 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.117 0.485 . . . . 73.15 111.848 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 50.7 mm -90.63 130.65 40.38 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.366 -0.379 . . . . 33.43 111.369 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 17.9 Cg_exo -66.92 70.42 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.626 2.217 . . . . 75.42 112.745 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.88 6.0 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.048 -0.523 . . . . 65.12 112.162 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.31 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.03 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.44 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 62.53 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.24 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 74.04 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HE2' HD13 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.34 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.43 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 71.52 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.11 112.377 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.51 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.12 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.0 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.04 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.33 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 64.12 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.04 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 72.12 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.43 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.3 128.16 41.92 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 62.11 109.668 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -107.34 151.52 25.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.304 0.574 . . . . 74.15 112.435 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 53' ' ' HIS . 27.4 m -89.72 27.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.056 -0.52 . . . . 61.1 112.021 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -70.25 173.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.434 0.531 . . . . 73.3 112.434 -178.081 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 90.34 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.196 -0.456 . . . . 63.12 111.773 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.5 112.1 5.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.053 0.454 . . . . 65.24 111.165 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.533 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -140.75 166.86 23.6 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.096 -0.502 . . . . 74.43 111.122 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -160.41 141.74 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.708 0.289 . . . . 74.4 111.592 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.66 -176.79 15.66 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.343 -0.456 . . . . 44.25 112.998 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.04 -41.08 91.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.104 0.478 . . . . 75.14 111.447 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.8 -69.75 0.03 OUTLIER Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.85 -0.613 . . . . 64.54 111.672 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 157.17 45.97 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.628 2.219 . . . . 73.32 111.717 170.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.33 117.87 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.447 2.098 . . . . 73.44 113.544 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.54 164.58 35.18 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.888 2.392 . . . . 75.22 112.407 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.75 106.74 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.551 2.167 . . . . 72.42 112.965 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.09 129.32 23.68 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.802 0.334 . . . . 75.35 111.811 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.8 162.02 10.56 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.845 2.364 . . . . 74.42 112.846 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.49 -42.85 64.3 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.486 2.124 . . . . 75.24 112.411 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.08 47.83 1.38 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.371 0.605 . . . . 64.54 110.849 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -66.43 140.85 58.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.308 0.575 . . . . 62.14 112.35 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 63.6 m80 -131.14 145.71 58.93 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.872 -0.604 . . . . 51.43 111.308 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 54.41 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 72.43 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 54.42 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 61.25 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 32.2 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 30.35 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 70.33 111.019 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 72.1 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.42 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.24 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -80.91 111.7 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.21 110.958 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.621 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.3 pt20 -85.06 95.79 9.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.976 0.732 . . . . 72.13 112.976 -172.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 7.8 t70 165.94 -74.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.103 0.961 . . . . 54.33 109.644 171.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.5 m 58.75 -72.61 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.159 1.17 . . . . 74.32 114.159 171.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 42.0 t -50.63 -50.96 53.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.833 0.679 . . . . 75.02 112.833 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.68 -170.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.525 -0.307 . . . . 74.21 111.226 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.647 -0.692 . . . . 60.44 110.727 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.834 0.35 . . . . 72.22 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -151.97 -164.29 1.94 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.859 0.362 . . . . 75.33 111.97 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.43 -19.66 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 112.4 0.519 . . . . 60.15 112.4 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -164.89 146.15 7.76 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.133 -0.354 . . . . 72.25 111.401 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 7' ' ' LEU . 36.9 mt-10 -78.26 -169.66 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.552 0.692 . . . . 74.4 112.815 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.9 m -58.69 -27.16 64.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.898 0.703 . . . . 61.45 112.898 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -61.53 -2.32 0.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.831 0.678 . . . . 72.44 112.831 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -72.7 179.03 3.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.394 0.616 . . . . 43.44 111.815 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.81 130.89 46.95 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 44.22 111.059 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.55 76.22 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.29 1.994 . . . . 63.31 112.123 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.95 2.89 24.86 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.02 112.558 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 43.22 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.52 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.52 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.01 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.32 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.32 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 72.05 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.33 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.42 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 71.21 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.35 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.3 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.33 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.22 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 62.03 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 63.34 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.32 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.12 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.54 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.41 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . -98.16 153.77 18.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 45.43 112.38 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 142.78 47.37 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.942 0.401 . . . . 71.01 111.813 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.43 -4.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.289 0.848 . . . . 71.52 113.289 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.54 -2.72 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 113.368 0.877 . . . . 74.22 113.368 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 25.5 t-20 62.13 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.793 0.437 . . . . 70.32 111.288 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 41.62 58.14 2.83 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.261 0.624 . . . . 64.02 112.24 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.31 5.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.086 -0.506 . . . . 73.03 111.698 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -73.02 129.79 38.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 63.45 110.96 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.34 19.28 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.072 -0.585 . . . . 41.5 113.595 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.68 21.77 1.77 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.31 0.576 . . . . 55.23 111.0 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.42 -133.16 4.76 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.8 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.75 114.84 3.73 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.171 1.914 . . . . 64.15 112.417 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.47 151.1 80.48 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.482 2.122 . . . . 72.11 113.154 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.98 157.28 4.01 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.017 2.478 . . . . 73.02 113.272 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.06 80.31 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.569 2.179 . . . . 72.54 113.503 -175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 27.0 m -114.95 137.86 23.1 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.363 -0.38 . . . . 75.15 111.456 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 48' ' ' VAL . 15.1 Cg_exo -70.5 143.56 47.62 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.706 2.271 . . . . 60.31 112.917 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.55 -8.94 23.73 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.579 2.186 . . . . 62.14 113.155 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.24 65.83 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.328 0.585 . . . . 52.04 111.497 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 31.2 tt0 -147.36 158.21 43.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.802 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.9 m80 -89.48 159.96 43.03 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.642 -0.254 . . . . 73.53 110.999 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.31 112.664 175.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.24 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 65.31 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.405 ' HA ' HD11 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.55 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 51.51 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.14 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.33 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 72.33 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 65.01 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 33.04 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.2 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.67 109.19 20.93 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.34 110.96 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.81 122.87 44.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 72.42 110.745 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.09 98.06 7.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.126 0.488 . . . . 75.51 110.383 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.5 p -76.19 96.47 3.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.583 0.586 . . . . 74.52 112.583 -173.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -95.65 98.0 10.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.192 0.52 . . . . 73.54 110.59 172.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.67 156.6 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.533 0.568 . . . . 65.1 112.533 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 119.086 -0.483 . . . . 75.35 111.055 175.295 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.813 0.339 . . . . 62.130000000000003 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 41.420000000000002 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.030000000000001 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.409999999999997 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.119999999999997 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.239999999999995 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.040000000000006 111.285 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.450000000000003 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.439999999999998 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 70.340000000000003 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.239999999999995 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.349999999999994 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.150000000000006 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.319999999999993 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.518 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.030000000000001 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 53.310000000000002 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.439999999999998 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.019999999999996 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 61.130000000000003 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.319999999999993 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.219999999999999 110.364 174.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 109.89 -0.411 . . . . 71.010000000000005 109.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.129999999999995 114.409 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.149999999999999 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.120000000000005 111.501 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 62.130000000000003 113.779 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 58' ' ' PRO . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.400000000000006 113.259 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.009999999999998 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.200000000000003 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.230000000000004 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.219999999999999 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 42.530000000000001 110.738 -176.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.121 0.415 . . . . 64.230000000000004 112.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.549999999999997 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.310000000000002 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 73.129999999999995 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.239999999999995 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.010000000000005 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.230000000000004 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.239999999999995 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.310000000000002 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.340000000000003 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.520000000000003 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 44.43 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 63.219999999999999 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.240000000000002 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 72.25 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 71.140000000000001 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.040000000000006 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 64.400000000000006 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 110.96 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.011 -0.366 . . . . 72.219999999999999 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 53.509999999999998 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.400000000000006 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.340000000000003 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.010000000000005 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.420000000000002 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 50.439999999999998 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 65.219999999999999 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.9 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 53.229999999999997 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.229999999999997 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.540000000000006 110.57 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.140000000000001 112.124 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 51.350000000000001 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.510000000000005 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.120000000000005 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 54.130000000000003 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.540000000000006 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 43.149999999999999 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.420000000000002 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 62.520000000000003 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.129999999999995 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 50.43 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.219999999999999 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 74.040000000000006 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.140000000000001 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.422 HD12 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.540000000000006 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.340000000000003 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 61.130000000000003 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 71.439999999999998 111.105 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 110.197 -0.298 . . . . 55.409999999999997 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.019999999999996 115.387 -168.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.9 m120 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 64.239999999999995 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 72.120000000000005 112.28 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 65.540000000000006 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.099999999999994 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.239999999999995 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.049999999999997 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.420000000000002 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 70.140000000000001 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.409999999999997 111.045 -178.181 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.593 0.235 . . . . 64.319999999999993 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.099999999999994 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.299999999999997 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.329999999999998 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.230000000000004 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.209999999999994 111.945 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 74.349999999999994 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.555 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.109999999999999 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 73.450000000000003 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 73.140000000000001 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 54.43 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.329999999999998 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.040000000000006 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 52.009999999999998 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 73.299999999999997 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.219999999999999 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 70.430000000000007 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.129999999999995 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.099999999999994 110.138 171.328 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.519 0.2 . . . . 73.5 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.477 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.129999999999995 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 65.239999999999995 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.477 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.109999999999999 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 41.130000000000003 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.329999999999998 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 34.030000000000001 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.009999999999998 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.239999999999995 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.230000000000004 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.109999999999999 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 64.5 111.623 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 74.310000000000002 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.319999999999993 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.329999999999998 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.299999999999997 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.010000000000005 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.010000000000005 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.230000000000004 112.048 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.230000000000004 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.140000000000001 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.129999999999995 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 73.310000000000002 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.120000000000005 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 45.210000000000001 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.566 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.540000000000006 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 73.040000000000006 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.350000000000001 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.450000000000003 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.450000000000003 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.451 172.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.737 0.303 . . . . 74.209999999999994 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 51.520000000000003 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.230000000000004 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 61.149999999999999 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.210000000000001 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.219999999999999 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.140000000000001 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.049999999999997 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.099999999999994 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.240000000000002 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.219999999999999 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.033 -178.723 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.858 0.361 . . . . 74.510000000000005 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.519999999999996 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.439999999999998 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.530000000000001 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.120000000000005 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 71.319999999999993 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 71.209999999999994 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.140000000000001 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 54.420000000000002 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.540000000000006 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.239999999999995 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 62.43 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 73.200000000000003 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 54.399999999999999 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.340000000000003 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.43 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 64.450000000000003 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.329999999999998 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.400000000000006 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 41.140000000000001 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 112.291 -179.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.716 0.293 . . . . 71.420000000000002 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.040000000000006 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 72.120000000000005 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.239999999999995 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.049999999999997 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 54.119999999999997 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 62.310000000000002 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.109999999999999 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.329999999999998 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.120000000000005 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.399999999999999 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 61.32 110.241 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.866 0.321 . . . . 72.319999999999993 111.866 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.150000000000006 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.409999999999997 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 62.030000000000001 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.010000000000005 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.109999999999999 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.120000000000005 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 71.519999999999996 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.140000000000001 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.299999999999997 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.540000000000006 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.219999999999999 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 63.130000000000003 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.150000000000006 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 72.439999999999998 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 65.430000000000007 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 72.540000000000006 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 73.299999999999997 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.112 173.205 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 110.012 -0.366 . . . . 72.510000000000005 110.012 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 72.530000000000001 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 63.200000000000003 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.340000000000003 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.539999999999999 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 71.019999999999996 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.340000000000003 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.430000000000007 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.530000000000001 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.299999999999997 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.230000000000004 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.239999999999995 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 63.439999999999998 111.435 -176.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.030000000000001 113.169 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.120000000000005 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.340000000000003 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.510000000000005 114.075 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.299999999999997 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.439999999999998 112.721 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 71.019999999999996 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.229999999999997 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.530000000000001 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.099999999999994 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 64.129999999999995 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 73.140000000000001 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.420000000000002 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.539999999999999 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 72.409999999999997 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.430000000000007 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.299999999999997 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 62.520000000000003 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.109999999999999 111.768 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 45.340000000000003 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 52.229999999999997 110.79 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.297 -0.26 . . . . 72.430000000000007 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.109999999999999 112.874 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.340000000000003 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.340000000000003 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.540000000000006 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.349999999999994 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 64.129999999999995 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.239999999999995 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.319999999999993 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.400000000000006 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.540000000000006 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.150000000000006 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.439999999999998 111.673 177.058 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.129999999999995 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 42.25 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.349999999999994 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.509999999999998 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 43.149999999999999 111.889 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.349999999999994 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.140000000000001 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.595 HD13 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 64.230000000000004 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.109999999999999 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.219999999999999 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 50.329999999999998 113.026 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 72.109999999999999 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.549999999999997 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 54.539999999999999 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.040000000000006 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 63.049999999999997 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 64.299999999999997 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 64.439999999999998 110.739 175.629 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 120.806 0.336 . . . . 74.099999999999994 111.132 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.420000000000002 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.129999999999995 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.702 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.430000000000007 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.049999999999997 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.010000000000005 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.099999999999994 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.140000000000001 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 43.210000000000001 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 55.420000000000002 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.010000000000005 111.252 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.705 0.288 . . . . 63.509999999999998 111.592 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.010000000000005 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 62.520000000000003 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.430000000000007 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.409999999999997 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.109999999999999 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.230000000000004 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.140000000000001 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 51.340000000000003 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.030000000000001 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 74.010000000000005 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.120000000000005 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.229999999999997 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 74.299999999999997 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.430000000000007 111.246 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.532 HD12 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 72.019999999999996 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.200000000000003 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.230000000000004 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.409999999999997 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.439999999999998 112.093 -177.676 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.518 0.199 . . . . 75.230000000000004 110.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.310000000000002 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 63.530000000000001 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.239999999999995 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 63.439999999999998 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.209999999999994 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 71.340000000000003 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.420000000000002 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 60.329999999999998 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.450000000000003 109.814 173.085 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 64.230000000000004 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 53.43 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.120000000000005 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 112.063 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.439999999999998 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.439999999999998 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.310000000000002 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.109999999999999 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 63.210000000000001 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 30.140000000000001 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.329999999999998 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 64.549999999999997 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.400000000000006 111.138 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 73.530000000000001 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 71.209999999999994 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 71.430000000000007 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.140000000000001 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 61.020000000000003 110.328 173.132 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 110.476 -0.194 . . . . 75.200000000000003 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.400000000000006 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.120000000000005 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 63.439999999999998 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.319999999999993 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.430000000000007 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 52.229999999999997 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.510000000000005 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 64.109999999999999 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.150000000000006 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.230000000000004 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.519999999999996 110.858 178.432 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.901 0.381 . . . . 75.230000000000004 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 51.020000000000003 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 54.0 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 63.109999999999999 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 63.219999999999999 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.530000000000001 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' A' ' 18' ' ' LYS . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 65.209999999999994 112.153 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.340000000000003 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.120000000000005 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.200000000000003 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 34.329999999999998 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 52.520000000000003 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 54.350000000000001 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 55.399999999999999 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 65.140000000000001 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.319999999999993 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.200000000000003 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.109999999999999 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.420000000000002 111.594 178.581 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.619 0.247 . . . . 71.310000000000002 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.439999999999998 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.349999999999994 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 64.310000000000002 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 61.310000000000002 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.209999999999994 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.109999999999999 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 32.25 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 70.519999999999996 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 71.349999999999994 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.319999999999993 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.420000000000002 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.519999999999996 109.975 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.781 0.324 . . . . 72.120000000000005 110.723 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.239999999999995 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 41.340000000000003 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.240000000000002 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.040000000000006 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.0 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.530000000000001 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 45.219999999999999 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.510000000000005 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.140000000000001 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.129999999999995 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.200000000000003 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 34.520000000000003 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 71.200000000000003 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.019999999999996 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.030000000000001 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.140000000000001 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 61.049999999999997 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.420000000000002 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 109.93 170.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 110.241 -0.281 . . . . 72.200000000000003 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.450000000000003 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.010000000000005 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 61.229999999999997 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.663 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.019999999999996 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.120000000000005 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.049999999999997 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.230000000000004 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.239999999999995 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 43.149999999999999 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.340000000000003 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 43.219999999999999 110.929 177.215 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.985 0.365 . . . . 63.229999999999997 111.985 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.120000000000005 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.340000000000003 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.010000000000005 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.510000000000005 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.726 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.519999999999996 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.549999999999997 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 111.645 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 52.130000000000003 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.120000000000005 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.240000000000002 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.519999999999996 113.244 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.329999999999998 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 71.329999999999998 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 71.150000000000006 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 60.219999999999999 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.119999999999997 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.200000000000003 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.319999999999993 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.209999999999994 111.44 178.009 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 80.2 m80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 110.004 -0.369 . . . . 74.420000000000002 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 65.340000000000003 112.974 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 63.119999999999997 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.409999999999997 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.420000000000002 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.409999999999997 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.549999999999997 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 73.109999999999999 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.120000000000005 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.439999999999998 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.140000000000001 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.37 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.530000000000001 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 72.530000000000001 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.430000000000007 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.099999999999994 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.420000000000002 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.450000000000003 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 62.020000000000003 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 64.329999999999998 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 63.530000000000001 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.150000000000006 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.340000000000003 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.340000000000003 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.120000000000005 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.150000000000006 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 72.439999999999998 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 62.140000000000001 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 65.409999999999997 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 73.120000000000005 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.140000000000001 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.219999999999999 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 71.310000000000002 111.547 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.998 0.427 . . . . 75.549999999999997 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.310000000000002 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.439999999999998 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.758 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.119999999999997 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.119999999999997 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 63.509999999999998 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.329999999999998 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 22.100000000000001 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 63.409999999999997 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.420000000000002 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.129999999999995 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.030000000000001 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.420000000000002 110.259 177.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.450000000000003 111.837 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 71.030000000000001 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 61.109999999999999 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 65.019999999999996 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.319999999999993 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.439999999999998 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD13 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.150000000000006 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.420000000000002 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.120000000000005 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.340000000000003 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.299999999999997 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 71.420000000000002 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.509999999999998 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.329999999999998 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 12' ' ' ALA . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.120000000000005 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 63.039999999999999 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.416 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.530000000000001 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 64.299999999999997 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.200000000000003 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.109999999999999 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.140000000000001 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 71.549999999999997 111.073 177.461 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 120.811 0.338 . . . . 70.439999999999998 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.310000000000002 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.46 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 71.340000000000003 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 61.329999999999998 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 70.010000000000005 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 23.550000000000001 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 53.420000000000002 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.230000000000004 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 53.130000000000003 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.150000000000006 111.11 178.468 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.1 0.407 . . . . 60.119999999999997 112.1 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 70.010000000000005 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.019999999999996 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.329999999999998 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.510000000000005 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 62.509999999999998 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.54 HG22 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.430000000000007 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.030000000000001 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.540000000000006 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 64.310000000000002 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 33.32 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.239999999999995 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.420000000000002 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 54.140000000000001 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.230000000000004 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 61.210000000000001 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 52.109999999999999 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 44.100000000000001 111.66 178.716 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 110.227 -0.286 . . . . 74.530000000000001 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 73.030000000000001 113.121 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.319999999999993 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 71.120000000000005 112.267 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 43.310000000000002 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.140000000000001 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.040000000000006 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.150000000000006 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 60.140000000000001 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 63.420000000000002 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 53.439999999999998 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.409999999999997 110.15 176.617 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.688 0.255 . . . . 72.310000000000002 111.688 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.540000000000006 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 55.420000000000002 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.439999999999998 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.219999999999999 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.129999999999995 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.299999999999997 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.239999999999995 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.140000000000001 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.040000000000006 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.230000000000004 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 54.310000000000002 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.420000000000002 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 65.140000000000001 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 72.030000000000001 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.430000000000007 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 71.030000000000001 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 72.5 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 72.319999999999993 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.140000000000001 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.329999999999998 111.964 -177.852 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.805 0.336 . . . . 74.349999999999994 111.463 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 64.25 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.049999999999997 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.200000000000003 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.450000000000003 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.310000000000002 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.409999999999997 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 13.119999999999999 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.129999999999995 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 51.240000000000002 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 51.43 111.984 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 110.807 179.698 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.162 0.43 . . . . 65.120000000000005 112.162 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.310000000000002 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.030000000000001 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.439999999999998 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 62.530000000000001 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.239999999999995 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 74.040000000000006 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HE2' HD13 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.340000000000003 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 71.519999999999996 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.109999999999999 112.377 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.510000000000005 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.120000000000005 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.0 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.039999999999999 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.329999999999998 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 64.120000000000005 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.039999999999999 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 72.120000000000005 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.430000000000007 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 62.109999999999999 109.668 170.306 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.77 0.319 . . . . 51.43 111.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 54.409999999999997 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 72.430000000000007 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 54.420000000000002 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 61.25 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 32.200000000000003 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 30.350000000000001 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 70.329999999999998 111.019 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 72.099999999999994 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.420000000000002 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.209999999999994 110.958 -175.622 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.020000000000003 112.558 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 43.219999999999999 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.519999999999996 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.009999999999998 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.319999999999993 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.319999999999993 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 72.049999999999997 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.329999999999998 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.420000000000002 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 71.209999999999994 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.349999999999994 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.299999999999997 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.329999999999998 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.219999999999999 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 62.030000000000001 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.120000000000005 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.409999999999997 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 45.43 112.38 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.605 0.24 . . . . 73.530000000000001 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.310000000000002 112.664 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 65.310000000000002 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.405 ' HA ' HD11 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.549999999999997 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 51.509999999999998 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.140000000000001 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.329999999999998 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 72.329999999999998 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 65.010000000000005 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 33.039999999999999 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.200000000000003 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.340000000000003 110.96 177.28 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 4' ' ' ASN . 49.3 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.619 0.247 . . . . 55.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -95.4 -53.69 3.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.868 0.366 . . . . 72.049999999999997 111.818 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 p -98.34 -7.25 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.529 0.68 . . . . 71.129999999999995 110.498 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' A' ' 1' ' ' SER . 4.4 m120 -78.86 142.01 37.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.684 -0.689 . . . . 52.229999999999997 111.735 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -100.88 -174.04 2.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.407 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.3 m -75.55 25.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.634 0.605 . . . . 75.099999999999994 112.634 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pp -98.2 2.44 48.39 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.186 0.439 . . . . 70.450000000000003 112.186 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -62.04 155.99 22.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.218 0.533 . . . . 64.409999999999997 112.361 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 11' ' ' GLU . 48.4 mm -92.69 136.83 24.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.198 -0.455 . . . . 54.100000000000001 111.008 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 9' ' ' ILE . 58.6 Cg_endo -70.2 43.91 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.718 2.279 . . . . 70.120000000000005 114.173 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 9' ' ' ILE . 41.8 mt-10 -78.59 6.47 8.64 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.907 -0.495 . . . . 62.130000000000003 111.69 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.53 156.31 21.93 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.884 -0.413 . . . . 41.420000000000002 109.884 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -99.2 133.11 43.96 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.982 -0.449 . . . . 71.030000000000001 111.941 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.4 119.44 23.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.493 -0.321 . . . . 73.409999999999997 110.807 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -10.3 71.41 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.858 -0.687 . . . . 55.119999999999997 112.55 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -127.78 154.86 44.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.772 -0.455 . . . . 73.239999999999995 109.772 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.7 mtm -91.27 145.12 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.276 0.56 . . . . 75.040000000000006 111.285 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -91.97 107.91 19.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.46 -0.791 . . . . 74.450000000000003 111.323 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.1 m -105.27 115.1 29.7 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.607 -0.27 . . . . 75.439999999999998 110.478 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 26' ' ' TYR . 33.8 pt -129.19 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 111.954 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -96.23 -179.09 4.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.973 0.416 . . . . 70.340000000000003 110.835 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -78.03 -9.14 58.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.987 0.422 . . . . 72.239999999999995 111.548 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -87.03 -23.25 25.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.468 -0.333 . . . . 75.349999999999994 111.635 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.39 -1.05 22.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 121.451 -0.404 . . . . 71.150000000000006 113.553 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.03 133.04 49.21 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.615 -0.326 . . . . 65.319999999999993 112.929 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.518 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 52.4 t80 -109.94 132.17 54.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.543 0.571 . . . . 74.030000000000001 112.543 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -141.04 150.1 42.55 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.017 -0.538 . . . . 53.310000000000002 111.008 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 47.4 m -123.37 129.79 51.8 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.039 0.447 . . . . 74.439999999999998 111.386 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.35 150.32 46.22 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.207 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.66 132.3 45.29 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.479 2.119 . . . . 71.019999999999996 112.698 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 66.9 ttt-85 -69.43 7.82 0.74 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.292 0.478 . . . . 61.130000000000003 112.292 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -54.23 -39.54 66.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.068 0.461 . . . . 73.319999999999993 111.275 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.96 113.43 23.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.364 -0.38 . . . . 74.219999999999999 110.364 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.47 137.0 32.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.176 0.512 . . . . 51.140000000000001 112.221 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.08 82.49 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.542 0.687 . . . . 75.540000000000006 111.529 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.0 pp -121.39 -166.93 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 112.45 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 164.08 2.06 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.864 0.69 . . . . 62.210000000000001 112.864 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.84 139.13 56.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.426 0.632 . . . . 65.219999999999999 112.115 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.78 51.11 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.927 -0.579 . . . . 64.239999999999995 110.805 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -64.09 -12.19 36.86 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 112.144 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.07 29.77 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.339 -0.458 . . . . 74.519999999999996 112.304 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.56 -179.22 3.96 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.077 0.465 . . . . 73.25 111.88 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.74 -115.77 5.73 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 116.111 -0.495 . . . . 35.109999999999999 113.975 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 69.7 Cg_endo -88.07 126.34 2.02 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 114.475 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 3.5 Cg_exo -77.67 140.08 18.46 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.831 2.354 . . . . 55.130000000000003 111.702 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.04 150.78 61.0 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.625 2.217 . . . . 74.109999999999999 113.396 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.27 -40.68 73.75 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.632 2.222 . . . . 73.5 112.253 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.71 102.13 52.76 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.255 -0.43 . . . . 73.519999999999996 110.466 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.44 127.5 14.13 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.542 2.162 . . . . 74.340000000000003 113.333 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.19 -4.45 14.34 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.695 2.263 . . . . 73.349999999999994 112.869 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -151.13 105.04 3.18 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.396 -0.366 . . . . 63.030000000000001 111.351 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -73.16 -27.91 61.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.451 0.643 . . . . 71.109999999999999 110.171 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -126.71 126.26 24.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.324 -0.853 . . . . 71.010000000000005 109.89 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 10.5 Cg_endo -52.14 -25.56 23.45 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.774 2.983 . . . . 75.129999999999995 114.409 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m120 55.04 62.15 8.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.214 0.449 . . . . 63.149999999999999 112.214 -170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.95 -18.15 56.79 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.457 2.104 . . . . 74.120000000000005 111.501 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.3 m -87.55 134.44 35.95 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.573 -0.739 . . . . 74.5 109.456 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 99.9 Cg_exo -44.31 128.65 8.03 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.989 2.459 . . . . 62.130000000000003 113.779 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 58' ' ' PRO . 2.6 Cg_endo -40.15 132.33 2.15 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.765 2.977 . . . . 72.400000000000006 113.259 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.92 -37.56 3.76 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.9 -0.88 . . . . 63.009999999999998 110.9 -169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.91 103.83 14.51 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.185 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.55 140.76 24.06 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 120.862 0.363 . . . . 70.200000000000003 111.649 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.06 128.5 20.78 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.409 2.073 . . . . 74.230000000000004 112.29 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.69 142.33 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.56 -0.291 . . . . 74.219999999999999 110.306 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -80.52 110.83 16.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.692 0.758 . . . . 42.530000000000001 110.738 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.1 99.12 11.16 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.497 -0.774 . . . . 73.319999999999993 111.761 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -113.97 108.88 17.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.79 -0.641 . . . . 74.150000000000006 110.81 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -118.55 145.68 45.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.323 0.583 . . . . 72.219999999999999 111.793 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.2 p -98.67 -3.18 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.761 -0.654 . . . . 72.510000000000005 112.014 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.93 159.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.029 0.381 . . . . 75.299999999999997 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.843 -0.599 . . . . 71.150000000000006 111.253 175.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 112.402 0.519 . . . . 73.209999999999994 112.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.56 -76.24 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.838 0.681 . . . . 61.229999999999997 112.838 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -82.79 -28.48 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.581 0.585 . . . . 74.120000000000005 112.581 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 4' ' ' ASN . 2.3 t-20 -92.78 171.01 9.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 110.94 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HB2' HD22 ' A' ' 7' ' ' LEU . 27.7 mt-10 -96.44 -170.48 2.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.365 0.505 . . . . 70.549999999999997 112.365 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.51 16.08 5.91 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.033 0.383 . . . . 44.509999999999998 112.033 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.5 pt? -69.3 -6.17 27.84 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.895 0.378 . . . . 63.100000000000001 111.496 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -77.41 -174.6 3.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.934 0.397 . . . . 71.120000000000005 111.298 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.93 126.47 89.39 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.182 -0.303 . . . . 71.109999999999999 110.182 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -37.8 103.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.55 2.834 . . . . 64.319999999999993 114.08 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.48 5.84 43.56 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.795 -0.639 . . . . 64.230000000000004 112.121 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.11 171.86 13.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.795 0.331 . . . . 72.549999999999997 111.24 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -100.99 134.53 43.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.703 0.287 . . . . 73.310000000000002 111.016 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.96 133.5 38.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 73.129999999999995 111.628 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.38 2.54 68.16 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.062 -0.589 . . . . 65.239999999999995 112.865 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -128.68 161.17 30.3 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.693 0.397 . . . . 75.010000000000005 110.691 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.7 mtm -93.65 138.87 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.761 0.315 . . . . 74.230000000000004 110.823 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.17 111.23 22.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.128 0.489 . . . . 73.239999999999995 110.896 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.0 m -104.84 106.48 16.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.07 -0.514 . . . . 70.310000000000002 110.642 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 64' ' ' ASP . 46.9 pt -126.18 162.31 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.976 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 34.1 p30 -131.84 174.67 9.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.214 0.53 . . . . 72.340000000000003 111.833 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -70.04 -14.49 62.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 111.101 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -78.32 -22.98 47.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.34 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.12 10.15 24.67 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.118 -0.563 . . . . 44.520000000000003 113.936 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.4 141.05 28.24 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.224 -0.513 . . . . 44.43 113.257 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 20' ' ' ILE . 81.5 t80 -124.51 117.93 25.46 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.748 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.7 154.09 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.748 0.309 . . . . 63.219999999999999 111.375 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.8 m -125.5 108.84 12.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.908 0.385 . . . . 53.240000000000002 110.668 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.71 155.34 37.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.325 -0.398 . . . . 72.25 111.987 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.29 134.76 66.24 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.584 2.189 . . . . 71.140000000000001 112.351 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 31' ' ' ARG . 16.6 ttt180 -81.92 12.1 4.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.253 0.549 . . . . 71.040000000000006 111.367 -175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -63.92 -9.6 16.36 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.076 -0.511 . . . . 64.400000000000006 112.342 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.07 154.11 22.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 110.96 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.15 124.57 31.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.086 0.47 . . . . 44.350000000000001 111.873 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.1 m -90.17 95.02 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.685 0.755 . . . . 62.329999999999998 111.827 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -125.6 -151.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.593 -0.73 . . . . 72.030000000000001 110.012 176.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.43 -160.8 0.8 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.094 -0.379 . . . . 74.439999999999998 110.966 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -64.44 -32.69 74.41 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.05 0.389 . . . . 73.040000000000006 112.05 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.16 112.02 8.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.986 0.422 . . . . 71.129999999999995 110.599 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -79.22 18.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.014 0.746 . . . . 71.310000000000002 113.014 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.61 22.49 64.33 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 114.528 0.571 . . . . 73.439999999999998 114.528 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.037 0.446 . . . . 61.509999999999998 111.358 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.11 -60.44 0.58 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.984 -0.627 . . . . 64.519999999999996 113.275 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.56 133.81 31.08 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.543 2.162 . . . . 74.209999999999994 112.826 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.9 151.87 14.47 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.641 2.228 . . . . 34.240000000000002 112.381 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 44.7 Cg_endo -68.39 127.0 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.114 1.876 . . . . 71.430000000000007 111.98 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 46' ' ' PRO . 9.5 Cg_endo -49.73 -48.56 18.78 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.772 2.315 . . . . 73.150000000000006 112.19 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.39 99.65 42.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.981 -0.554 . . . . 65.209999999999994 110.288 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 16.6 Cg_exo -68.41 119.08 6.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.627 2.218 . . . . 74.340000000000003 112.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 49' ' ' PRO . 31.2 Cg_endo -63.38 -29.96 72.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.186 1.924 . . . . 75.200000000000003 111.679 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.59 170.37 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.24 -0.891 . . . . 42.240000000000002 109.769 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.07 12.18 4.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 111.553 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -104.25 157.56 33.78 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.707 -0.679 . . . . 72.219999999999999 110.011 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 36.2 Cg_endo -64.25 -27.76 64.07 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.621 2.214 . . . . 53.509999999999998 113.414 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m120 52.74 62.24 10.39 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 121.046 0.45 . . . . 75.400000000000006 112.111 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 38.5 Cg_endo -65.38 -15.13 48.48 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.168 2.579 . . . . 74.340000000000003 112.289 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.41 153.54 56.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.686 -0.688 . . . . 74.010000000000005 110.307 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.57 150.56 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.032 2.488 . . . . 63.420000000000002 113.2 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.13 129.99 26.82 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.019 2.479 . . . . 50.439999999999998 112.355 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 103.0 3.61 48.56 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.754 -0.736 . . . . 72.5 112.56 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 85.4 m-85 -134.47 155.83 49.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.745 0.418 . . . . 65.219999999999999 111.371 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 15.4 pt-20 -135.37 156.69 77.72 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.9 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 12.9 Cg_exo -70.69 126.51 12.77 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.417 2.078 . . . . 53.229999999999997 112.243 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 20' ' ' ILE . 27.5 t70 -86.11 106.07 16.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.923 0.392 . . . . 44.229999999999997 111.616 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.15 107.63 15.85 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.024 0.44 . . . . 74.540000000000006 110.57 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -117.91 102.05 8.77 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.954 0.407 . . . . 74.340000000000003 110.944 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -66.77 -18.88 65.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.89 0.376 . . . . 51.149999999999999 111.27 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.7 m -62.65 -29.88 70.96 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.708 0.632 . . . . 74.329999999999998 112.708 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.76 152.41 51.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.267 0.469 . . . . 72.450000000000003 112.267 -174.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.33 174.24 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 111.627 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 119.021 -0.514 . . . . 74.420000000000002 111.704 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.604 0.24 . . . . 75.040000000000006 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.73 125.22 23.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.765 0.317 . . . . 74.010000000000005 111.828 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -76.87 146.62 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.519 0.676 . . . . 51.32 112.695 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.17 142.79 47.08 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.793 -0.64 . . . . 73.019999999999996 110.357 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HB2' HD22 ' A' ' 7' ' ' LEU . 36.4 mt-10 -73.37 -178.93 3.18 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.152 0.501 . . . . 72.420000000000002 111.724 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.1 m -65.16 4.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.987 1.106 . . . . 61.219999999999999 113.987 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 7' ' ' LEU . 2.6 pt? -84.43 -14.11 50.22 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.062 -0.399 . . . . 74.530000000000001 111.282 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 5' ' ' GLU . 9.8 t -65.96 139.65 58.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.809 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.98 126.66 79.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 116.326 -0.397 . . . . 72.219999999999999 111.123 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.63 94.91 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.46 2.107 . . . . 64.510000000000005 112.363 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.09 -6.76 59.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.124 0.416 . . . . 51.140000000000001 112.124 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.56 170.88 10.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 51.350000000000001 112.725 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.7 m -98.81 137.05 37.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 109.734 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -74.58 124.3 26.41 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.047 0.451 . . . . 73.510000000000005 111.633 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.1 2.81 89.27 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.185 -0.461 . . . . 60.43 113.52 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.82 162.44 35.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.677 0.391 . . . . 72.120000000000005 110.63 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 27.7 mtm -89.56 135.17 33.76 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.745 0.646 . . . . 54.130000000000003 112.745 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.9 tttt -91.52 114.09 26.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.393 -0.821 . . . . 74.540000000000006 110.823 176.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 85.5 m -105.55 110.3 22.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.325 -0.398 . . . . 43.149999999999999 111.013 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 pt -130.8 163.11 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.917 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -133.29 167.75 19.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.22 0.533 . . . . 62.420000000000002 111.404 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -66.66 -8.7 29.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.769 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -84.4 -16.74 41.66 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.969 0.359 . . . . 62.520000000000003 111.969 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.44 -3.55 27.99 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.925 -0.655 . . . . 74.129999999999995 114.082 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.71 145.85 42.58 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.309 -0.472 . . . . 50.43 113.854 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -131.63 130.81 42.62 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.73 0.412 . . . . 74.219999999999999 111.839 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.0 mt -141.52 158.46 43.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.822 0.449 . . . . 74.040000000000006 111.189 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -125.53 119.98 29.63 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.733 0.302 . . . . 53.140000000000001 110.402 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.422 HD12 ' SG ' ' A' ' 19' ' ' CYS . 79.3 mt -110.0 153.88 42.95 Favored Pre-proline 0 N--CA 1.471 0.577 0 N-CA-C 111.864 0.32 . . . . 71.540000000000006 111.864 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 143.3 98.88 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.65 2.234 . . . . 74.340000000000003 112.631 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -69.93 0.46 5.85 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 112.129 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -61.1 -21.99 64.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.805 0.336 . . . . 61.130000000000003 111.648 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . -86.88 154.24 21.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.691 0.282 . . . . 71.439999999999998 111.105 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.94 36.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.879 0.696 . . . . 61.340000000000003 112.879 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -98.83 -2.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 111.676 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 pp -77.85 -161.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 112.453 0.538 . . . . 70.400000000000006 112.453 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -41.17 136.03 1.7 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.823 0.675 . . . . 70.439999999999998 112.823 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.93 112.94 0.74 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.02 -0.536 . . . . 75.109999999999999 111.789 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.74 63.0 5.82 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.449 0.537 . . . . 74.219999999999999 112.449 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -173.73 117.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.07 0.462 . . . . 71.329999999999998 111.369 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.58 74.47 0.44 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.392 -0.432 . . . . 75.150000000000006 112.352 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -71.61 114.12 9.36 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 73.420000000000002 111.914 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.28 -141.13 20.41 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.07 -0.586 . . . . 74.329999999999998 114.079 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.04 164.57 17.55 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.193 2.595 . . . . 64.319999999999993 113.352 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 54.7 Cg_endo -68.95 118.28 5.57 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 122.321 2.014 . . . . 61.200000000000003 112.323 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 24.7 Cg_exo -64.17 136.44 51.87 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.756 2.304 . . . . 73.140000000000001 113.186 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.74 -45.24 34.49 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.699 2.266 . . . . 65.030000000000001 112.377 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.7 p -135.08 98.43 12.88 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 121.526 0.679 . . . . 75.129999999999995 110.137 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -88.37 152.66 6.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.868 2.379 . . . . 61.310000000000002 114.003 -174.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.92 -0.03 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.628 2.219 . . . . 64.120000000000005 111.998 170.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.72 37.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.72 -0.673 . . . . 75.140000000000001 111.92 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 174.08 -20.55 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.814 -0.63 . . . . 72.239999999999995 110.487 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -149.0 118.79 4.02 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.801 -0.636 . . . . 55.409999999999997 110.197 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -50.1 -26.13 14.22 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 124.345 3.364 . . . . 72.019999999999996 115.387 -168.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.9 m120 54.8 60.7 9.86 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-O 121.05 0.453 . . . . 64.239999999999995 111.507 -168.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.96 -17.25 25.34 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.846 2.364 . . . . 72.120000000000005 112.28 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.2 m -86.28 153.0 56.22 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.972 -0.558 . . . . 65.540000000000006 110.632 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -47.6 144.73 10.18 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.726 2.284 . . . . 72.099999999999994 113.275 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.91 129.34 9.66 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.936 2.424 . . . . 73.239999999999995 113.105 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 1.6 56.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 54.049999999999997 112.643 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.21 135.11 42.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.002 0.429 . . . . 73.420000000000002 111.821 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.2 pt-20 -115.31 152.36 46.81 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.057 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.06 124.78 7.52 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.451 2.101 . . . . 70.140000000000001 113.213 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.7 t70 -91.32 132.92 35.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.146 -0.479 . . . . 51.5 110.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.8 111.23 17.84 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.435 0.636 . . . . 74.409999999999997 111.045 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -93.78 100.23 12.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.497 0.665 . . . . 74.329999999999998 112.066 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -87.39 -63.78 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.604 -0.517 . . . . 74.129999999999995 109.604 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.5 m 58.9 103.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.542 -0.753 . . . . 73.340000000000003 112.206 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.16 105.01 0.29 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.732 0.301 . . . . 72.129999999999995 110.563 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t 74.64 90.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.022 0.929 . . . . 53.329999999999998 111.354 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.417 -0.81 . . . . 63.409999999999997 110.407 179.379 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.814 0.34 . . . . 72.230000000000004 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -115.49 -79.96 0.59 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.182 0.438 . . . . 73.030000000000001 112.182 -172.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -121.88 113.15 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.549 0.69 . . . . 75.010000000000005 111.697 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.88 110.03 22.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.445 0.64 . . . . 70.400000000000006 111.782 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 7' ' ' LEU . 41.6 mt-10 -99.23 71.0 1.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.715 -0.675 . . . . 54.439999999999998 111.467 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.0 m 69.61 -37.61 0.38 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.163 0.431 . . . . 53.350000000000001 112.163 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 pt? -76.24 35.65 0.14 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.352 0.596 . . . . 73.25 111.559 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -58.05 144.32 40.34 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.939 0.718 . . . . 74.349999999999994 112.939 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.0 mm -74.66 139.43 74.2 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.43 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 65.56 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.811 2.341 . . . . 75.310000000000002 113.382 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -94.44 4.85 53.32 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.144 -0.48 . . . . 64.319999999999993 111.192 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -131.61 172.67 11.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.949 0.404 . . . . 70.099999999999994 111.965 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.2 m -98.31 137.46 37.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.278 -0.419 . . . . 74.299999999999997 110.764 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -75.69 127.01 32.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.619 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 80.76 0.92 88.9 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 116.143 -0.48 . . . . 53.329999999999998 113.024 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.35 161.99 34.26 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.672 -0.311 . . . . 65.230000000000004 110.672 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtm -89.86 145.71 24.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.368 0.604 . . . . 71.209999999999994 111.945 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HE2' HD13 ' A' ' 20' ' ' ILE . 79.0 tttt -97.66 112.82 24.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.72 -0.673 . . . . 74.349999999999994 111.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.2 111.23 23.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.537 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.555 HD13 ' HE2' ' A' ' 18' ' ' LYS . 42.3 pt -131.97 161.74 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.231 0.539 . . . . 75.109999999999999 111.715 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -120.24 170.6 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.092 -0.504 . . . . 73.450000000000003 110.521 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.34 -10.63 56.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.299 0.481 . . . . 73.140000000000001 112.299 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -77.89 -31.38 51.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.82 0.343 . . . . 54.43 111.668 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.48 11.13 10.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.355 -0.45 . . . . 71.329999999999998 113.54 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -72.47 119.97 7.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.212 -0.518 . . . . 73.040000000000006 112.475 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HA ' HG22 ' A' ' 20' ' ' ILE . 79.4 t80 -110.39 122.66 48.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.262 0.467 . . . . 72.25 112.262 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -133.33 153.51 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.864 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -125.47 124.91 42.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.897 0.38 . . . . 52.009999999999998 111.489 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.81 146.89 35.03 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.496 -0.32 . . . . 73.299999999999997 111.063 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.75 149.66 86.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.501 2.134 . . . . 63.219999999999999 113.004 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 62.6 ttt180 -71.13 -1.19 11.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.944 0.35 . . . . 70.430000000000007 111.944 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p -59.9 -24.96 64.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.169 0.509 . . . . 71.129999999999995 110.582 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.15 133.21 35.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.929 -0.578 . . . . 64.099999999999994 110.138 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB1' HG13 ' A' ' 36' ' ' ILE . . . -87.58 146.78 25.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.639 0.607 . . . . 72.430000000000007 112.639 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.31 -9.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.143 -0.48 . . . . 72.030000000000001 111.635 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.567 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.7 pp -78.26 173.96 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.154 0.502 . . . . 72.010000000000005 112.317 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -101.92 106.25 17.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.602 0.593 . . . . 74.150000000000006 112.602 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -107.63 23.88 13.76 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.235 -0.438 . . . . 50.520000000000003 111.308 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' H ' HD22 ' A' ' 39' ' ' LEU . 2.7 mm? -70.63 85.29 0.63 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.35 0.595 . . . . 62.25 110.38 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -111.08 -14.53 13.88 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.734 -0.666 . . . . 62.43 111.654 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.2 -139.02 41.72 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.226 -0.511 . . . . 61.329999999999998 113.492 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.82 -1.86 54.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.86 0.362 . . . . 73.150000000000006 111.641 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 169.88 -93.35 0.1 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.215 -0.516 . . . . 52.43 112.77 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 1.1 Cg_endo -82.69 111.58 2.02 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.926 2.417 . . . . 73.510000000000005 112.266 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.38 154.66 71.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.289 1.993 . . . . 64.25 112.625 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.83 150.18 79.05 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.766 2.311 . . . . 74.140000000000001 112.822 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.32 -8.24 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.82 2.347 . . . . 55.450000000000003 113.181 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.58 105.39 14.37 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.363 0.265 . . . . 64.340000000000003 111.15 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -97.1 92.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 123.201 2.6 . . . . 64.450000000000003 112.845 173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.23 -16.79 19.51 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.483 2.122 . . . . 74.040000000000006 113.31 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.4 -45.83 10.81 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.887 0.329 . . . . 44.049999999999997 111.887 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 6.4 tp60 56.72 20.13 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.59 0.709 . . . . 74.439999999999998 111.341 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.85 148.5 30.39 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.966 -0.561 . . . . 73.5 110.726 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.477 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.3 Cg_endo -67.11 -27.38 41.99 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.701 2.267 . . . . 75.129999999999995 112.998 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 53.21 62.09 10.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 112.612 0.597 . . . . 65.239999999999995 112.612 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.477 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.4 Cg_endo -69.32 -15.15 38.54 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.961 2.44 . . . . 74.109999999999999 112.097 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.6 m -85.7 153.78 58.33 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.861 -0.608 . . . . 41.130000000000003 110.6 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.64 147.08 7.13 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.942 2.428 . . . . 64.329999999999998 113.665 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.36 130.06 24.18 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.964 2.443 . . . . 34.030000000000001 112.668 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.7 -32.16 7.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.245 -0.502 . . . . 60.009999999999998 112.768 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -90.37 129.43 36.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.447 0.641 . . . . 71.239999999999995 111.418 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -114.92 140.43 25.5 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.671 -0.695 . . . . 71.230000000000004 111.095 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.03 126.82 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 71.109999999999999 112.689 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.07 127.67 35.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 111.288 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -94.76 110.39 22.25 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.782 0.325 . . . . 64.5 111.623 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.86 144.15 44.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 72.5 110.711 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.01 104.04 14.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.299999999999997 110.795 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -79.32 -22.86 43.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.112 -0.495 . . . . 51.350000000000001 111.221 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m 60.72 21.03 11.05 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.142 0.423 . . . . 54.329999999999998 112.142 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.8 t -111.75 128.98 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.339 -0.391 . . . . 63.409999999999997 110.727 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.968 -0.539 . . . . 64.420000000000002 111.78 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.049 0.389 . . . . 73.420000000000002 112.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -65.89 -67.37 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.363 0.505 . . . . 62.43 112.363 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.23 152.87 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.109 0.48 . . . . 73.030000000000001 112.112 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -134.98 160.61 37.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 75.340000000000003 110.647 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.16 -171.0 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.068 0.461 . . . . 70.150000000000006 112.226 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.84 -17.17 34.31 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.374 0.879 . . . . 71.030000000000001 113.374 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.1 pt? -82.02 6.33 16.5 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.074 -0.391 . . . . 73.409999999999997 111.677 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -69.12 157.61 36.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.201 0.524 . . . . 74.340000000000003 112.31 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.6 134.65 57.49 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.05 -0.523 . . . . 64.299999999999997 111.062 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.52 79.77 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.82 2.347 . . . . 71.310000000000002 113.821 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -92.26 5.9 48.76 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.053 0.454 . . . . 74.310000000000002 111.254 173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.84 162.75 27.82 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.122 -0.49 . . . . 70.319999999999993 110.426 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.57 138.46 36.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.922 0.391 . . . . 54.329999999999998 111.83 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.25 123.67 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 71.299999999999997 111.682 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 3.49 64.95 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.874 -0.679 . . . . 65.010000000000005 112.734 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -130.69 148.77 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.783 0.433 . . . . 75.010000000000005 109.954 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.62 ' SD ' HG13 ' A' ' 35' ' ' VAL . 54.5 mtm -89.86 139.18 30.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.359 0.599 . . . . 72.230000000000004 112.048 -172.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.67 112.23 24.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.624 -0.716 . . . . 75.230000000000004 111.039 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.2 m -105.46 109.38 21.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.305 -0.407 . . . . 62.0 110.262 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 26' ' ' TYR . 40.9 pt -132.2 162.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.364 -0.38 . . . . 74.140000000000001 111.393 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.8 p30 -125.38 163.57 22.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.666 0.27 . . . . 74.129999999999995 110.878 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -65.78 -9.23 26.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 111.896 0.332 . . . . 73.310000000000002 111.896 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -76.77 -25.93 53.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.695 0.258 . . . . 72.120000000000005 111.695 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 11.46 10.22 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 121.025 -0.607 . . . . 45.210000000000001 114.353 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.32 143.64 28.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.104 -0.57 . . . . 74.5 112.735 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.566 ' HA ' HG22 ' A' ' 20' ' ' ILE . 86.6 t80 -130.68 120.15 23.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.540000000000006 112.265 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.34 149.44 50.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.437 -0.347 . . . . 73.040000000000006 111.64 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.5 m -121.99 115.16 22.02 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 116.687 -0.233 . . . . 50.350000000000001 110.969 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -104.84 155.13 38.0 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.722 0.296 . . . . 65.450000000000003 111.638 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.71 162.99 16.76 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.591 2.194 . . . . 73.450000000000003 113.035 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -81.48 11.44 4.56 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 111.628 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -53.56 -33.76 55.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.168 0.508 . . . . 74.0 110.654 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.76 154.39 22.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.451 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.46 141.22 50.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.115 0.483 . . . . 74.129999999999995 112.124 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.62 HG13 ' SD ' ' A' ' 17' ' ' MET . 23.1 m -80.57 45.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.154 0.502 . . . . 72.099999999999994 111.858 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.566 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -68.74 -166.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 112.517 0.562 . . . . 52.530000000000001 112.517 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -75.27 -83.24 0.06 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.358 0.503 . . . . 72.329999999999998 112.358 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -165.93 114.85 0.97 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.071 0.462 . . . . 72.409999999999997 111.614 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -110.61 61.25 0.61 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.148 0.499 . . . . 74.109999999999999 110.465 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -78.25 78.66 4.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.433 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 57.9 5.02 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.131 -0.556 . . . . 51.329999999999998 112.042 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -144.99 97.08 2.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.945 0.402 . . . . 73.430000000000007 110.715 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.22 -160.66 12.46 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.023 -0.535 . . . . 73.299999999999997 113.995 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.5 Cg_endo -79.17 115.69 3.54 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.632 2.221 . . . . 74.329999999999998 112.637 176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 15.1 Cg_exo -70.14 138.36 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.794 2.329 . . . . 74.019999999999996 112.885 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 31.4 Cg_exo -60.44 160.08 25.07 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.639 2.226 . . . . 64.239999999999995 112.853 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.02 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.3 2.0 . . . . 73.219999999999999 112.555 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.89 141.75 43.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.219 -0.446 . . . . 63.409999999999997 111.221 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.67 141.3 54.34 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.33 2.02 . . . . 75.040000000000006 112.685 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.08 -20.66 68.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.869 2.379 . . . . 72.299999999999997 113.317 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.92 85.87 0.98 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.052 0.453 . . . . 35.530000000000001 110.482 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 51.6 tt0 -151.16 174.08 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.255 -0.429 . . . . 60.420000000000002 111.282 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.495 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.2 m80 -125.07 150.2 65.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.609 0.363 . . . . 74.209999999999994 110.958 174.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 58.3 Cg_endo -69.59 -26.81 28.0 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.172 2.581 . . . . 51.520000000000003 113.437 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 54.2 63.91 6.97 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.426 0.631 . . . . 71.230000000000004 111.833 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 85.6 Cg_endo -73.73 -14.82 24.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.83 3.02 . . . . 61.149999999999999 113.252 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.3 m -83.43 153.24 65.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.553 -0.294 . . . . 62.210000000000001 110.987 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.53 146.28 2.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.256 2.638 . . . . 72.219999999999999 113.91 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.63 129.53 14.1 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.906 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 94.84 3.41 62.27 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.162 -0.542 . . . . 72.140000000000001 113.157 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -133.68 117.83 17.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.04 0.448 . . . . 73.049999999999997 111.342 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 12.4 pt-20 -102.85 158.52 31.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.161 -0.472 . . . . 70.099999999999994 111.222 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.11 135.04 20.29 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.637 2.225 . . . . 61.240000000000002 113.464 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.29 133.81 46.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.581 -0.526 . . . . 54.219999999999999 109.581 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -81.47 110.51 16.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.033 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -93.42 99.46 11.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.664 -0.698 . . . . 75.319999999999993 111.83 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.43 63.68 1.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.367 0.603 . . . . 71.530000000000001 110.586 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 m -72.8 83.85 1.2 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.22 -0.445 . . . . 52.030000000000001 111.073 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -76.41 -20.48 57.08 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.377 -0.374 . . . . 75.010000000000005 111.399 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.5 t -94.27 131.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.829 0.347 . . . . 75.310000000000002 111.196 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.933 -0.556 . . . . 63.229999999999997 111.431 177.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.849 0.356 . . . . 55.229999999999997 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.48 18.42 8.22 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.543 0.571 . . . . 73.450000000000003 112.543 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.98 150.98 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.66 0.384 . . . . 74.040000000000006 110.328 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -138.94 172.47 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.096 0.474 . . . . 75.329999999999998 111.344 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.11 -174.74 3.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.24 -0.437 . . . . 74.209999999999994 111.442 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 69' ' ' CYS . 55.0 m -70.43 5.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.602 0.964 . . . . 74.310000000000002 113.602 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 7' ' ' LEU . 2.2 pt? -97.76 13.61 29.81 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.115 0.483 . . . . 73.400000000000006 110.753 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.5 t -71.33 178.1 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.66 0.615 . . . . 64.430000000000007 112.66 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.1 mm -86.2 141.73 35.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.625 -0.716 . . . . 75.129999999999995 110.552 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.61 82.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.562 2.175 . . . . 72.129999999999995 113.396 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 67.1 mt-10 -75.32 -35.79 61.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.082 -0.508 . . . . 74.510000000000005 111.038 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.7 172.65 8.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.581 0.705 . . . . 73.519999999999996 112.316 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.68 136.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.57 -0.741 . . . . 62.32 110.804 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.02 119.46 15.17 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.501 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.44 90.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.01 -0.614 . . . . 52.439999999999998 113.207 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.97 163.29 29.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.737 0.415 . . . . 65.530000000000001 111.335 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 40.0 mtm -90.53 145.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 112.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE2' HD13 ' A' ' 20' ' ' ILE . 71.4 tttt -102.51 112.51 25.28 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.757 -0.656 . . . . 71.120000000000005 111.343 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.3 m -106.38 114.44 28.56 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.4 -0.363 . . . . 71.319999999999993 111.109 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' HB2' ' A' ' 64' ' ' ASP . 44.6 pt -131.75 162.71 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.883 0.373 . . . . 71.209999999999994 111.403 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 32.6 p30 -129.68 167.26 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.886 0.374 . . . . 72.140000000000001 111.653 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -64.75 -9.23 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.009 0.374 . . . . 54.420000000000002 112.009 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -87.68 -14.83 38.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.713 0.292 . . . . 72.540000000000006 111.556 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -0.5 31.91 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 114.604 0.602 . . . . 73.239999999999995 114.604 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.41 142.24 32.32 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 117.144 0.472 . . . . 62.43 113.462 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -130.83 125.33 33.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.149 0.426 . . . . 73.200000000000003 112.149 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.79 153.1 50.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.854 0.462 . . . . 54.399999999999999 111.19 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.99 114.59 22.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.391 . . . . 71.340000000000003 111.787 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.43 HD12 ' SG ' ' A' ' 19' ' ' CYS . 88.4 mt -103.08 157.4 33.84 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.234 -0.439 . . . . 64.450000000000003 111.729 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.74 154.74 24.76 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 72.329999999999998 113.523 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 74.6 ttt180 -81.86 11.69 4.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.121 0.486 . . . . 74.400000000000006 111.801 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -67.12 -10.86 54.54 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.396 0.517 . . . . 41.140000000000001 112.396 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.94 154.43 20.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 112.291 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -112.78 154.01 26.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.265 -0.425 . . . . 72.329999999999998 110.881 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.35 14.56 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 113.088 0.773 . . . . 60.520000000000003 113.088 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -75.03 161.28 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.735 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -91.52 126.31 36.56 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.034 0.445 . . . . 71.040000000000006 112.108 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t70 60.6 115.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.973 0.909 . . . . 74.140000000000001 112.816 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -138.49 30.3 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.233 -0.894 . . . . 73.230000000000004 110.713 178.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -57.51 112.84 1.55 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.051 -0.522 . . . . 71.319999999999993 111.667 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.1 -1.85 64.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.149 -0.548 . . . . 63.520000000000003 113.255 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.77 -57.62 4.18 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.673 -0.31 . . . . 72.239999999999995 111.464 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.18 -138.82 2.87 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.762 -0.733 . . . . 64.530000000000001 113.62 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 24.2 Cg_exo -64.56 129.96 25.19 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.073 2.515 . . . . 72.109999999999999 113.658 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 35.7 Cg_exo -61.89 134.53 50.54 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.038 2.492 . . . . 73.209999999999994 113.487 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.56 155.22 37.71 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.016 2.477 . . . . 74.329999999999998 113.183 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.63 -14.09 19.93 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.684 2.256 . . . . 75.150000000000006 113.785 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.34 100.58 7.67 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 121.435 0.636 . . . . 64.109999999999999 112.57 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.3 147.83 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.178 2.585 . . . . 72.109999999999999 112.283 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.44 -20.33 69.73 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.385 2.057 . . . . 75.140000000000001 113.049 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.2 171.7 4.02 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.595 0.358 . . . . 65.409999999999997 111.03 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.06 31.15 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.015 0.436 . . . . 62.439999999999998 111.932 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -123.06 148.03 53.24 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 122.114 -0.366 . . . . 71.420000000000002 111.632 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 39' ' ' LEU . 52.1 Cg_endo -67.84 -29.58 34.83 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.097 2.531 . . . . 74.040000000000006 113.402 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.8 m-20 52.33 62.84 9.83 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 121.092 0.473 . . . . 72.120000000000005 111.948 -173.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 19.9 Cg_exo -65.06 -15.68 51.62 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.372 2.715 . . . . 64.239999999999995 112.314 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.64 129.52 54.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.078 -0.51 . . . . 75.049999999999997 110.302 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.1 150.8 6.68 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 54.119999999999997 114.09 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 133.29 13.37 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.008 2.472 . . . . 62.310000000000002 112.95 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.91 -20.23 29.3 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.152 -0.547 . . . . 51.109999999999999 111.952 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 88.8 m-85 -125.13 166.33 16.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.866 0.466 . . . . 73.329999999999998 110.676 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.7 pt-20 -146.78 150.56 39.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 120.732 0.301 . . . . 74.120000000000005 111.085 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.43 127.97 13.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.385 2.056 . . . . 63.399999999999999 113.073 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 20' ' ' ILE . 29.4 t70 -99.89 108.2 20.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.084 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.22 107.36 17.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.949 -0.3 . . . . 61.32 110.241 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.59 127.02 53.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.926 0.393 . . . . 70.040000000000006 110.64 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.82 104.04 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.132 -0.485 . . . . 73.239999999999995 111.893 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -78.43 83.5 4.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.28 -0.418 . . . . 73.409999999999997 111.218 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 80.6 m -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.295 -0.411 . . . . 55.310000000000002 112.098 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -129.81 136.85 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.755 0.312 . . . . 60.140000000000001 111.296 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.924 -0.56 . . . . 41.5 111.759 178.646 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.831 0.348 . . . . 63.350000000000001 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -135.04 151.02 50.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.289 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -88.45 146.83 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.87 0.366 . . . . 71.5 111.482 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 3.3 p-10 -143.14 143.12 31.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.173 0.434 . . . . 71.400000000000006 112.173 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.539 ' HB2' HD22 ' A' ' 7' ' ' LEU . 29.9 mt-10 -92.04 -158.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.904 -0.406 . . . . 64.329999999999998 109.904 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.73 -21.97 60.04 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 111.959 0.355 . . . . 62.350000000000001 111.959 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.8 pt? -71.14 -0.94 10.8 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.157 0.429 . . . . 74.329999999999998 112.157 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 4' ' ' ASN . 12.8 t -58.98 177.37 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.706 0.632 . . . . 41.5 112.706 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -73.74 133.92 79.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.154 -0.475 . . . . 64.099999999999994 111.092 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.29 72.14 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.754 2.302 . . . . 73.409999999999997 113.402 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -86.32 2.5 47.14 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 111.866 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.74 31.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.953 0.406 . . . . 75.150000000000006 111.644 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -98.4 136.81 38.02 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.983 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.59 132.62 40.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.788 0.328 . . . . 62.409999999999997 111.065 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.64 4.67 76.4 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.791 -0.718 . . . . 62.030000000000001 112.386 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -139.08 160.94 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.982 0.42 . . . . 72.010000000000005 111.621 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.2 mtm -97.53 147.04 24.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 111.286 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 20' ' ' ILE . 77.7 tttt -91.68 116.89 29.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.477 . . . . 71.109999999999999 111.605 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -106.88 109.56 21.49 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.55 -0.295 . . . . 72.120000000000005 111.052 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 18' ' ' LYS . 48.0 pt -132.27 162.23 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 111.668 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.9 p30 -129.85 168.44 16.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.369 -0.378 . . . . 71.519999999999996 111.463 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -59.12 -22.41 60.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.365 -0.379 . . . . 74.140000000000001 111.486 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -66.85 -31.71 72.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.4 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.17 -0.6 22.53 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.275 -0.488 . . . . 70.299999999999997 113.457 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.17 140.02 36.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 75.540000000000006 112.976 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HA ' HG22 ' A' ' 20' ' ' ILE . 82.9 t80 -124.56 127.8 47.95 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.966 0.412 . . . . 72.219999999999999 111.991 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.3 mt -138.36 158.28 44.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.25 -0.432 . . . . 63.130000000000003 110.693 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.5 m -131.61 130.6 42.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.704 0.288 . . . . 71.150000000000006 110.932 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.4 mt -119.91 145.59 40.0 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 116.381 -0.372 . . . . 72.439999999999998 111.78 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.62 126.46 16.32 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.852 2.368 . . . . 65.430000000000007 112.638 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -77.92 0.75 22.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 111.985 0.365 . . . . 72.540000000000006 111.985 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 p -50.3 -33.33 19.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.784 0.326 . . . . 73.299999999999997 111.527 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 36' ' ' ILE . . . -121.87 109.51 14.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.112 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.4 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.199 -0.455 . . . . 64.109999999999999 110.94 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 18.3 m 42.67 25.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.765 1.024 . . . . 63.43 113.765 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 33' ' ' ALA . 2.2 pp -93.99 2.71 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 112.499 0.555 . . . . 61.420000000000002 112.499 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' ND2' HD21 ' A' ' 39' ' ' LEU . 14.5 p-10 -145.37 132.89 20.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.211 0.529 . . . . 72.040000000000006 112.296 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.73 115.44 29.56 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.866 -0.606 . . . . 72.109999999999999 109.88 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD21 ' ND2' ' A' ' 37' ' ' ASN . 3.1 mm? -99.45 168.84 9.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.346 0.498 . . . . 74.439999999999998 112.346 -173.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 67.79 -6.18 0.73 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.284 0.846 . . . . 71.329999999999998 113.284 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.18 66.3 2.91 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.765 -0.731 . . . . 61.149999999999999 112.785 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -125.06 104.89 8.79 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.864 0.364 . . . . 72.200000000000003 111.634 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.22 -122.09 5.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.304 -0.474 . . . . 75.510000000000005 113.043 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.83 111.44 3.29 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.847 2.365 . . . . 63.439999999999998 113.304 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -92.66 159.86 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.032 2.488 . . . . 64.340000000000003 112.95 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.62 144.72 79.6 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.191 1.927 . . . . 73.25 112.532 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.19 -26.14 77.49 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.542 2.162 . . . . 61.119999999999997 112.987 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.95 105.78 48.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.469 -0.332 . . . . 72.150000000000006 111.211 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 2.8 Cg_exo -76.8 105.64 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.804 2.336 . . . . 62.420000000000002 111.951 174.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 49' ' ' PRO . 32.1 Cg_endo -62.64 -51.09 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.422 2.082 . . . . 74.219999999999999 113.3 -173.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -178.13 115.57 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.746 0.418 . . . . 53.009999999999998 110.618 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.54 83.04 0.41 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.695 0.76 . . . . 74.209999999999994 112.114 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -107.45 146.48 33.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.401 -0.818 . . . . 72.510000000000005 110.012 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HG3' ' H ' ' A' ' 35' ' ' VAL . 58.0 Cg_endo -70.32 -29.91 20.47 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.253 1.969 . . . . 72.530000000000001 113.751 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.12 61.29 13.33 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.671 0.619 . . . . 63.200000000000003 112.671 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 61.0 Cg_endo -73.55 -14.89 24.81 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.76 2.307 . . . . 74.340000000000003 111.832 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.5 144.6 40.54 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.516 -0.765 . . . . 53.539999999999999 110.668 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.31 136.89 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.336 2.691 . . . . 71.019999999999996 114.091 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.41 129.43 16.27 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.756 2.304 . . . . 73.340000000000003 112.544 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.13 -14.07 31.19 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.247 -0.501 . . . . 72.430000000000007 112.16 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 97.2 m-85 -116.86 149.06 40.67 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.862 0.465 . . . . 70.530000000000001 110.58 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 11.3 pt-20 -125.77 147.63 59.34 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 120.94 0.4 . . . . 75.299999999999997 111.405 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 13.1 Cg_exo -70.32 118.14 5.52 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.719 2.28 . . . . 73.230000000000004 113.14 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 20' ' ' ILE . 38.5 t70 -94.58 125.2 39.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.043 -0.526 . . . . 71.239999999999995 110.053 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.55 126.07 31.86 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.099 0.476 . . . . 63.439999999999998 111.435 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -93.45 137.19 32.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.804 -0.634 . . . . 62.450000000000003 111.617 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -103.16 34.1 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.399 0.618 . . . . 63.32 110.958 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.7 m -61.81 96.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.822 -0.627 . . . . 72.430000000000007 111.148 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.68 -32.7 70.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.376 -0.374 . . . . 74.519999999999996 111.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.3 152.28 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.957 0.408 . . . . 61.530000000000001 111.888 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.852 -0.594 . . . . 74.129999999999995 111.25 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.626 0.25 . . . . 63.140000000000001 111.246 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -84.82 -33.25 22.95 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.715 0.635 . . . . 74.209999999999994 112.715 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 71' ' ' ASP . 12.5 p -144.88 145.2 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 51.130000000000003 111.661 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.1 177.59 4.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.054 0.454 . . . . 75.150000000000006 111.989 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.4 mt-10 -122.76 168.75 11.84 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.064 0.459 . . . . 54.229999999999997 111.461 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -83.03 31.38 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.013 0.435 . . . . 75.200000000000003 111.67 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.7 pt? -86.79 -3.54 59.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.382 -0.372 . . . . 53.5 111.467 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 t -79.55 173.27 12.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.349 0.595 . . . . 74.5 112.43 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.4 135.93 22.19 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.917 -0.583 . . . . 73.409999999999997 111.339 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.61 77.08 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.375 2.05 . . . . 65.129999999999995 112.004 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.78 -29.74 62.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.169 0.803 . . . . 74.030000000000001 113.169 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.9 171.16 10.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.605 0.594 . . . . 64.120000000000005 112.605 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.4 m -99.16 135.8 40.05 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.911 -0.586 . . . . 73.409999999999997 110.946 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -67.42 119.93 13.05 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.868 0.366 . . . . 75.340000000000003 111.533 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.3 2.37 78.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.344 -0.455 . . . . 72.510000000000005 114.075 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -134.41 161.49 34.86 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.241 0.521 . . . . 74.299999999999997 110.603 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 31.7 mtm -90.03 151.97 21.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.508 0.671 . . . . 72.439999999999998 112.721 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -108.55 113.51 26.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.377 -0.829 . . . . 71.019999999999996 111.682 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.0 m -108.5 115.55 30.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.251 -0.431 . . . . 53.229999999999997 110.627 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.8 pt -132.06 162.54 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.167 0.508 . . . . 63.530000000000001 111.757 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 31.3 p30 -129.11 163.56 25.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.292 -0.413 . . . . 71.099999999999994 110.878 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -68.49 -9.91 52.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.814 0.34 . . . . 64.129999999999995 111.612 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -70.81 -30.58 67.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.366 -0.379 . . . . 73.140000000000001 111.219 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.86 9.98 13.1 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.178 -0.534 . . . . 64.420000000000002 113.276 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.19 139.9 18.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.794 -0.241 . . . . 61.539999999999999 112.839 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -130.66 125.56 34.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.496 0.318 . . . . 72.409999999999997 111.712 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.57 138.53 34.53 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.763 0.425 . . . . 74.430000000000007 110.862 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.4 m -103.52 136.31 43.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.51 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.9 mt -112.91 151.14 43.83 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.335 -0.393 . . . . 65.299999999999997 111.203 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.61 146.74 96.55 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.799 2.333 . . . . 62.520000000000003 113.105 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 54.1 ttt85 -73.09 6.43 2.72 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.382 0.61 . . . . 74.109999999999999 111.768 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.4 m -61.74 -26.02 67.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.067 0.461 . . . . 45.340000000000003 110.951 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' ' HE1' ' A' ' 17' ' ' MET . . . -88.69 141.62 28.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.071 -0.513 . . . . 52.229999999999997 110.79 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' HG13 ' A' ' 36' ' ' ILE . . . -86.93 144.99 26.71 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.255 0.465 . . . . 73.109999999999999 112.255 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.5 m -101.54 4.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.256 0.465 . . . . 73.200000000000003 112.256 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.3 pp -69.69 165.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.168 0.432 . . . . 71.519999999999996 112.168 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.048 0.452 . . . . 64.420000000000002 111.665 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -129.04 158.67 38.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.318 -0.401 . . . . 72.530000000000001 110.235 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.5 mm? -88.95 136.75 32.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.943 0.402 . . . . 72.200000000000003 111.263 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -66.15 -47.55 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.915 0.339 . . . . 43.340000000000003 111.915 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.68 95.66 1.02 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.822 -0.704 . . . . 53.119999999999997 112.88 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.85 5.09 49.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.047 0.388 . . . . 74.129999999999995 112.047 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.17 -69.63 0.49 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.611 -0.328 . . . . 63.509999999999998 112.537 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.94 172.09 5.27 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.917 2.411 . . . . 54.399999999999999 112.686 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.05 115.0 2.22 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.238 1.959 . . . . 64.219999999999999 112.06 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.15 121.16 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.743 2.962 . . . . 54.439999999999998 115.173 -172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.42 158.78 50.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.803 2.335 . . . . 72.439999999999998 112.547 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.61 108.84 58.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 112.599 0.592 . . . . 62.210000000000001 112.599 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 52' ' ' GLN . 62.3 Cg_endo -90.14 167.29 4.53 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.112 2.542 . . . . 75.319999999999993 112.661 171.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.73 -18.33 58.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.462 2.108 . . . . 74.329999999999998 113.151 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.22 145.76 7.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.05 0.54 . . . . 72.129999999999995 110.104 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 8.6 tp-100 -166.91 154.39 9.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.619 0.723 . . . . 72.310000000000002 112.62 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -103.59 146.06 31.79 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.767 -0.651 . . . . 72.430000000000007 110.297 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 26.7 Cg_endo -60.38 -27.86 85.68 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.242 . . . . 74.109999999999999 112.874 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.5 m-20 52.2 60.91 12.82 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.624 0.601 . . . . 65.340000000000003 112.624 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 33.4 Cg_exo -59.3 -16.94 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.674 2.249 . . . . 62.340000000000003 112.214 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.8 m -87.26 137.12 32.86 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.540000000000006 110.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.78 148.06 51.66 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.425 2.083 . . . . 73.349999999999994 113.22 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.33 129.25 6.28 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.846 2.364 . . . . 64.129999999999995 112.856 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' ASN . . . 110.03 -24.7 18.2 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.232 -0.747 . . . . 71.239999999999995 111.232 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.96 123.8 21.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.562 0.745 . . . . 74.319999999999993 109.738 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.0 152.65 52.13 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 120.796 0.332 . . . . 72.400000000000006 111.467 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.81 139.87 59.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.348 2.032 . . . . 73.540000000000006 113.146 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -114.06 131.24 56.45 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.164 -0.471 . . . . 72.150000000000006 111.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -104.2 107.41 18.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.227 0.537 . . . . 74.439999999999998 111.673 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.75 106.53 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.093 0.473 . . . . 74.340000000000003 110.247 165.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.95 -64.6 0.82 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.698 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.4 p -159.66 -172.95 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.984 0.421 . . . . 73.0 111.248 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.93 -30.08 70.66 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.05 0.759 . . . . 72.450000000000003 113.05 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.84 156.68 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.746 0.647 . . . . 74.5 112.746 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HB2' HG23 ' A' ' 3' ' ' VAL . 4.7 m-20 . . . . . 0 C--O 1.256 1.447 0 CA-C-N 115.623 -0.717 . . . . 62.240000000000002 111.526 175.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.578 0.228 . . . . 73.150000000000006 111.229 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -64.01 0.96 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.911 0.337 . . . . 74.420000000000002 111.911 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.44 113.05 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.089 0.471 . . . . 51.219999999999999 111.372 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -132.66 157.15 45.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.457 . . . . 74.109999999999999 110.788 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.4 mt-10 -130.5 -171.92 2.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.054 0.454 . . . . 74.109999999999999 111.458 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -81.85 23.81 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.349 0.5 . . . . 65.430000000000007 112.349 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -93.71 -15.57 25.11 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 111.915 0.339 . . . . 75.120000000000005 111.915 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -79.59 176.8 9.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.637 0.606 . . . . 75.409999999999997 112.637 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.67 132.7 39.76 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 111.153 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.66 78.6 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.367 2.045 . . . . 34.210000000000001 113.403 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.5 7.0 31.36 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.166 0.508 . . . . 73.129999999999995 111.175 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . . . -106.04 171.68 7.21 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.486 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -99.92 135.87 40.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 111.423 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.67 125.87 30.01 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.984 -0.553 . . . . 42.25 112.127 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.4 -17.05 8.59 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.349999999999994 113.727 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -119.38 162.22 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.786 0.434 . . . . 62.509999999999998 110.477 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.802 ' SD ' HG12 ' A' ' 35' ' ' VAL . 46.1 mtm -88.5 145.98 25.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.457 0.646 . . . . 43.149999999999999 111.889 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 12' ' ' ALA . 87.5 tttt -105.36 117.48 34.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.694 -0.685 . . . . 73.349999999999994 111.768 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.3 m -105.73 109.85 21.95 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.984 0.421 . . . . 63.140000000000001 110.701 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.595 HD13 ' HE2' ' A' ' 18' ' ' LYS . 44.7 pt -131.97 162.25 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 110.767 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 29.2 p30 -125.69 164.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.731 0.301 . . . . 64.230000000000004 111.15 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -59.36 -21.01 59.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.711 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.49 -26.0 61.63 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.008 0.373 . . . . 73.109999999999999 112.008 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 0.85 21.8 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.969 -0.634 . . . . 62.219999999999999 114.551 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.45 133.18 35.64 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 117.463 0.631 . . . . 50.329999999999998 113.026 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.0 t80 -116.84 125.42 51.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.413 0.523 . . . . 72.109999999999999 112.413 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.02 153.76 45.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.735 0.414 . . . . 74.549999999999997 110.871 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.1 m -131.35 117.46 18.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.796 0.331 . . . . 54.539999999999999 111.332 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 57' ' ' CYS . 84.5 mt -92.07 148.76 37.48 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.262 -0.426 . . . . 72.040000000000006 112.118 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 148.38 93.25 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.916 2.411 . . . . 63.049999999999997 112.735 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -69.47 -8.72 49.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.046 0.387 . . . . 64.299999999999997 112.046 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -71.07 -8.61 54.57 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.815 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.59 155.67 21.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.718 0.294 . . . . 64.439999999999998 110.739 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -83.89 120.6 26.27 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.057 0.456 . . . . 73.439999999999998 111.88 -174.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG12 ' SD ' ' A' ' 17' ' ' MET . 17.4 m -81.58 -15.71 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.001 -0.545 . . . . 70.409999999999997 112.018 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.5 pp -86.43 167.26 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.026 0.75 . . . . 70.549999999999997 113.026 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.52 119.56 5.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.625 -0.716 . . . . 52.329999999999998 112.123 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 32.3 t70 -148.99 145.65 27.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.147 0.499 . . . . 63.43 111.682 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.31 160.9 41.99 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.044 -0.525 . . . . 61.229999999999997 110.914 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -139.02 -177.39 4.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.408 0.623 . . . . 63.350000000000001 112.113 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 141.93 -156.76 26.11 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.467 -0.788 . . . . 73.510000000000005 111.447 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -152.0 127.8 10.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.46 0.63 . . . . 73.409999999999997 111.297 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.58 -134.93 13.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.159 -0.544 . . . . 64.450000000000003 112.466 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.24 118.09 2.57 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.709 2.273 . . . . 64.329999999999998 113.544 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.49 168.45 22.72 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.112 2.542 . . . . 72.510000000000005 112.15 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.77 151.05 86.91 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.38 2.053 . . . . 74.0 112.898 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.91 17.4 1.71 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.805 2.337 . . . . 71.120000000000005 113.208 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.26 123.46 16.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.849 0.357 . . . . 65.430000000000007 111.665 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 124.43 6.12 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.178 1.919 . . . . 61.43 112.386 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.25 -37.4 18.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.19 1.927 . . . . 73.319999999999993 112.376 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.14 168.87 16.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 64.319999999999993 110.869 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -82.11 -10.08 59.31 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.087 0.47 . . . . 75.420000000000002 110.837 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 72.5 m80 -105.85 154.07 39.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 111.132 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 43.5 Cg_endo -65.03 -26.03 58.54 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.644 2.896 . . . . 52.420000000000002 115.767 -169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.8 62.02 8.53 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-O 121.23 0.538 . . . . 75.129999999999995 110.653 -165.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.702 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -74.09 -17.8 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.176 2.584 . . . . 74.430000000000007 113.191 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' A' ' 29' ' ' LEU . 1.6 p -88.09 149.7 45.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.439 -0.346 . . . . 73.049999999999997 111.244 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.58 146.45 3.51 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.296 2.664 . . . . 73.010000000000005 114.421 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.42 137.17 14.95 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.091 2.527 . . . . 63.32 113.344 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.46 17.89 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.095 -0.502 . . . . 64.099999999999994 112.749 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 91.3 m-85 -120.66 164.74 16.07 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 111.634 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.6 pt-20 -137.7 152.67 73.05 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.376 -0.375 . . . . 72.140000000000001 110.75 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.63 127.66 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.438 2.092 . . . . 43.210000000000001 112.699 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.21 138.35 33.95 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.061 0.458 . . . . 55.420000000000002 111.143 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -90.42 112.79 24.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.396 0.617 . . . . 73.010000000000005 111.252 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -104.57 101.55 11.2 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.673 -0.694 . . . . 64.519999999999996 112.227 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.14 102.69 15.23 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.352 -0.385 . . . . 74.040000000000006 110.904 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.1 p -126.44 112.61 15.81 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.063 0.459 . . . . 70.239999999999995 111.638 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.36 -19.66 63.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.261 -0.427 . . . . 54.539999999999999 111.656 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -103.41 144.22 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.917 0.389 . . . . 73.030000000000001 111.76 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 111.226 -178.529 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.775 0.322 . . . . 61.119999999999997 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.25 161.75 30.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.12 0.486 . . . . 55.219999999999999 112.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.19 123.07 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.261 -0.427 . . . . 64.439999999999998 111.0 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -160.92 165.56 29.83 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.631 0.253 . . . . 63.020000000000003 110.836 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.675 ' HB2' HD22 ' A' ' 7' ' ' LEU . 30.7 mt-10 -70.97 169.1 15.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.083 0.468 . . . . 64.329999999999998 111.027 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 67' ' ' ASP . 26.5 p -81.56 25.67 0.51 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.281 0.475 . . . . 70.120000000000005 112.281 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.675 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -82.77 -0.37 47.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.499 . . . . 71.049999999999997 110.829 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -60.64 156.48 16.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.336 0.589 . . . . 55.229999999999997 112.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 138.62 74.74 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.003 -0.544 . . . . 75.329999999999998 110.567 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG3' HG11 ' A' ' 70' ' ' VAL . 50.2 Cg_exo -57.04 77.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.509 2.139 . . . . 75.219999999999999 112.984 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.51 -0.37 37.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.118 -0.492 . . . . 63.509999999999998 111.592 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 172.81 8.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 73.010000000000005 110.596 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.8 m -97.27 135.01 39.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.927 0.394 . . . . 71.0 110.083 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -74.87 119.21 18.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.164 0.507 . . . . 62.520000000000003 111.773 -169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.86 84.61 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.191 -0.528 . . . . 74.430000000000007 112.734 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.61 164.29 16.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.156 0.583 . . . . 71.409999999999997 111.326 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 74.9 mtp -89.95 141.27 28.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.031 0.443 . . . . 72.109999999999999 111.946 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.95 110.79 21.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.963 0.411 . . . . 74.230000000000004 111.676 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 60.1 m -110.14 118.25 35.88 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.249 -0.432 . . . . 70.140000000000001 110.569 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG22 ' HA ' ' A' ' 26' ' ' TYR . 43.7 pt -131.5 161.32 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 111.718 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -110.81 172.9 6.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.311 -0.404 . . . . 51.340000000000003 110.579 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.88 -9.48 58.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.134 0.493 . . . . 73.030000000000001 111.145 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -80.07 -21.42 43.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.967 -0.56 . . . . 74.010000000000005 111.574 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.03 -4.97 22.23 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.261 -0.495 . . . . 71.120000000000005 113.679 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 126.49 38.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.93 0.365 . . . . 41.229999999999997 113.356 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' ILE . 74.0 t80 -109.81 121.55 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.085 0.402 . . . . 74.299999999999997 112.085 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.46 139.59 45.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.538 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.0 m -108.49 138.16 45.26 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.915 0.388 . . . . 73.430000000000007 111.246 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD12 ' SG ' ' A' ' 19' ' ' CYS . 75.0 mt -122.18 155.7 61.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.403 -0.362 . . . . 72.019999999999996 111.231 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.29 155.02 26.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.82 2.347 . . . . 73.200000000000003 113.174 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 31' ' ' ARG . 20.3 ttt85 -75.02 11.67 1.06 Allowed 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.561 0.578 . . . . 75.230000000000004 112.561 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -59.96 -21.4 61.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.255 0.835 . . . . 74.409999999999997 113.255 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.33 143.06 46.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.091 0.472 . . . . 64.439999999999998 112.093 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.99 154.4 22.23 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.261 -0.427 . . . . 72.129999999999995 111.408 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.466 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 15.5 m -90.85 85.52 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.516 0.674 . . . . 61.100000000000001 112.326 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -133.69 177.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 116.086 -0.506 . . . . 75.030000000000001 111.429 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.05 157.23 13.3 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.973 0.416 . . . . 71.219999999999999 112.002 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.78 116.49 2.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 111.924 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.8 mm? -73.37 -23.65 60.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.386 0.612 . . . . 74.230000000000004 110.763 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -87.74 144.81 26.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.846 -0.615 . . . . 74.409999999999997 111.368 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.98 133.27 1.45 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.789 -0.719 . . . . 50.240000000000002 113.805 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.96 161.36 13.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.88 0.372 . . . . 73.030000000000001 111.568 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.83 -142.9 47.13 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 116.123 -0.49 . . . . 62.100000000000001 113.596 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.66 168.94 5.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.099 2.533 . . . . 62.149999999999999 112.881 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.48 120.03 7.38 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.325 2.016 . . . . 72.120000000000005 112.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.36 162.54 33.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.528 2.152 . . . . 61.109999999999999 112.971 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.93 79.27 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 71.120000000000005 112.774 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -114.36 147.29 37.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 71.5 111.6 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.27 151.92 60.85 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.626 2.217 . . . . 72.129999999999995 113.162 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -16.46 55.36 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.629 2.219 . . . . 45.140000000000001 112.969 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.93 34.89 0.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.125 0.488 . . . . 74.310000000000002 111.378 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.47 156.68 10.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.479 0.657 . . . . 73.549999999999997 112.731 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.37 133.68 8.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.714 -0.675 . . . . 75.230000000000004 110.597 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 67.6 Cg_endo -73.19 -28.67 12.4 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.623 2.216 . . . . 75.310000000000002 113.128 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.37 62.65 10.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -65.27 -15.28 49.35 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.403 2.736 . . . . 63.530000000000001 112.666 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 m -85.19 138.55 36.65 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.438 -0.346 . . . . 72.239999999999995 110.508 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.22 141.68 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.323 2.682 . . . . 63.439999999999998 113.937 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.32 129.05 15.48 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.699 2.266 . . . . 71.209999999999994 112.816 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.83 -34.82 5.02 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 111.889 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.13 139.69 49.12 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.012 0.434 . . . . 74.5 110.709 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.61 156.72 79.33 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.829 0.347 . . . . 71.340000000000003 111.521 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.96 135.71 56.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 75.420000000000002 112.869 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.46 110.83 22.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.77 0.319 . . . . 60.329999999999998 111.5 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -82.75 107.35 15.31 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.814 -0.439 . . . . 70.450000000000003 109.814 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.17 150.88 38.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.739 0.304 . . . . 65.099999999999994 111.753 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 2.6 m-20 -70.04 89.14 0.6 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.029 0.442 . . . . 71.450000000000003 110.255 172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 p -78.55 77.55 5.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.235 0.541 . . . . 72.299999999999997 112.292 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.3 m -82.84 -9.72 59.19 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.904 0.383 . . . . 61.539999999999999 111.404 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 10' ' ' PRO . 5.3 p -104.4 104.11 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.518 0.675 . . . . 55.539999999999999 111.878 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 118.634 -0.698 . . . . 72.329999999999998 111.79 178.067 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.923 0.392 . . . . 70.109999999999999 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.39 -64.16 1.21 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.03 0.443 . . . . 72.310000000000002 111.167 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.7 146.73 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.37 -0.377 . . . . 71.430000000000007 111.332 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -88.78 112.73 23.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.009 0.433 . . . . 73.549999999999997 110.73 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.6 47.81 0.51 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 112.163 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 m 66.04 -3.32 0.79 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.641 0.978 . . . . 62.43 113.641 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt? -73.05 60.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.521 1.153 . . . . 64.530000000000001 108.633 166.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 t -57.6 117.44 4.19 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.725 -1.125 . . . . 63.130000000000003 113.89 -165.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.96 120.74 83.1 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.476 -0.783 . . . . 61.229999999999997 108.991 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.38 90.84 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.284 1.989 . . . . 73.540000000000006 113.55 -172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -67.65 -31.95 72.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.266 -0.424 . . . . 75.430000000000007 110.66 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.89 168.13 12.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.604 . . . . 64.230000000000004 111.503 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 63.6 m -100.16 136.46 40.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.024 -0.535 . . . . 53.43 111.077 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.42 121.35 15.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 111.296 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 77.11 4.34 83.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.901 -0.666 . . . . 72.120000000000005 113.273 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -133.64 161.61 34.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.71 0.404 . . . . 52.43 110.944 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.667 ' SD ' HG13 ' A' ' 35' ' ' VAL . 36.3 mtm -92.05 151.77 20.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 112.063 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HE2' HD13 ' A' ' 20' ' ' ILE . 72.2 tttt -105.71 113.16 26.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.678 -0.692 . . . . 74.439999999999998 111.091 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.43 111.16 23.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.555 -0.293 . . . . 73.439999999999998 110.892 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -131.66 162.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.491 0.186 . . . . 74.310000000000002 110.772 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 30.2 p30 -118.91 166.53 12.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 73.109999999999999 110.938 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -56.81 -28.01 60.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 111.809 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -63.67 -33.34 75.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.323 -0.399 . . . . 63.210000000000001 111.952 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 10.78 10.86 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.154 -0.545 . . . . 30.140000000000001 113.94 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.73 143.13 32.03 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.108 -0.568 . . . . 75.329999999999998 112.006 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.6 t80 -128.85 132.04 47.74 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.945 0.72 . . . . 72.25 112.945 -174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -141.3 155.63 45.95 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.976 -0.556 . . . . 64.549999999999997 111.213 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 m -122.18 128.5 51.29 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.815 0.34 . . . . 73.400000000000006 111.138 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -113.37 147.78 38.17 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.626 -0.261 . . . . 73.530000000000001 111.346 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.77 156.97 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.579 2.186 . . . . 71.209999999999994 112.972 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 63.8 ttt180 -80.03 10.87 3.81 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.021 0.378 . . . . 71.430000000000007 112.021 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.3 p -62.77 -35.34 79.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.27 0.557 . . . . 71.140000000000001 110.619 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.62 113.14 25.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 61.020000000000003 110.328 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.95 153.75 20.37 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.496 0.554 . . . . 63.5 112.496 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.667 HG13 ' SD ' ' A' ' 17' ' ' MET . 26.6 m -83.39 32.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.187 -0.461 . . . . 72.329999999999998 112.149 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 pp -69.46 174.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.493 0.553 . . . . 72.120000000000005 112.493 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.86 86.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.601 . . . . 72.129999999999995 112.236 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.77 134.69 12.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.233 -0.439 . . . . 55.409999999999997 110.709 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -150.72 148.18 28.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.638 0.256 . . . . 74.420000000000002 110.641 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -138.33 -70.05 0.43 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.876 0.37 . . . . 75.230000000000004 111.87 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.31 -95.93 0.32 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.82 -0.705 . . . . 64.319999999999993 112.382 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -171.14 119.81 0.5 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.971 0.415 . . . . 71.329999999999998 111.72 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.53 -110.7 1.96 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 114.692 0.637 . . . . 72.329999999999998 114.692 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.38 129.89 2.33 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.12 2.546 . . . . 64.530000000000001 113.848 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 73.5 Cg_endo -77.47 154.13 31.27 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.393 2.062 . . . . 63.32 112.394 175.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 25.6 Cg_exo -63.03 152.31 80.14 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.573 2.182 . . . . 51.219999999999999 112.831 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.07 -37.55 93.9 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.538 2.159 . . . . 61.229999999999997 112.216 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.11 99.6 43.79 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.042 -0.526 . . . . 72.420000000000002 110.206 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -98.57 98.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.201 2.601 . . . . 75.510000000000005 113.498 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.47 -3.88 12.73 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.389 2.059 . . . . 72.310000000000002 112.667 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.26 104.85 14.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.037 -0.529 . . . . 73.120000000000005 112.197 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -104.27 2.59 31.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.126 0.489 . . . . 74.209999999999994 110.662 170.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.428 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 69.8 m80 -94.54 147.67 33.63 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.911 -0.586 . . . . 75.200000000000003 110.476 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.3 Cg_endo -59.66 -25.78 80.09 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 123.081 2.521 . . . . 73.400000000000006 112.646 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.29 63.6 7.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 121.33 0.586 . . . . 75.120000000000005 112.099 -172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 27.8 Cg_endo -61.23 -16.86 49.2 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.046 2.497 . . . . 63.439999999999998 111.795 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.9 116.75 66.94 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 153.03 30.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.799 2.332 . . . . 65.319999999999993 113.604 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -39.5 139.23 0.74 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.448 2.765 . . . . 72.430000000000007 113.466 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.9 -21.21 34.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.341 -0.457 . . . . 52.229999999999997 111.977 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.0 m-85 -133.68 159.15 41.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.829 0.452 . . . . 74.510000000000005 110.776 175.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 11.0 pt-20 -136.06 154.49 77.54 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 120.801 0.334 . . . . 64.109999999999999 111.234 -176.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.08 125.01 12.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.542 2.162 . . . . 71.150000000000006 113.051 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.6 t70 -100.99 127.96 47.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.497 -0.319 . . . . 64.230000000000004 110.552 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -109.49 105.8 15.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.856 0.36 . . . . 75.519999999999996 110.858 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -119.24 119.41 34.0 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.732 0.301 . . . . 74.099999999999994 110.901 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.92 -56.13 2.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.373 0.509 . . . . 63.310000000000002 112.373 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.0 m -112.29 -66.26 1.1 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.562 0.579 . . . . 73.230000000000004 112.562 -173.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.6 m -124.79 151.45 45.14 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.694 0.283 . . . . 62.119999999999997 111.265 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.54 145.86 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.055 0.455 . . . . 65.540000000000006 111.376 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.256 1.423 0 CA-C-O 118.856 -0.592 . . . . 62.229999999999997 111.317 -175.159 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.141 0.496 . . . . 52.020000000000003 111.469 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.86 -175.52 4.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.156 0.503 . . . . 71.120000000000005 111.875 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.83 113.97 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.491 0.662 . . . . 62.310000000000002 112.137 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -100.7 116.67 33.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.454 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 164.77 25.1 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.045 -0.525 . . . . 63.020000000000003 111.994 -174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.9 t -80.98 38.87 0.48 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.344 0.592 . . . . 44.009999999999998 111.638 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 7' ' ' LEU . 1.5 pp -87.76 23.7 1.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.23 0.538 . . . . 71.150000000000006 111.936 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -73.52 130.67 40.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.961 0.726 . . . . 51.43 112.961 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 11' ' ' GLU . 48.6 mm -74.66 146.08 82.81 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.549 -0.75 . . . . 73.209999999999994 109.133 169.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 9' ' ' ILE . 85.2 Cg_exo -50.4 72.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 123.054 2.503 . . . . 65.219999999999999 114.609 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' ILE . 43.7 mt-10 -95.25 6.4 49.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.06 0.544 . . . . 75.230000000000004 110.929 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -135.82 167.49 21.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 111.149 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 79.5 m -101.01 135.34 42.61 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.786 0.291 . . . . 51.020000000000003 111.786 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.78 128.17 33.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.056 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.49 89.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.03 -0.605 . . . . 54.0 112.878 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 13' ' ' CYS . 42.5 mt-10 -131.88 160.95 34.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.982 0.513 . . . . 63.109999999999999 110.282 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.0 mtm -92.36 144.27 25.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.129 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD2' ' HB2' ' A' ' 12' ' ' ALA . 79.7 tttt -95.82 109.9 22.15 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.203 0.525 . . . . 63.219999999999999 111.36 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.23 115.81 30.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.530000000000001 110.701 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' A' ' 18' ' ' LYS . 36.3 pt -130.46 160.73 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.142 0.496 . . . . 65.209999999999994 112.153 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -112.24 174.17 6.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.273 -0.421 . . . . 55.340000000000003 110.235 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -74.05 -9.71 58.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.306 0.484 . . . . 70.120000000000005 112.306 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -83.66 -25.32 30.82 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.967 0.413 . . . . 74.200000000000003 111.366 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 2.52 20.09 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 121.399 -0.429 . . . . 34.329999999999998 113.628 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 131.91 47.16 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.375 -0.44 . . . . 52.520000000000003 112.759 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.02 125.72 51.79 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.385 0.513 . . . . 54.350000000000001 112.385 -172.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.3 mt -134.25 151.67 51.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.782 0.433 . . . . 55.399999999999999 110.992 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.2 m -125.9 120.25 29.93 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.475 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.1 mt -111.9 159.91 31.77 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.299 -0.409 . . . . 65.140000000000001 111.321 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.79 142.5 83.33 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.474 2.116 . . . . 72.319999999999993 113.547 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -80.25 10.69 4.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.334 0.587 . . . . 75.200000000000003 111.441 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -16.74 63.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.076 -0.511 . . . . 63.109999999999999 112.004 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.19 154.55 20.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.917 0.389 . . . . 55.420000000000002 111.594 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 54' ' ' PRO . . . -93.62 126.13 38.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.753 0.311 . . . . 72.120000000000005 111.399 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -85.46 9.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.837 0.68 . . . . 73.409999999999997 112.837 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.4 pp -83.55 -172.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.63 0.604 . . . . 64.439999999999998 112.63 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -47.14 133.17 11.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.071 0.767 . . . . 60.310000000000002 113.071 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 25.2 t0 -66.67 144.79 56.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.125 0.488 . . . . 75.109999999999999 111.519 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 39' ' ' LEU . 3.1 mm? -78.46 170.71 16.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.299 0.481 . . . . 74.439999999999998 112.299 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.0 m170 66.02 18.05 10.94 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.875 0.694 . . . . 74.340000000000003 112.875 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.0 83.7 0.71 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.993 -0.622 . . . . 74.319999999999993 111.77 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.33 -175.81 2.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.182 0.808 . . . . 73.409999999999997 113.182 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.05 -175.97 48.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.822 -0.627 . . . . 65.219999999999999 112.974 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.81 158.25 57.52 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.335 2.023 . . . . 71.109999999999999 112.103 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.04 114.9 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.913 2.409 . . . . 61.130000000000003 113.116 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.09 123.33 12.96 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.762 2.308 . . . . 74.120000000000005 112.829 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.66 -42.47 53.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.672 2.248 . . . . 74.299999999999997 112.83 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 50' ' ' PRO . 17.7 t -122.29 97.69 44.96 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-O 120.775 0.321 . . . . 75.329999999999998 111.205 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -112.8 63.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.282 3.322 . . . . 44.549999999999997 113.799 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 48' ' ' VAL . 95.6 Cg_endo -84.37 -49.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.07 1.847 . . . . 61.329999999999998 115.07 -171.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.53 -0.54 37.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.506 0.928 . . . . 74.129999999999995 113.506 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -60.02 111.19 1.4 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.998 0.74 . . . . 65.129999999999995 112.998 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -117.99 154.38 51.43 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 110.721 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 39.0 Cg_endo -64.77 -26.89 59.99 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.075 2.517 . . . . 74.439999999999998 113.97 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.84 61.49 10.23 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 121.167 0.508 . . . . 71.349999999999994 111.853 -171.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 74.3 Cg_endo -73.41 -15.36 25.03 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.102 2.535 . . . . 64.310000000000002 112.138 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.27 157.96 55.69 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 115.678 -0.692 . . . . 61.310000000000002 110.687 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.49 138.77 5.03 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.901 2.401 . . . . 64.209999999999994 113.293 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.1 128.71 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.19 1.926 . . . . 71.109999999999999 112.326 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.35 -1.94 46.67 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.135 -0.555 . . . . 32.25 112.356 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.93 148.83 43.54 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.02 0.438 . . . . 70.519999999999996 111.195 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.3 155.36 61.94 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.399 -0.364 . . . . 71.349999999999994 111.357 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.0 130.47 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.454 2.103 . . . . 71.319999999999993 112.558 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 110.1 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.506 -0.316 . . . . 74.420000000000002 111.274 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.93 104.91 13.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.975 -0.379 . . . . 72.519999999999996 109.975 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.17 141.36 48.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.086 0.47 . . . . 73.430000000000007 111.757 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -92.97 97.23 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.114 0.483 . . . . 65.129999999999995 111.614 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -82.23 134.42 35.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.867 0.365 . . . . 73.209999999999994 111.145 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 p -93.81 -21.19 19.44 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.981 0.363 . . . . 71.430000000000007 111.981 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.14 171.55 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 111.985 0.365 . . . . 71.329999999999998 111.985 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 119.123 -0.465 . . . . 74.409999999999997 111.444 176.668 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.743 0.306 . . . . 74.140000000000001 111.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.87 -28.76 19.03 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.777 0.288 . . . . 70.329999999999998 111.777 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 3' ' ' VAL . 6.8 p -64.9 85.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 121.825 0.821 . . . . 55.310000000000002 112.243 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.54 108.64 14.31 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.784 -0.644 . . . . 64.019999999999996 110.048 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HB2' HD22 ' A' ' 7' ' ' LEU . 37.3 mt-10 -77.49 -172.32 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.243 0.544 . . . . 72.310000000000002 111.713 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.0 t -77.84 24.81 0.22 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.761 0.652 . . . . 72.019999999999996 112.761 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -113.59 9.78 17.96 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 122.082 -0.386 . . . . 73.420000000000002 111.96 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -69.17 169.17 12.54 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.651 0.611 . . . . 65.420000000000002 112.651 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -83.76 131.1 53.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.999 -0.546 . . . . 55.439999999999998 110.479 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.18 90.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.784 2.323 . . . . 73.140000000000001 113.498 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB2' HE22 ' A' ' 66' ' ' GLN . 40.5 mt-10 -81.12 -11.27 59.51 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.104 -0.498 . . . . 72.120000000000005 110.723 174.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.45 172.59 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.355 0.598 . . . . 70.239999999999995 112.041 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -99.34 136.64 38.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 41.340000000000003 110.737 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.0 123.79 19.92 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 112.002 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 75.26 3.28 69.71 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.177 -0.465 . . . . 61.240000000000002 112.933 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 49.6 mt-10 -136.14 162.18 33.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.96 0.41 . . . . 72.040000000000006 111.118 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.9 mtm -91.6 150.46 21.16 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.661 0.615 . . . . 73.0 112.661 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -102.17 120.4 40.4 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.737 -0.665 . . . . 70.530000000000001 111.425 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HG ' ' A' ' 29' ' ' LEU . 61.2 m -112.09 117.09 31.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.319 -0.401 . . . . 45.219999999999999 111.398 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' A' ' 64' ' ' ASP . 38.6 pt -130.56 161.89 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 110.428 -0.212 . . . . 75.510000000000005 110.428 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.6 p30 -125.36 169.78 11.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.153 0.501 . . . . 54.140000000000001 112.077 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -61.87 -13.62 26.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 112.004 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -77.56 -24.52 49.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.743 0.306 . . . . 75.129999999999995 111.673 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 11.0 28.63 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.574 -0.346 . . . . 52.200000000000003 113.805 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.77 43.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.254 -0.498 . . . . 34.520000000000003 113.594 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -130.64 126.92 37.83 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.188 0.44 . . . . 71.200000000000003 112.188 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.4 158.34 44.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.901 0.48 . . . . 73.019999999999996 110.751 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.37 139.52 53.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.808 0.337 . . . . 55.030000000000001 111.086 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' ' 57' ' ' CYS . 76.9 mt -114.37 140.84 25.62 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 116.6 -0.273 . . . . 73.140000000000001 111.718 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.8 147.23 95.82 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.539 2.16 . . . . 61.049999999999997 112.194 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.8 ttt180 -67.69 -1.88 5.99 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.076 0.465 . . . . 74.420000000000002 111.783 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.7 m -56.73 -25.58 55.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 110.924 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.21 126.02 35.32 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 109.93 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.86 21.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.634 0.605 . . . . 62.439999999999998 112.634 -173.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.3 6.99 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.874 -0.603 . . . . 75.540000000000006 111.958 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 36' ' ' ILE . 2.4 pp -58.37 148.01 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 112.38 0.511 . . . . 74.510000000000005 112.38 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.14 36.65 1.04 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.21 0.528 . . . . 64.530000000000001 111.203 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB2' HD13 ' A' ' 36' ' ' ILE . 28.8 m-20 -87.32 93.03 9.28 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.709 0.766 . . . . 74.349999999999994 111.604 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.618 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -105.71 161.03 14.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.316 -0.857 . . . . 61.450000000000003 110.611 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -106.97 112.27 25.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.174 0.512 . . . . 73.530000000000001 112.107 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.04 148.58 17.3 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.972 -0.558 . . . . 73.25 111.71 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -73.66 85.58 1.62 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.187 -0.596 . . . . 52.240000000000002 111.491 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.36 -111.26 3.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.637 -0.71 . . . . 64.409999999999997 114.275 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 53.4 Cg_exo -54.04 139.69 70.65 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.065 2.51 . . . . 74.109999999999999 113.47 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' PRO . 50.5 Cg_exo -54.83 134.07 61.03 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.745 2.297 . . . . 73.140000000000001 112.914 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.0 149.84 59.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.282 1.988 . . . . 72.340000000000003 112.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.19 -48.72 18.7 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.567 2.178 . . . . 73.099999999999994 112.907 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.632 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 47.0 t -114.86 130.12 24.44 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 71.120000000000005 110.683 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.14 100.93 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.801 2.334 . . . . 72.340000000000003 113.204 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 48' ' ' VAL . 56.6 Cg_endo -93.33 -27.68 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.798 2.332 . . . . 63.32 113.486 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.74 77.51 6.37 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.134 0.493 . . . . 51.25 111.646 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.16 6.35 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.849 -0.614 . . . . 64.219999999999999 111.267 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -144.5 153.15 54.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 110.241 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 25.3 Cg_endo -61.64 -27.55 81.55 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.59 2.194 . . . . 73.450000000000003 112.648 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.88 61.67 12.0 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.816 -0.629 . . . . 64.010000000000005 111.682 -173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 58.3 Cg_endo -68.66 -15.63 41.34 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.425 2.75 . . . . 61.229999999999997 112.601 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.663 ' HA ' HD11 ' A' ' 29' ' ' LEU . 7.2 m -85.43 135.28 38.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 110.4 -175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.76 128.76 22.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.698 2.265 . . . . 75.019999999999996 112.94 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -41.04 129.09 2.95 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.916 2.411 . . . . 65.120000000000005 112.841 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.63 -26.48 9.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.422 -1.071 . . . . 72.049999999999997 110.422 -167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 75.3 m-85 -130.85 142.8 50.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 75.230000000000004 110.217 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.2 pt-20 -125.49 153.95 72.54 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.696 0.258 . . . . 72.239999999999995 111.696 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 130.93 19.9 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.458 2.105 . . . . 43.149999999999999 113.065 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 20' ' ' ILE . 34.7 t70 -103.85 137.61 41.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.341 -0.39 . . . . 71.340000000000003 111.632 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -108.09 106.48 16.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.017 0.437 . . . . 43.219999999999999 110.929 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.494 HE22 ' HB2' ' A' ' 11' ' ' GLU . 4.0 pt20 -119.14 153.58 34.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.345 -0.389 . . . . 74.340000000000003 111.022 171.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 64.61 38.88 6.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.9 0.381 . . . . 63.100000000000001 111.721 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.0 t -72.07 70.98 0.81 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.373 0.606 . . . . 73.510000000000005 111.642 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 m -103.45 26.24 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.049 -0.523 . . . . 74.510000000000005 110.506 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.2 93.18 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.602 0.715 . . . . 72.310000000000002 112.004 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.11 -0.948 . . . . 74.329999999999998 110.618 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.893 0.378 . . . . 71.109999999999999 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.07 -168.51 2.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.431 -0.35 . . . . 73.549999999999997 110.541 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.53 116.98 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.403 0.621 . . . . 71.439999999999998 111.908 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 68' ' ' SER . 62.8 t30 -147.46 175.61 10.69 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.07 -0.513 . . . . 72.109999999999999 110.668 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.85 158.09 16.99 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.906 -0.496 . . . . 70.299999999999997 111.24 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 69' ' ' CYS . 9.0 t -82.27 63.54 6.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.629 0.728 . . . . 53.049999999999997 111.171 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 23.89 5.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.59 -0.732 . . . . 61.130000000000003 110.488 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -79.96 -179.94 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.59 -0.732 . . . . 73.430000000000007 112.215 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.95 130.38 81.1 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.003 -0.544 . . . . 73.129999999999995 110.99 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.36 85.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.334 2.023 . . . . 71.340000000000003 112.77 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.38 -36.45 17.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 111.985 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.44 169.62 9.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.031 0.752 . . . . 71.25 113.031 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.62 136.57 39.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.681 -0.69 . . . . 72.120000000000005 110.971 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -77.01 120.38 22.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.052 0.453 . . . . 74.340000000000003 111.988 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 -1.24 89.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.2 -0.524 . . . . 65.010000000000005 113.063 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.0 161.86 23.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.873 0.469 . . . . 74.510000000000005 110.334 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.4 mtm -90.51 133.9 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.726 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 80.4 tttt -91.39 106.23 18.35 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 74.519999999999996 110.892 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.4 m -105.69 119.07 38.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.315 -0.402 . . . . 64.549999999999997 110.654 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.59 158.54 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 111.645 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -108.53 -175.21 2.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.015 0.436 . . . . 52.130000000000003 111.04 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -82.03 -8.45 59.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.096 -0.378 . . . . 73.120000000000005 111.985 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -84.78 -24.71 28.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 111.61 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.06 0.2 22.59 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.335 -0.46 . . . . 44.240000000000002 113.268 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.82 129.08 46.19 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.725 -0.274 . . . . 64.519999999999996 113.244 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 90.8 t80 -110.2 130.57 55.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.43 0.53 . . . . 74.329999999999998 112.43 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.57 145.3 44.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.653 0.381 . . . . 71.329999999999998 111.314 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 60.5 m -117.49 104.09 10.74 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.027 0.441 . . . . 71.150000000000006 111.227 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.5 148.9 35.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.398 -0.364 . . . . 60.219999999999999 111.249 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.49 154.44 41.86 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.518 2.145 . . . . 63.119999999999997 112.569 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 39.9 ttp180 -78.81 12.97 1.86 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.01 0.433 . . . . 73.200000000000003 111.808 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -51.73 -27.77 12.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.115 0.413 . . . . 74.319999999999993 112.115 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.79 142.56 28.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.979 0.418 . . . . 75.209999999999994 111.44 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.02 116.93 33.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.938 0.399 . . . . 45.210000000000001 111.208 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 19.5 m -78.23 62.02 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 112.418 0.525 . . . . 73.120000000000005 112.418 -176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.83 8.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.634 0.975 . . . . 71.319999999999993 113.634 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -122.71 151.55 41.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.283 0.845 . . . . 74.400000000000006 113.283 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.93 120.02 38.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.659 -0.701 . . . . 75.109999999999999 110.569 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.54 139.88 42.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.435 0.636 . . . . 73.409999999999997 112.032 176.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.38 -171.77 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.553 . . . . 72.120000000000005 110.758 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.35 -122.7 0.37 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.566 0.586 . . . . 42.350000000000001 114.566 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -103.63 165.13 11.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.353 0.501 . . . . 74.209999999999994 112.353 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.81 -155.09 53.2 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.094 -0.503 . . . . 45.109999999999999 113.87 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.45 154.36 71.98 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.86 2.373 . . . . 73.019999999999996 112.696 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.22 124.14 15.47 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.559 2.173 . . . . 55.530000000000001 112.655 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.54 155.92 39.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.554 2.169 . . . . 71.209999999999994 112.842 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.17 67.05 1.41 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.966 2.444 . . . . 64.030000000000001 113.421 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.06 134.39 21.44 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.091 -0.504 . . . . 74.230000000000004 110.154 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.89 142.56 99.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.636 2.224 . . . . 62.420000000000002 113.15 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.78 -27.78 54.2 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.067 2.511 . . . . 73.140000000000001 113.311 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.17 70.58 1.12 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.344 0.592 . . . . 65.5 110.333 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 16.1 tt0 -118.72 160.74 21.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.719 -0.673 . . . . 74.099999999999994 111.627 -171.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 80.2 m80 -107.12 144.77 29.81 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 110.004 171.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 12.5 Cg_endo -55.77 -29.37 71.44 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.713 2.275 . . . . 65.340000000000003 112.974 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 4.7 m-20 51.22 61.93 12.16 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 121.231 0.539 . . . . 52.43 112.136 -174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 55' ' ' ASN . 32.3 Cg_exo -58.6 -16.04 28.35 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.575 2.85 . . . . 63.119999999999997 113.885 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.9 m -84.56 148.59 52.41 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-O 120.623 0.249 . . . . 72.409999999999997 111.092 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.43 149.98 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.086 2.524 . . . . 63.420000000000002 113.62 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -49.25 129.73 22.98 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.163 2.575 . . . . 71.409999999999997 112.979 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.3 30.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 116.123 -0.489 . . . . 62.549999999999997 112.385 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -113.85 134.84 54.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.192 0.52 . . . . 73.109999999999999 111.352 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.09 145.34 34.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.324 -0.398 . . . . 72.120000000000005 111.596 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 132.56 22.29 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.227 1.951 . . . . 73.439999999999998 111.773 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.21 122.49 29.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.929 0.395 . . . . 71.140000000000001 111.93 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -84.77 111.13 19.33 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.37 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -110.56 99.44 8.42 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.616 0.722 . . . . 65.109999999999999 110.699 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.21 -50.2 7.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.69 -0.686 . . . . 70.219999999999999 112.54 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 70.9 m -73.41 74.0 1.38 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.302 0.482 . . . . 75.109999999999999 112.302 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 1.6 m -176.32 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.032 -0.531 . . . . 64.439999999999998 111.498 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.87 150.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.286 -0.416 . . . . 62.509999999999998 111.573 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.098 -0.477 . . . . 71.430000000000007 110.805 178.257 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 111.666 0.247 . . . . 65.540000000000006 111.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.77 -32.77 72.75 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.085 -0.385 . . . . 44.140000000000001 110.905 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.91 115.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.203 0.525 . . . . 55.350000000000001 111.407 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' OD1' ' HB ' ' A' ' 8' ' ' THR . 28.5 t-20 -146.51 124.82 12.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.33 -0.396 . . . . 75.549999999999997 111.028 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HB2' HD22 ' A' ' 7' ' ' LEU . 34.5 mt-10 -103.08 -176.82 3.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.391 -0.368 . . . . 75.120000000000005 111.546 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 69' ' ' CYS . 44.6 t -59.82 -11.88 6.26 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.439 0.903 . . . . 71.239999999999995 113.439 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 5' ' ' GLU . 1.9 pt? -76.23 18.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.912 -0.492 . . . . 73.530000000000001 112.018 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.411 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 14.5 t -84.24 175.24 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.022 0.749 . . . . 64.200000000000003 113.022 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.94 135.53 28.6 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.736 -0.665 . . . . 72.430000000000007 110.735 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.71 80.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.321 2.014 . . . . 60.119999999999997 113.28 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.42 7.31 45.01 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.094 0.473 . . . . 61.530000000000001 111.338 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.79 171.39 8.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.996 -0.547 . . . . 72.530000000000001 110.358 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.5 m -100.52 135.15 42.4 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.896 0.379 . . . . 72.430000000000007 111.345 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.56 118.99 20.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 111.582 -174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.47 84.78 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.153 -0.546 . . . . 74.099999999999994 112.673 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.67 161.0 31.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.806 0.442 . . . . 74.420000000000002 110.969 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' A' ' 31' ' ' ARG . 46.0 mtm -91.91 140.63 29.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 74.450000000000003 111.358 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.65 114.12 26.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.006 -0.543 . . . . 62.020000000000003 111.45 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 60.3 m -106.3 116.54 32.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.414 -0.357 . . . . 64.329999999999998 110.77 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.7 pt -132.39 155.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.996 0.427 . . . . 63.530000000000001 111.639 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -113.2 164.26 13.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.735 0.302 . . . . 75.150000000000006 110.866 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.56 -9.24 40.83 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.88 0.371 . . . . 64.340000000000003 111.613 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -75.85 -29.8 58.71 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.474 -0.33 . . . . 74.340000000000003 111.426 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.99 12.1 9.51 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.381 -0.438 . . . . 73.120000000000005 114.019 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.66 155.9 41.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.034 0.417 . . . . 72.150000000000006 113.332 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -130.52 125.04 33.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.404 0.52 . . . . 72.439999999999998 112.404 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 96.1 mt -135.79 158.24 44.89 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.672 0.389 . . . . 62.140000000000001 111.322 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.7 m -133.79 115.1 14.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.868 0.366 . . . . 65.409999999999997 111.506 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 70.7 mt -109.57 159.84 30.06 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.51 -0.314 . . . . 73.120000000000005 111.385 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.3 139.04 88.92 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 113.096 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 64.0 ttt180 -77.64 -0.52 26.9 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.448 0.642 . . . . 75.140000000000001 111.057 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 m -72.38 -7.37 49.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.745 -0.661 . . . . 75.219999999999999 112.273 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.65 155.58 23.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.971 0.415 . . . . 71.310000000000002 111.547 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.62 144.28 28.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.158 0.504 . . . . 60.43 112.226 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.76 11.86 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.211 0.819 . . . . 64.439999999999998 113.211 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.569 HG12 ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -68.89 -59.94 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 113.073 0.768 . . . . 74.340000000000003 113.073 -175.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' N ' HG12 ' A' ' 36' ' ' ILE . 7.2 t30 175.31 171.74 0.29 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.95 0.5 . . . . 73.510000000000005 109.653 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.01 151.81 46.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.816 0.341 . . . . 73.049999999999997 110.766 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.3 mm? -108.98 17.1 22.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.683 0.278 . . . . 53.310000000000002 111.436 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -94.53 -6.52 43.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.713 0.292 . . . . 74.299999999999997 111.781 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.4 150.55 51.93 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.145 -0.55 . . . . 54.450000000000003 113.834 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 30.6 tt0 -109.09 -178.47 3.58 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 110.041 -0.355 . . . . 53.130000000000003 110.041 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' H ' ' HG2' ' A' ' 42' ' ' GLU . . . -44.19 -61.57 3.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.592 -0.337 . . . . 62.0 113.616 176.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -99.39 88.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.348 2.699 . . . . 63.200000000000003 113.13 171.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 39.2 Cg_endo -99.33 162.79 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.363 2.708 . . . . 73.439999999999998 113.582 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.62 116.75 4.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.475 2.116 . . . . 74.129999999999995 112.253 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.48 20.34 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.725 2.283 . . . . 73.030000000000001 114.292 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 48' ' ' VAL . 15.4 m -131.74 99.81 16.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 121.485 0.66 . . . . 74.129999999999995 112.115 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -93.1 161.84 2.58 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.022 2.481 . . . . 70.409999999999997 112.774 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.48 -25.45 79.71 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.258 1.972 . . . . 52.310000000000002 111.665 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.3 9.97 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.202 -0.908 . . . . 74.129999999999995 109.562 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.58 64.68 1.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.391 0.615 . . . . 64.140000000000001 110.586 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -151.17 150.32 26.97 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.209 -0.451 . . . . 75.549999999999997 111.15 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 35.5 Cg_endo -64.94 -24.01 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.329 2.686 . . . . 71.310000000000002 112.99 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 m120 56.19 63.13 6.13 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.16 0.505 . . . . 64.439999999999998 111.785 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.758 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 34.4 Cg_endo -63.06 -16.9 57.33 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.705 2.27 . . . . 62.119999999999997 111.703 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.04 146.37 40.34 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.552 -0.749 . . . . 54.119999999999997 110.05 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -40.07 131.72 2.13 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.091 2.527 . . . . 63.509999999999998 113.648 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.44 129.06 3.48 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.389 2.726 . . . . 54.329999999999998 113.678 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.86 -27.21 12.35 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.32 -0.467 . . . . 22.100000000000001 112.203 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.61 132.56 44.86 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.78 0.324 . . . . 63.409999999999997 111.402 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.1 pt-20 -103.92 148.04 35.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 120.684 0.278 . . . . 74.420000000000002 110.512 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 15.8 Cg_exo -69.4 124.72 11.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.18 1.92 . . . . 74.129999999999995 111.951 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -82.77 114.97 21.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.932 0.396 . . . . 74.030000000000001 111.187 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.8 110.96 18.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.832 0.349 . . . . 74.420000000000002 110.259 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 3.7 pt20 -100.87 99.07 9.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.734 0.778 . . . . 65.239999999999995 111.354 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.31 -2.62 56.3 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.7 -0.682 . . . . 72.409999999999997 110.682 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -48.29 -56.52 7.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.42 -0.809 . . . . 60.329999999999998 112.52 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 12.8 t -136.01 103.5 5.38 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.105 -0.372 . . . . 71.099999999999994 111.739 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.2 175.5 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 111.289 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.802 -0.618 . . . . 73.040000000000006 111.719 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.695 0.283 . . . . 62.149999999999999 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.73 157.48 34.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 65.129999999999995 111.496 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.73 131.34 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.032 0.444 . . . . 72.299999999999997 111.803 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -123.78 138.91 54.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.421 -0.354 . . . . 75.329999999999998 111.5 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 7' ' ' LEU . 41.8 mt-10 -81.69 -170.89 3.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.321 0.582 . . . . 73.209999999999994 111.633 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.5 m -73.22 1.58 9.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.438 0.903 . . . . 50.140000000000001 113.438 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.3 pt? -83.89 8.56 14.58 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.135 0.493 . . . . 71.409999999999997 110.988 174.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -68.66 165.71 18.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.162 0.506 . . . . 61.350000000000001 112.058 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 47.8 mm -80.95 127.39 74.79 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.229 -0.441 . . . . 55.240000000000002 111.394 -177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 8.2 Cg_exo -73.15 66.74 4.25 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.893 2.395 . . . . 74.0 113.031 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -76.84 -3.44 38.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.837 0.31 . . . . 72.450000000000003 111.837 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . -89.83 170.07 10.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.797 0.332 . . . . 71.030000000000001 111.45 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.7 m -98.44 133.3 43.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.698 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.98 123.93 28.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.043 -0.526 . . . . 61.109999999999999 111.414 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.67 2.77 88.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.933 -0.651 . . . . 65.019999999999996 113.071 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -137.34 162.02 34.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.742 0.417 . . . . 74.319999999999993 110.363 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.5 mtm -90.2 139.8 30.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.281 0.562 . . . . 74.439999999999998 111.893 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HE2' HD13 ' A' ' 20' ' ' ILE . 80.1 tttt -91.64 108.61 20.03 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.451 -0.795 . . . . 73.150000000000006 111.161 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 58.3 m -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.068 -0.514 . . . . 71.420000000000002 110.569 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 36.5 pt -127.84 162.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.846 0.355 . . . . 74.120000000000005 111.863 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -118.87 168.9 10.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.611 0.243 . . . . 74.340000000000003 110.701 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -61.36 -14.19 25.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.312 0.486 . . . . 63.299999999999997 112.312 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -83.53 -29.55 27.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.825 0.345 . . . . 71.420000000000002 111.738 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.64 11.1 10.67 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.057 -0.592 . . . . 55.509999999999998 113.743 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ILE . . . -67.18 142.85 41.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.254 -0.498 . . . . 63.329999999999998 111.963 173.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 12' ' ' ALA . 89.3 t80 -130.6 125.64 34.64 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.43 0.53 . . . . 73.120000000000005 112.43 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 97.1 mt -132.33 146.42 51.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.856 -0.611 . . . . 63.039999999999999 111.225 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.416 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 90.7 m -118.32 102.53 9.02 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.888 0.375 . . . . 63.530000000000001 111.465 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -96.29 153.27 39.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.38 -0.373 . . . . 64.299999999999997 110.951 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.25 136.24 67.15 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.193 1.929 . . . . 62.200000000000003 112.607 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -75.67 9.77 2.11 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.168 0.508 . . . . 73.109999999999999 111.488 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 t -69.29 -9.82 55.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.927 0.394 . . . . 75.140000000000001 111.243 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.18 156.18 20.43 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.303 -0.408 . . . . 71.549999999999997 111.073 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.58 115.11 22.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 64.140000000000001 111.109 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.15 -10.18 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 112.009 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 2.3 pp -64.28 167.73 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 116.224 -0.444 . . . . 74.049999999999997 112.101 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.64 54.82 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.167 0.803 . . . . 50.119999999999997 113.167 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.27 102.67 10.09 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.034 0.445 . . . . 74.349999999999994 110.633 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.74 145.42 40.56 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.192 0.52 . . . . 61.149999999999999 111.228 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -81.78 64.14 6.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.317 0.58 . . . . 62.439999999999998 110.406 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.47 149.06 38.08 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.562 -0.745 . . . . 35.219999999999999 113.9 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -112.12 144.68 41.1 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.848 0.356 . . . . 63.43 111.265 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.06 -153.44 35.98 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.336 -0.459 . . . . 55.329999999999998 113.637 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.41 168.3 13.12 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.031 2.487 . . . . 64.540000000000006 112.791 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -85.69 108.78 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.348 2.032 . . . . 70.310000000000002 113.118 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 171.7 13.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.711 2.274 . . . . 72.329999999999998 112.048 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.62 76.85 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.873 1.715 . . . . 54.020000000000003 112.715 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.17 150.25 59.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.879 -0.6 . . . . 71.230000000000004 111.048 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 52.8 Cg_exo -53.64 130.19 37.66 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.709 2.273 . . . . 75.049999999999997 113.699 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.29 -4.28 13.39 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.229 1.953 . . . . 63.409999999999997 112.488 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.47 -4.26 58.66 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.136 0.421 . . . . 60.240000000000002 112.136 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 49' ' ' PRO . 15.8 mm100 -51.62 138.02 23.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.327 0.584 . . . . 74.5 112.119 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -90.03 160.31 40.77 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.887 -0.597 . . . . 70.439999999999998 111.309 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 12.5 Cg_endo -54.57 -25.92 43.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.36 2.707 . . . . 72.5 113.1 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.04 62.05 9.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.068 -0.514 . . . . 55.310000000000002 111.886 -171.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.46 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 46.2 Cg_endo -67.55 -17.5 48.5 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.524 2.15 . . . . 71.340000000000003 111.508 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.17 136.99 33.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.737 -0.665 . . . . 61.329999999999998 109.805 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.19 138.68 4.35 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.151 2.567 . . . . 70.010000000000005 114.134 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -44.76 133.33 10.42 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.348 2.698 . . . . 74.25 113.177 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.13 -37.18 3.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.623 -0.591 . . . . 23.550000000000001 111.623 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -98.45 159.53 14.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.14 0.495 . . . . 53.420000000000002 111.09 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 10.7 pt-20 -139.63 147.5 52.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.509 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 3.5 Cg_exo -75.17 126.42 9.85 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.884 2.389 . . . . 74.230000000000004 112.07 175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.57 119.76 36.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.898 0.38 . . . . 53.130000000000003 111.802 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.07 112.0 19.39 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.865 0.364 . . . . 64.150000000000006 111.11 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -110.25 116.37 31.36 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.154 0.502 . . . . 70.040000000000006 111.467 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.44 64.61 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.208 0.528 . . . . 73.019999999999996 111.066 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -69.93 103.18 2.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.421 0.526 . . . . 74.019999999999996 112.421 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.39 -39.32 82.96 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.926 0.394 . . . . 60.140000000000001 111.403 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.34 103.75 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.582 0.706 . . . . 71.340000000000003 111.142 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.774 -0.648 . . . . 73.010000000000005 111.548 -178.587 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.817 0.341 . . . . 63.240000000000002 111.219 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -81.24 48.15 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.907 0.384 . . . . 73.099999999999994 111.529 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.4 t 58.0 74.63 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.46 0.647 . . . . 63.240000000000002 110.951 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.45 138.25 0.69 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.635 -0.711 . . . . 74.200000000000003 110.682 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' HB2' HD22 ' A' ' 7' ' ' LEU . 55.7 mt-10 -95.06 -169.59 2.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.332 0.586 . . . . 64.099999999999994 111.669 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.7 m -81.83 5.79 17.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.909 0.707 . . . . 74.439999999999998 112.909 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.2 pt? -73.03 -4.41 32.23 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.924 0.392 . . . . 72.120000000000005 111.638 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -70.71 -176.63 1.35 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.135 0.493 . . . . 65.209999999999994 112.245 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 50.7 mm -96.1 136.43 22.1 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.415 -0.357 . . . . 71.310000000000002 111.135 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.91 78.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.323 2.015 . . . . 74.030000000000001 112.366 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 51.0 mt-10 -80.68 -12.63 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.23 -0.441 . . . . 60.119999999999997 112.1 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 163.78 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.224 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.2 m -100.33 136.2 40.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.024 -0.535 . . . . 62.5 110.067 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.4 133.2 39.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.921 0.391 . . . . 70.010000000000005 111.464 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.39 -3.56 58.53 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.129 -0.558 . . . . 64.019999999999996 112.973 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.79 161.36 29.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.035 0.534 . . . . 61.329999999999998 110.408 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 29.9 mtm -91.59 135.9 33.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 73.510000000000005 111.654 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE2' HD13 ' A' ' 20' ' ' ILE . 68.4 tttt -91.55 108.12 19.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.149 0.499 . . . . 62.509999999999998 110.546 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 29' ' ' LEU . 67.3 m -105.6 110.81 23.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 110.412 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.54 HG22 ' HA ' ' A' ' 26' ' ' TYR . 48.0 pt -131.69 162.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.075 0.465 . . . . 65.430000000000007 111.296 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -125.02 156.62 37.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 64.030000000000001 110.395 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.33 -8.57 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.21 0.448 . . . . 74.540000000000006 112.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -79.29 -20.03 49.02 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.924 0.342 . . . . 64.310000000000002 111.924 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.81 4.32 21.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.107 -0.568 . . . . 72.0 114.242 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.76 131.58 11.17 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.952 -0.642 . . . . 33.32 112.757 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.4 t80 -118.29 127.72 53.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.281 0.475 . . . . 73.239999999999995 112.281 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.56 148.48 44.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 111.655 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' MET . 66.1 m -119.74 115.95 24.95 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.911 -0.403 . . . . 72.420000000000002 109.911 168.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD12 ' SG ' ' A' ' 19' ' ' CYS . 67.6 mt -110.48 158.13 36.29 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 111.842 0.312 . . . . 54.140000000000001 111.842 -174.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.43 139.43 81.92 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.808 2.339 . . . . 74.230000000000004 113.072 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -83.83 12.21 6.4 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.883 -0.599 . . . . 61.210000000000001 111.837 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 m -53.82 -22.45 9.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.767 0.654 . . . . 52.109999999999999 112.767 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.94 137.9 31.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.018 0.437 . . . . 44.100000000000001 111.66 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.15 153.03 22.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.022 0.439 . . . . 64.430000000000007 112.015 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 31.6 m -78.34 46.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.443 0.535 . . . . 65.319999999999993 112.443 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.75 ' HB ' HD11 ' A' ' 39' ' ' LEU . 2.3 pp -102.55 155.56 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.176 0.435 . . . . 75.519999999999996 112.176 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -79.55 55.73 2.03 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.624 0.601 . . . . 74.230000000000004 112.624 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.37 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.149 0.796 . . . . 55.399999999999999 113.149 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -146.85 175.7 10.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.01 -0.541 . . . . 74.099999999999994 111.222 171.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -121.01 157.35 30.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.841 0.353 . . . . 64.209999999999994 111.378 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.03 -43.65 98.87 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.821 -0.704 . . . . 51.439999999999998 112.287 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.01 105.86 18.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.81 0.338 . . . . 72.310000000000002 110.991 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -179.39 18.54 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.039 -0.601 . . . . 64.219999999999999 113.534 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.2 167.11 3.6 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.135 2.557 . . . . 63.229999999999997 113.116 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.94 125.46 13.15 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.036 1.824 . . . . 74.340000000000003 111.846 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.58 118.33 2.91 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.859 2.372 . . . . 74.109999999999999 113.147 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.07 -52.43 4.8 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.072 2.515 . . . . 74.319999999999993 113.139 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.38 100.22 18.52 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.401 -0.363 . . . . 74.150000000000006 110.296 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.28 128.15 28.79 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.797 2.331 . . . . 71.329999999999998 113.297 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.96 -27.58 85.23 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.609 2.206 . . . . 52.439999999999998 113.147 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.37 154.53 35.81 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.681 0.277 . . . . 73.25 111.305 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.55 16.99 9.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 111.309 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -133.68 137.05 27.88 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.829 -0.623 . . . . 74.530000000000001 110.227 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 19.8 Cg_endo -58.73 -29.67 90.26 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.72 2.28 . . . . 73.030000000000001 113.121 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.9 m-20 48.1 63.09 10.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 121.658 0.742 . . . . 74.319999999999993 112.177 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.5 -16.27 38.54 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 71.120000000000005 112.267 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.3 m -86.65 144.77 37.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 110.322 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.98 151.12 84.8 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.506 2.137 . . . . 43.310000000000002 113.03 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.89 128.74 9.27 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.76 2.306 . . . . 72.140000000000001 112.84 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.83 -23.34 14.87 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 116.089 -0.505 . . . . 75.040000000000006 112.287 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -132.76 126.33 32.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.712 0.405 . . . . 74.150000000000006 110.899 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.5 pt-20 -101.22 159.76 28.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.478 -0.328 . . . . 60.140000000000001 111.158 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 6.5 Cg_exo -73.73 128.98 13.02 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.587 2.191 . . . . 63.420000000000002 112.555 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 20' ' ' ILE . 35.0 t70 -92.66 132.91 36.5 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.779 0.323 . . . . 53.439999999999998 111.252 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -82.49 110.86 17.97 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.828 0.347 . . . . 72.409999999999997 110.15 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -95.68 135.01 37.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.647 0.61 . . . . 74.5 112.647 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 67.2 109.41 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.495 -0.775 . . . . 71.200000000000003 112.056 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 6.55 38.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.021 0.438 . . . . 73.340000000000003 111.509 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.8 m -101.63 1.12 37.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.15 -0.344 . . . . 75.25 111.81 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.35 143.32 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 120.651 0.262 . . . . 71.519999999999996 110.848 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.607 -0.711 . . . . 64.109999999999999 112.082 -178.471 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.822 0.344 . . . . 64.049999999999997 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.56 158.01 15.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.849 0.357 . . . . 75.049999999999997 110.736 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.27 131.5 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.479 0.548 . . . . 61.509999999999998 112.479 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.82 132.17 45.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.366 -0.208 . . . . 65.140000000000001 110.6 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 33.4 mt-10 -69.8 177.68 2.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.031 0.443 . . . . 73.319999999999993 111.976 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 69' ' ' CYS . 84.1 m -75.48 -6.2 48.94 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.334 0.865 . . . . 63.32 113.334 -170.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 1.6 pt? -81.79 24.29 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.278 0.561 . . . . 73.040000000000006 111.342 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -83.22 176.89 8.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.052 -0.522 . . . . 75.439999999999998 111.996 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.81 127.64 81.51 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.437 -0.347 . . . . 64.120000000000005 111.71 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.42 87.62 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.316 2.011 . . . . 72.239999999999995 113.185 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.85 6.65 38.1 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.981 -0.554 . . . . 72.310000000000002 111.688 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.51 170.45 9.38 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.001 0.429 . . . . 71.540000000000006 111.747 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.37 142.24 31.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.148 0.499 . . . . 55.420000000000002 111.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -77.27 118.66 19.98 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.08 -0.509 . . . . 75.439999999999998 111.63 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.48 -36.8 2.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.325 -0.464 . . . . 63.219999999999999 113.169 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 162.33 16.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.767 0.427 . . . . 73.129999999999995 111.217 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.7 mtm -89.33 136.83 32.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 111.759 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HD13 ' A' ' 20' ' ' ILE . 81.7 tttt -91.55 105.56 17.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.794 -0.639 . . . . 74.299999999999997 111.572 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.49 110.7 22.98 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.909 -0.587 . . . . 74.239999999999995 110.583 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 18' ' ' LYS . 37.5 pt -126.59 157.9 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.131 0.491 . . . . 73.140000000000001 112.155 -177.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -118.75 163.66 16.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 109.92 171.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -68.71 -9.66 51.74 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 122.053 -0.405 . . . . 74.040000000000006 111.861 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -70.03 -29.53 66.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.829 0.347 . . . . 74.230000000000004 111.486 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 2.66 21.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.453 -0.403 . . . . 54.310000000000002 112.796 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.83 118.66 8.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.475 -0.393 . . . . 51.420000000000002 112.368 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HA ' HG22 ' A' ' 20' ' ' ILE . 67.9 t80 -109.92 109.54 20.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.226 0.536 . . . . 65.140000000000001 111.316 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.76 135.64 53.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.107 -0.497 . . . . 72.030000000000001 111.158 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.73 124.72 51.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.782 0.325 . . . . 73.430000000000007 111.199 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.71 149.95 36.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.743 -0.208 . . . . 71.030000000000001 111.243 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.23 155.09 25.83 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.806 2.337 . . . . 72.5 113.162 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -78.19 11.1 2.49 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.056 0.455 . . . . 72.319999999999993 112.103 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -63.42 -32.23 73.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.045 0.387 . . . . 72.140000000000001 112.045 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.2 154.25 19.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.023 0.44 . . . . 71.329999999999998 111.964 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.99 154.18 44.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.043 0.449 . . . . 45.200000000000003 111.657 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.2 92.67 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.434 0.635 . . . . 72.030000000000001 111.971 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.59 139.72 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.037 0.446 . . . . 65.400000000000006 111.91 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.5 11.98 1.42 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.089 0.403 . . . . 75.129999999999995 112.089 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' HIS . 7.3 m-20 -93.38 -14.15 27.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.648 0.24 . . . . 74.409999999999997 111.648 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER 29.15 -70.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.984 1.476 . . . . 64.019999999999996 114.984 -173.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.2 m-70 -63.44 -41.7 98.66 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.981 -0.449 . . . . 63.030000000000001 111.328 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.43 -64.07 3.58 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.316 -0.468 . . . . 61.210000000000001 113.756 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.64 124.77 22.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.73 0.3 . . . . 74.310000000000002 110.884 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.67 -154.0 32.07 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.214 -0.517 . . . . 75.150000000000006 112.499 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.806 2.337 . . . . 70.099999999999994 112.598 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.15 153.04 31.67 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.029 1.819 . . . . 44.140000000000001 112.127 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.85 154.84 53.07 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.276 1.984 . . . . 62.509999999999998 112.272 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 86.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.328 2.018 . . . . 71.120000000000005 112.471 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.01 154.03 81.19 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.948 -0.569 . . . . 72.319999999999993 111.197 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.17 151.95 39.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.318 2.012 . . . . 73.439999999999998 112.053 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.11 -16.41 33.15 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.535 2.157 . . . . 65.510000000000005 113.497 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 -12.2 60.02 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.458 0.54 . . . . 71.409999999999997 112.458 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -62.92 138.22 58.49 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.139 0.495 . . . . 75.109999999999999 111.521 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -106.8 139.2 20.14 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.359 -0.382 . . . . 74.349999999999994 111.463 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG2' ' HD3' ' A' ' 56' ' ' PRO . 37.7 Cg_endo -63.67 -25.36 69.0 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 123.688 2.925 . . . . 64.25 114.178 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.94 63.78 5.78 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.293 0.568 . . . . 73.049999999999997 111.678 -169.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 41.4 Cg_endo -64.74 -16.96 57.99 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.087 2.525 . . . . 71.200000000000003 112.342 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.7 145.21 38.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.77 -0.65 . . . . 51.450000000000003 110.349 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -42.53 137.08 4.02 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 123.21 2.607 . . . . 73.310000000000002 114.017 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -46.54 129.7 14.05 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.03 2.487 . . . . 62.409999999999997 113.151 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.3 -21.92 32.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.866 -0.494 . . . . 13.119999999999999 111.866 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -102.21 163.34 12.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.932 0.493 . . . . 72.129999999999995 110.374 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.24 141.08 25.07 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 120.735 0.302 . . . . 51.240000000000002 111.218 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 59.3 Cg_endo -72.69 128.07 13.02 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.204 1.936 . . . . 51.43 111.984 176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -83.25 132.41 35.04 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.882 0.372 . . . . 70.25 111.265 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.71 111.48 18.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 110.807 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.25 107.76 17.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 75.319999999999993 112.071 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.33 -164.43 1.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.412 -0.813 . . . . 73.310000000000002 109.359 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.9 p -173.84 155.16 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.939 0.876 . . . . 74.349999999999994 113.068 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 28.6 p -155.23 168.08 28.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.861 -1.063 . . . . 44.130000000000003 109.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.66 94.63 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.929 0.395 . . . . 52.030000000000001 112.063 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.618 -0.706 . . . . 73.239999999999995 111.256 173.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.527 0.203 . . . . 63.350000000000001 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.66 -62.3 1.42 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.132 0.492 . . . . 70.340000000000003 110.647 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.78 90.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.616 0.722 . . . . 73.099999999999994 111.617 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -114.55 130.2 56.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 65.129999999999995 110.822 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.38 175.81 3.77 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.326 0.584 . . . . 44.43 111.828 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.666 ' N ' ' SG ' ' A' ' 69' ' ' CYS . 79.6 m -68.25 9.7 0.3 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.507 0.558 . . . . 73.219999999999999 112.507 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 8' ' ' THR . 2.5 pp -70.91 -14.07 62.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.963 0.411 . . . . 75.349999999999994 111.788 175.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.403 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.7 t -73.76 174.81 7.89 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.117 0.485 . . . . 73.150000000000006 111.848 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 50.7 mm -90.63 130.65 40.38 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.366 -0.379 . . . . 33.43 111.369 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 17.9 Cg_exo -66.92 70.42 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.626 2.217 . . . . 75.420000000000002 112.745 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.88 6.0 23.22 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.048 -0.523 . . . . 65.120000000000005 112.162 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 154.08 20.02 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.128 -0.357 . . . . 71.310000000000002 111.496 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.0 m -98.98 137.08 38.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.861 0.362 . . . . 65.030000000000001 111.28 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.44 120.47 15.3 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.781 0.324 . . . . 74.439999999999998 111.639 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.72 3.55 67.85 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.935 -0.65 . . . . 62.530000000000001 113.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.26 151.69 50.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.488 0.315 . . . . 74.239999999999995 110.684 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 63.4 mtm -89.47 150.82 22.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.181 0.515 . . . . 74.040000000000006 111.534 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HE2' HD13 ' A' ' 20' ' ' ILE . 86.7 tttt -101.03 111.3 23.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.968 -0.56 . . . . 74.340000000000003 111.488 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.0 m -106.15 109.84 21.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.81 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 30.0 pt -126.88 162.29 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.331 -0.395 . . . . 71.519999999999996 111.156 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . 36.4 p30 -130.31 -179.27 5.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.474 0.654 . . . . 74.109999999999999 112.377 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -72.71 -9.66 58.89 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.661 -0.699 . . . . 74.510000000000005 111.949 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -90.3 -18.55 25.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.786 0.326 . . . . 74.120000000000005 111.472 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.52 1.17 32.8 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.226 -0.512 . . . . 64.0 113.455 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.38 138.55 40.95 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.364 -0.446 . . . . 55.039999999999999 113.008 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -126.8 117.43 22.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.978 0.418 . . . . 74.329999999999998 111.994 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 79.0 mt -127.36 147.87 50.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.23 -0.441 . . . . 64.120000000000005 111.28 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' MET . 62.1 m -121.74 114.65 21.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.113 0.483 . . . . 72.5 110.623 171.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 76.5 mt -106.18 162.59 19.23 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.834 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 29.7 Cg_endo -61.6 142.63 95.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.539 2.16 . . . . 63.039999999999999 113.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -76.57 -4.85 45.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.207 -0.451 . . . . 72.120000000000005 111.579 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.9 p -55.14 -28.34 52.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 75.430000000000007 111.282 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.3 128.16 41.92 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.668 -0.493 . . . . 62.109999999999999 109.668 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -107.34 151.52 25.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.304 0.574 . . . . 74.150000000000006 112.435 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 53' ' ' HIS . 27.4 m -89.72 27.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.056 -0.52 . . . . 61.100000000000001 112.021 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -70.25 173.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.434 0.531 . . . . 73.299999999999997 112.434 -178.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 90.34 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 111.773 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.5 112.1 5.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.053 0.454 . . . . 65.239999999999995 111.165 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -140.75 166.86 23.6 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.122 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -160.41 141.74 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.708 0.289 . . . . 74.400000000000006 111.592 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.66 -176.79 15.66 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.343 -0.456 . . . . 44.25 112.998 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.04 -41.08 91.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.104 0.478 . . . . 75.140000000000001 111.447 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.8 -69.75 0.03 OUTLIER Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.85 -0.613 . . . . 64.540000000000006 111.672 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 157.17 45.97 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.628 2.219 . . . . 73.319999999999993 111.717 170.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.33 117.87 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.447 2.098 . . . . 73.439999999999998 113.544 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.54 164.58 35.18 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.888 2.392 . . . . 75.219999999999999 112.407 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.75 106.74 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.551 2.167 . . . . 72.420000000000002 112.965 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.09 129.32 23.68 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.802 0.334 . . . . 75.349999999999994 111.811 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.8 162.02 10.56 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.845 2.364 . . . . 74.420000000000002 112.846 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.49 -42.85 64.3 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.486 2.124 . . . . 75.239999999999995 112.411 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.08 47.83 1.38 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.371 0.605 . . . . 64.540000000000006 110.849 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -66.43 140.85 58.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.308 0.575 . . . . 62.140000000000001 112.35 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 63.6 m80 -131.14 145.71 58.93 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.872 -0.604 . . . . 51.43 111.308 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 36' ' ' ILE . 19.0 Cg_endo -60.19 -25.27 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.235 2.623 . . . . 54.409999999999997 112.66 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 3.3 m-20 55.67 63.56 6.19 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.052 -0.522 . . . . 72.430000000000007 112.314 -172.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' A' ' 54' ' ' PRO . 28.0 Cg_endo -59.15 -16.01 31.38 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.768 2.979 . . . . 65.25 113.387 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.9 m -85.14 129.26 56.61 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 122.292 -0.255 . . . . 54.420000000000002 110.332 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.91 150.53 22.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.299 2.666 . . . . 61.25 113.798 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -44.2 129.02 8.02 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.843 2.362 . . . . 32.200000000000003 112.832 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.28 -15.91 27.44 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.91 -0.476 . . . . 30.350000000000001 111.91 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 21' ' ' ASN . 96.7 m-85 -135.72 158.3 44.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.865 0.466 . . . . 70.329999999999998 111.019 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 13.8 pt-20 -131.68 154.57 81.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.671 0.272 . . . . 72.099999999999994 110.933 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HG3' ' HA ' ' A' ' 55' ' ' ASN . 92.8 Cg_endo -77.65 132.31 11.98 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.585 2.19 . . . . 73.420000000000002 113.241 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -109.28 130.64 55.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -80.91 111.7 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.483 0.659 . . . . 74.209999999999994 110.958 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.621 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.3 pt20 -85.06 95.79 9.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.976 0.732 . . . . 72.129999999999995 112.976 -172.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 7.8 t70 165.94 -74.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.103 0.961 . . . . 54.329999999999998 109.644 171.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.5 m 58.75 -72.61 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.159 1.17 . . . . 74.319999999999993 114.159 171.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 42.0 t -50.63 -50.96 53.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.833 0.679 . . . . 75.019999999999996 112.833 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.68 -170.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.525 -0.307 . . . . 74.209999999999994 111.226 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.647 -0.692 . . . . 60.439999999999998 110.727 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.834 0.35 . . . . 72.219999999999999 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -151.97 -164.29 1.94 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.859 0.362 . . . . 75.329999999999998 111.97 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.43 -19.66 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 112.4 0.519 . . . . 60.149999999999999 112.4 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -164.89 146.15 7.76 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.133 -0.354 . . . . 72.25 111.401 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 7' ' ' LEU . 36.9 mt-10 -78.26 -169.66 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.552 0.692 . . . . 74.400000000000006 112.815 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.9 m -58.69 -27.16 64.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.898 0.703 . . . . 61.450000000000003 112.898 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 5' ' ' GLU . 2.1 pt? -61.53 -2.32 0.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.831 0.678 . . . . 72.439999999999998 112.831 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -72.7 179.03 3.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.394 0.616 . . . . 43.439999999999998 111.815 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.81 130.89 46.95 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 44.219999999999999 111.059 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.55 76.22 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.29 1.994 . . . . 63.310000000000002 112.123 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.95 2.89 24.86 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.558 0.577 . . . . 62.020000000000003 112.558 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.33 172.75 9.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.826 0.346 . . . . 43.219999999999999 111.333 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.8 m -96.72 134.83 39.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.148 0.499 . . . . 72.519999999999996 111.062 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -75.22 119.66 19.66 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 111.444 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 82.08 4.08 90.36 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.945 -0.645 . . . . 52.009999999999998 112.757 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.04 162.33 31.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.74 0.416 . . . . 64.319999999999993 111.034 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 33' ' ' ALA . 31.3 mtm -90.9 147.71 22.96 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.179 0.514 . . . . 73.319999999999993 111.642 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 79.9 tttt -105.04 111.64 24.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.8 -0.636 . . . . 72.049999999999997 111.511 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.5 m -108.34 124.54 50.5 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.426 -0.352 . . . . 72.329999999999998 110.865 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.09 148.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.966 0.413 . . . . 72.420000000000002 111.913 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -98.78 -174.78 2.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.996 0.427 . . . . 71.209999999999994 111.757 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -74.27 -9.42 58.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.987 0.366 . . . . 72.349999999999994 111.987 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -88.56 -33.13 17.82 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.213 0.53 . . . . 62.299999999999997 111.647 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.99 8.59 17.49 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.011 -0.54 . . . . 64.329999999999998 112.353 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.23 45.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.582 -0.342 . . . . 74.219999999999999 112.84 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.477 ' OH ' ' SG ' ' A' ' 28' ' ' CYS . 82.6 t80 -122.51 123.56 41.54 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.336 0.495 . . . . 62.030000000000001 112.336 -171.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -132.14 142.63 49.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.856 0.36 . . . . 75.25 111.385 174.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' OH ' ' A' ' 26' ' ' TYR . 99.6 m -110.22 124.0 50.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 111.504 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 57' ' ' CYS . 59.0 mt -110.37 156.69 39.9 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.39 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.58 161.19 15.22 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.778 2.318 . . . . 64.120000000000005 113.482 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 67.4 ttt180 -78.05 11.65 2.18 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 111.924 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.5 m -70.32 -16.66 63.03 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.258 0.836 . . . . 71.409999999999997 113.258 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 17' ' ' MET . . . -98.16 153.77 18.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.38 0.511 . . . . 45.43 112.38 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 142.78 47.37 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.942 0.401 . . . . 71.010000000000005 111.813 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.43 -4.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.289 0.848 . . . . 71.519999999999996 113.289 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.54 -2.72 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 113.368 0.877 . . . . 74.219999999999999 113.368 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 25.5 t-20 62.13 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.793 0.437 . . . . 70.319999999999993 111.288 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 41.62 58.14 2.83 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.261 0.624 . . . . 64.019999999999996 112.24 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.31 5.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.086 -0.506 . . . . 73.030000000000001 111.698 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -73.02 129.79 38.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.792 0.33 . . . . 63.450000000000003 110.96 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.34 19.28 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.072 -0.585 . . . . 41.5 113.595 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.68 21.77 1.77 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.31 0.576 . . . . 55.229999999999997 111.0 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.42 -133.16 4.76 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.8 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.75 114.84 3.73 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.171 1.914 . . . . 64.150000000000006 112.417 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.47 151.1 80.48 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.482 2.122 . . . . 72.109999999999999 113.154 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.98 157.28 4.01 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.017 2.478 . . . . 73.019999999999996 113.272 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.06 80.31 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.569 2.179 . . . . 72.540000000000006 113.503 -175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 27.0 m -114.95 137.86 23.1 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.363 -0.38 . . . . 75.150000000000006 111.456 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 48' ' ' VAL . 15.1 Cg_exo -70.5 143.56 47.62 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.706 2.271 . . . . 60.310000000000002 112.917 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.55 -8.94 23.73 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.579 2.186 . . . . 62.140000000000001 113.155 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.24 65.83 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.328 0.585 . . . . 52.039999999999999 111.497 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 53' ' ' HIS . 17.2 tt0 -147.36 158.21 43.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.802 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 76.9 m80 -89.48 159.96 43.03 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.642 -0.254 . . . . 73.530000000000001 110.999 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 28.9 Cg_endo -63.55 -28.81 70.21 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.521 2.148 . . . . 72.310000000000002 112.664 175.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.3 62.39 11.32 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 112.365 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 63' ' ' PRO . 97.1 Cg_endo -77.02 -14.08 17.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.247 2.632 . . . . 65.310000000000002 112.277 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.405 ' HA ' HD11 ' A' ' 29' ' ' LEU . 5.0 m -85.27 149.44 52.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.838 -0.619 . . . . 72.549999999999997 111.729 -169.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.54 139.79 17.23 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.138 2.558 . . . . 51.509999999999998 113.798 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.93 129.61 18.25 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.604 2.203 . . . . 63.140000000000001 112.891 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.04 -29.06 10.67 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.453 -0.659 . . . . 63.329999999999998 111.453 -172.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -105.25 153.85 21.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.085 0.554 . . . . 72.329999999999998 110.494 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.61 155.91 60.04 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 120.719 0.295 . . . . 65.010000000000005 111.207 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 27.1 Cg_exo -63.42 126.8 18.42 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.472 . . . . 33.039999999999999 113.261 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.71 135.56 33.8 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.764 0.316 . . . . 61.200000000000003 111.055 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.67 109.19 20.93 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.638 0.256 . . . . 74.340000000000003 110.96 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.81 122.87 44.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 72.420000000000002 110.745 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.09 98.06 7.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.126 0.488 . . . . 75.510000000000005 110.383 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.5 p -76.19 96.47 3.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.583 0.586 . . . . 74.519999999999996 112.583 -173.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -95.65 98.0 10.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.192 0.52 . . . . 73.540000000000006 110.59 172.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.67 156.6 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.533 0.568 . . . . 65.099999999999994 112.533 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 119.086 -0.483 . . . . 75.349999999999994 111.055 175.295 . . . . . . . . 0 0 . 1 stop_ save_